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In the field of bio-organic research, steroids have been one of the most 
attractive areas for exploration due to the biological activities associated v^ 'ith 
such molecules. Organic chemists have reported a number of modification in 
natural, steroids resulting in the promotion or loss of their biological activities. 
This still continues to be a fascinating field world wide. Previous work from our 
laboratories described the preparation and study of a number of unknovra 
steroidal derivatives in the cholestane series. These included azasteroids, 
oxasteroids, pyrazoles, pyrans etc. In continuation of the above work an attempt 
has been made to prepare new compounds with probable biological properties. 
In some cases, fbnormal products have been obtained and this has offered scope 
for som . lechanistic and stereochemical studies also. The results are 
summarized as below. 
Cftapt^-1 
oxido-lTiazQle 
Steroidal and non steroidal thiadiazoles, triazoles and oxide "^ia lole are 
of vast utility in the field of synthetic organic chemistry and are used as 
intermediate in organic synthesis as drugs and medicine. The function of any 
heterocyclic ring system to steroid or introduction of heteroatoms such as N, O, 
S or halogen found to enhance e^ir biological and industrial a^ ^ppcation. A 
survey of the literature has revealed tJiat little attention has been p?id ^'^'^- .ids tlie 
synthesis of steroidal thiadiazoles, triazoles and oxidotriazoles a: '':eir wide 
spread application in pharmaceutical, agricultural and industrial area. This 
prompted us to try the synthesis of some new steroidal thiadiazoles, triazoles and 
oxidotriazoles.With this aim cholest-5-en-3y5-ol (cholesterol) is treated with ethyl 
chloroacetate to get ethyl-5-cholesten-3/?-0-acetate 46, which on treatmcit with 
thiosemicarbazide afforded cholest-5-en-3/?-gloxy acetic acid thiosemicaibazide 
47. Compound 47 on further treatment with conc.H2S04, cone. NaOH and I2 in 
Summary 
NaOH gave title compounds 3y5-[5'-amino-r,3',4'-thiadiazole-2'-
yl]methoxycholest-5-ene 48, 3y9-[5'-mercapto-r,2',4'-triazole-3'-
yl]methoxycholest-5-ene 49 and 3)5-[5'-mercapto-3',5'-oxido-r,2',4'-triazolo-3'-
yl]methoxy-5a-cholestane 50, respectively. The structures of title compounds 
have been established on the basis of elemental and spectral data. 
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Synthesis of steroidal 1.3.4-oxadiazole.p.i. ole^..t ^ razole 
In the recent past, the synthesis of steroidal oxadiazole, pyrrole and 
pyrazole derivatives have attracted the attention of organic chemists because of 
the unusual physiological activities associated with ^hem. \ ' ' "ns realization, 
some papers appeared dealing with such compou steroiaiu aCiies. This 
prompted us to undertake the work m the area. 5U. ' chosen for the 
present exploratory studies is cholest-5en-3y8-0-acetyl hyora^ '<; 146 which was 
obtained from ethyl-5-cholesten-3y^-0-acetate 145. Compound 145 was obtained 
by the treatment of compound cholest-5-en-3^-ol (cholesterol) 144 with ethyl 
chloroacetate. Steroidal hydrazide 146 on further treatment with acetyl acetone, 
CS2/KOH, and acetonyl acetone furnished title compounds 3)5-[3',5'-dimethyl 
pyrazole-1-yI] carbonylmethoxycholest-5-ene 147, 3yff-[5'-mercapto-r,3',4'-
oxadiazol-2-yl] raethoxycholest-5-ene 148 and 3/9-[2',5'-dimethylpyrrol-l-yl] 
aminocarbonylmethoxycholest-5-ene 149. 
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Synthesis of phenyl substituted thiazolone-lb-thiadiazolo-[3'. 4 -
c] thiazoline of 3p-substituted cholestane through conventional 
and non conyentional method 
It has been known for a long time that microwaves can be used to heat 
materials. In fact the development of microwave oven for the heating of food has 
a history of more than 50 years. In inorganic chemistry microwave technology 
has been used since the late 1970s; however it has only been implemented in 
organic chemistry since the mid 1980s. The development of the technology for 
the organic chemistry has been rather slow as compared to combinatorial 
chemistry and computational chemistry. This slow uptake of the technology has 
been principally attributed to its lack of controllability and reproducibility, safely 
aspects and a generally low degree of understanding of the basics of microwave 
dielectric heating. In comparison with traditional heating methods, MW heating 
does not depend on the thermal conductivity of the vessel materials but on a 
direct coupling with the molecules leading to rapid increase in temperature 
(molecular heating). Since the 1990s however the number of publications has 
increased significantly mainly because the availability of commercial microwave 
equipment intended for organic chemistry and to an increased interest in shorter 
reaction times. Keeping this in view we planned to apply this new methodology 
for the synthesis of the title compounds 6-5'/?/ro-[3"'-(2"'-phenyl-4"'-oxo-I"',3"'-
thiazolidin-5"-yl)-l",3",4"-thiadiazolo-(3',4'-b)-thiazolin]-5a-cholestane 74, 3/?-
Chloro-6-jrp/ro-[3"'-(2"'-phenyl-4'"-r",3'"-oxo-thiazolidin-5"-yl)-l",3",4"-
thiadiazolo-(3',4'-b)-thiazolin]-5«-cholestane 79 and 3fi-acetoxy-6-spiro-[3'"-
(2'"-phenyI-4"'-oxo-1 "•,3'"-thiazolidin-5"-yl)-1 ",3",4"-thiadiazolo-(3',4'-b)-
thiazolin]-5a-cholestane 84 by the condensation of 5a-cholestan-6-one-
thiosemicarbazone 71, 3^-chloro-5ct-cholestan-6-one-thiosemicarbazone 76 and 
3;ff-acetoxy-5a-'^ holestan-6-one-thiosemicarbazone 81 with benzaldehyde 
followed by the treatment with thioglycolic acid in dioxane under MWI as well 
(V) 
Summary 
as by conventional heating. Thiosemicarbazones were prepared from 5 a-
cholestan-6-one 70, 3y5-chloro-5a-choiestan-6-one 75 ahd 3y5-acetoxy-5a-
cholestan-6-one 80. 
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Convenient synthesis of ster oicl.l r-»-jlar and linear pvran-4-
ones 
It is known that many pyran derivatives exhibit a wide spectrum of 
pharmacological activities and biological activities. Various natural products 
also contain pyranone nucleus. Due to their biological sisnificance there is a 
need to develop a new protocol for the synthesis of these compounds. 
Furthermore the development of new methods >vith greater efficacy convenient 
procedures and better yield is of nter^st. A survey of the literature reveals that 
no pyranone derivative of the cholestai^ e series is reported. This prompted us to 
(vi) 
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try to synthesize some new steroidal pyranone derivatives. With this aim some 
easily accessible ketones cholest-5-en-3one 102, 3y9-acetoxycholest-5-en-7one 
105, 3y5-chlbrocholest-5-en-7one 108 and cholest-5-en-7one 111 were treated 
with acetyl chloride in presence of pyridine to give 2-acetylcholesta-2,4-dien-3-
ol 103, 6-acetyl-3yff-acetoxycholestit-l,6-dien-7-ol 106, 6-acetyl-3/5-
chlorocholesta-4,6-dien-7-ol 109 and 6-acetylcholesta-4,6-dien-7-ol 112. 
Compound 103, 106,109 and 112 on further treatment with pyrrolidine afforded 
2',2'-dimethylcholesta-2,4-dien-[3,2-b]-pyran-4'-one 104, 2',2'-Jimethyl-3y5-
acetoxycholesta-4,6-dien[7,6-b]-pyran-4'-one 137, 2',2'-dimethy l-3y9-
chlorocholesta-4,6-dien-[7,6-b]-pyran-4'-one 110 and 2',2'-dimethylcholesta-4,6-
dien[7,6-b]-pyran-4'-one 113. 
102 
H,C-C, 
Acetyl chloride^ 
Pyridine 
PyiTolidjrfe_ 
104 
105,108,111 
Acetyl chloride ^ 
Pyridine R 
Pyrrolidine 
O 
106,109,112 
,<^"^CH3 
107,110,113 
R = OAc, CI, H 
(vii) 
CHEMICAL AND SPECTRAL STUDIES 
OF MODIFIED STEROIDS 
THESIS 
SUBMITTED FOR THE AWARD OF THE DEGREE OF 
IBoctor of $i)tlos(op})P 
in 
Cfiemiitrp 
By 
TABASSUM SIDDIQUI 
DEPARTMENT DF CHEMISTRY 
ALIBARH MUSLIM UNIVERSITY 
ALIGARH (INDIA) 
2000 
^ ^ * * 
f^ In Computer 
N-o: 
*^r:^  
^«fiP« IDtl 
T7476 
. ^ 
/ 

Reader 
DEPARTMENT OF CHEMISTRY 
ALIGARH MUSLIM UNIVERSITY, 
ALIGARH-202002, INDIA 
E-mail ID: shams_chem@rediffmail.com, 
Tel.;+91-9411003465 
Certifitate 
This is to certify that work described in this thesis entitled 
''Chemical and Spectral Studies of Modified Steroids'*, is the 
A' \\ 
original work carried out by Ms. Tabassum Siddiqui under my 
supervision. The thesis is suitable for submission for the award of 
Ph.D. degree in Chemistry. 
Dr. Shams-uz-Zaman 
I kneel before almighty Allah to thank him for the kindness he has shown 
to his humble slave and for bestowing upon me the ability to comply with 
his first command "IQRA" (RE/ADI) 
I t gives me a great pleasure to express my deep sense of gratitude to 
Dr. Shamsuzzoman, Reader, Department of Chemistry for his keen 
interest, supervision, encouragement and inspiring guidance through out 
the work reported in the thesis. 
I am also grateful to OP. Arunima Lai Chairman, Department of Chemistry 
for providing necessary facilities. 
I am also thankful to Prof. Kabir-ud-din, Prof. Shoffiullah, former 
Chairman Department of Chemistry for providing help and facilities 
necessary to complete the work. 
I would like to accord my sincere thanks to Prof. M. Mushfiq for his 
benevolent guidance, invaluable suggestion, useful discussion and 
affectionate behaviour. 
I t is with immense pleasure that I record my indebtedness and heartful 
gratitude to my loving parents, brother, sister for their constant 
encouragement throughout my career. 
Special words of thanks are due to Mohd. Gulfam Alam, who has given me 
strength, extreme support, valuable suggestions and also has been with me 
through out my research career. He has went through quite conscientiously 
in order to minimize the error bring it in its present shape. 
I am also thankful to my research colleagues for their cooperation. At the 
end I would like to say thanks to Aftab Alam for editing the Manuscript. 
J^ 
TABASSUtA S I D b l Q U I 
CONTENTS 
SUMMARY 
CflAPTER-I 
CflAFTER-n 
Synthesis of substituted steroidaC 
triazole andoj^db-triazok 
Theoretical 
Discussion 
Experimental 
References 
Syntfiesis of steroiddC 
pyrrole andpyrazofe 
Theoretical 
Discussion 
Experimental 
References 
IM-
(i-vii) 
thiadRazote 
1-11 
12-22 
23-26 
27-29 
-oj(adiazoie, 
30-55 
56-64 
65-68 
69-73 
CflAPT£R-in Syntfiesis of (PfienyC suSstitutecC tfiiazolbne-
l6-tfmdiazoib-(3',4'c) thiazoGne of 3fi -
suBtituted chotestane tkrotigfi conventionaC 
amCnon conventionaC metHod 
CHAPTEB-IV 
Theoretical 
Discussion 
Experimental 
References 
74-86 
87-104 
105-121 
122-125 
Convenient syntfiesis of steroiddC angufar and 
Rnearpyran-4-ones 
Theoretical 
Discussion 
Experimental 
References 
126-139 
140-150 
151-161 
162-165 
UST OF PUBUCATIONS 
Cfuipter-I 
Syntfiesis of suBstitutecf steroicfaC 
tfiiadiazote, triazoCe andoo^otriazoCe 

It has been observed that during last few years by the virtue of toxophoric 
-N=C-S grouping, heterocyclic compounds, such as 1,2,4-triazoles, 1,3,4-
thiadiazoles and oxido-triazoles have been reported to enjoy pharmacological 
properties.''^ '^ •'' 
The 1,2,4-triazole nucleus has been incorporated into a wide variety of 
therapeutically interesting drug candidates including H1/H2 histamine receptor 
blocker, cholinesterase-active agents, CNS stimulants, anti anxiety and 
sedatives.^  It was also found that the thiadiazole nucleus, exhibits a large 
number of biological activities.^ '^  A number of 1,3,4-thiadiazole derivatives 
Q 
possess antibacterial properties comparable with those of sulphonamide drugs. 
In addition, 1,2,4-triazoles, 1,3,4-thiadiazoles and oxidotriazoles have also been 
tested for potential antihypertensive agents.^  Thus prompted by varied biological 
activities of such compounds and continuation of our work on the synthesis, a 
new series of steroidal thiadiazole 48, triazole 49 and oxidotriazole 50 has been 
obtained starting from steroidal thiosemicarbazide 47. These steroidal 
thiadiazoles, triazoles and oxidotriazole may prove to be potent pharmaceutically 
active compounds. 
Here we are giving some recent methods reported by different workers for 
the preparation of triazoles, thiadiazoles, and oxidotriazole derivatives. 
Khare et al}^ reported the formation of 4-aryl-5-(2,6-dichlorophenyl)-3-
mercapto-1,2,4-triazoles 2 and 2-arylamino-5-(2,6-dichlorophenyl)-1,3,4-
thiadiazoles 3 from thiosemicarbazide 1 in the presence of cone. NaOH and 
cone. H2SO4, respectively. 
CHapterl 
^Cl 
^ ^CONHNH-C-NH-( ( )> 
CI 1 
cone. NaOH, cone. H2SO4 
Pathak et al. reported that l-(a-aryloxypropionyl)-4-
arylthiosemicarbazides 4 had shown significant biological activity. They also 
converted 4 to the substituted 2-arylamino-5-(a-aryloxyethyl)-l,3,4-thiadiazoles 
5 and 3-(a-aryloxypropionyl)-4-aryl-5-mercapto-l,2,4-triazoles 6 [R = 2-Cl; R' = 
H, 4-Cl, 2-CH3, 3-CH3, 4-CH3] which also exhibited antitubular, antifungal and 
antibacterial properties. 
chapter I 
CH3 
0-CH-CO-NH-NH-C-NH^ // 
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CH3N—N C H 3 N — N 
Chaban et al synthesized 2-arylamino-5-(o-hydroxyphenyl)-1,3,4-
thiadiazoles 8 from the l-salicoyl-4-arylthiosemicarbazides 7 [R = CeHs, 4(C1) 
C6H4, 4(Br) C6H4, 4(MeO) C6H4] by treating it with cone. H2SO4 in absolute 
ethanol. 
CO-NH-NH-C-NH-R I. cone. H2SO4 NHR 
7 8 
Gawande and Shingare*^ reported that 4-aryl-l-(4-aryl-2-methylthiazole-
5-carbonyl)- thiosemicarbazides 9 on cyclization with sod. hydroxide and iodine 
in presence of alkali and cone, sulphuric acid gave 4-aryl-3-(4-aryl-2-
methylthiazol-5-yl)-5-mercapto-l,2,4-triazoles 10 and 5-arylamino-2-(4-aryl-2-
methylthiazol-5-yl)-l,3,4-thiadiazoles 11 respectively, which showed fungicidal 
activity. [R= H, NO2; R' = H, Br, CI, Me, OMe] 
CHapUrJ 
— i f "^""^  
cone. H2SO4 cone. NaOH 
H3C ^ J \^^\_)~^' 
11 
Aly et al. ''^  proposed that hydrazides 12 have been reported as versatile 
synthetic intermediates, for the preparation of many heterocycUc moieties e.g. 1-
//-2-mercapto-5-(2'-thienyl)[l,3,4]triazole 13 in basic medium and 2-amino-5(2'-
thienyl)[l,3,4]thiadiazole 14 in strong acidic medium. 
O S 
(H-NH-NH-t-NHz 
12 
cone. NaOH cone. H2SO4 
13 14 
ChapUrl 
Parekh et al}^ synthesized substituted thiosemicarbazide 15 which on 
chemoselective heterocyciization with cone. H2SO4 and NaOH separately 
afforded 2-aryiamino-5[2( 1^-quinoxaUnon-1 '-yi-methyl]-1,3,4-thiadiazoles 16 
and l-A'-aryl-2-mercapto-5[2(li/)-quinoxaHnon-r-yl-methyl]-l,3,4-triazoles 17, 
respectively. These compounds along with their derivatives have been screened 
for their antimicrobial activity. [R = H, CHzCgHs, 3-Cl, 4-Cl] 
15 
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CHapterl 
Ziyi et al}^ synthesized the series of 5-(6'-nitro benzimidazole-1-
ylmethyl)-4-phenyl-3-mercapto-1,2,4-triazole 20, 5-(6'-nitrobenzimidazole-1 -
ylmethyl)-4-phenylamino-1,3,4-thiadiazole 21 and 5-(6'-nitrobenzimidazole-1 -
ylmethyl)-4-phenylamino-l,3,4-oxadiazole 22 from l-A'-(6-nitrobenzimidazole-
l-cabonylmethyl)-4-phenyi-3-thiosemicarbazide 19 which was obtained from 6-
nitrobenzimidazole-1-acetic acid hydrazide 18 in good yield. 
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Srivastava et al}^ reported that 1,2,4-triazole 23 on reaction with ethyl 
chloroacetate afforded 1,2,4-triazoloacetate 24 which on furthur treatment with 
hydrazine hydrate yielded (acetohydrazido)-1,2,4-triazole 25. 
N • ^ ^ / / ' ^ 
N 
•^  CH2COOC2H5 CH2CONHNH2 
23 24 25 
Koparir et aO^ converted fliran-2-carboxylic acid hydrazide 26 and 
phenylacetic acid hydrazide 29 into l-(2-furoyl or phenylacetyl)-4-substituted 
thiosemicarbazides 27 (a-e) and 30 (a-e) respectively. These compounds (27 and 
30) on further treatment with 2N NaOH provided 5-(furan-2-yl or benzyl)-4-
(aryl)-4//-l,2,4-triazole-3-thiols 28 (a-e) and 31(a-e) respectively. Among the 
pharmacological profiles of 1,2,4-triazoles, their antimicrobial, anticonvulsant 
and antidepressant properties seemed to be the best documented. [R = C6H5, p-
C6H4OCH3, p- C6H4C1,;7- C6H4N02,p- C6H4CH3] 
chapter I 
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Habib et al}^ synthesized l-(4-substituted-4//-l,2,4-triazole-3-thione-5-
yl)methyl-lJ7-benzotriazoles 35 from 4-substituted-l-(l-carbonylmethyl-l//-
benzotriazole)thiosemicarbazides 33 by treating it with cone. NaOH. Compound 
33 was obtained from 1/f-benzotriazol-l-acetic acid hydrazide 32. [R = n-C4H9, 
CgHf, C6H4-CH3] 
Cfutpterl 
32 
CH2-CONHNH2 CH2-CONHNH-C-NHR 
33 
cone. NaOH 
HM > 
35 
N 
I 
R 
34 
20 Giri et al. was prepared 2-amino-5-(/7-chlorophenyl)-l,3,4-thiadiazole 
37 by cyclodehydration of appropriate 4-arylacetothiosemicarbazide 36 with 
conc.H2S04. 
CI 
\ / 
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II CONHNH-C-NH, 
36 
cone. H2SO4 
N N 
37 
chapter I 
Hussain et al.^^ reported the synthesis of 4-aryl-5-aryloxymethyl-3-
mercapto-l,2,4(//)-triazoles 39 from 4-aryl-l-aryloxyacetylthiosemicarbazides 
38 by treatment with 2 //NaOH. [R = 2-OCH3, 4-OCH3; R' - H, 4-CH3, 3-Ci, 4-
Cl] 
CH2CONHNHCS H,C-
N N // w 
o NH 
12V 
R 
NaOH O 
N 
•SH 
X 
R' 
38 
R R 
39 
22 Rakib et al. synthesized triazolo[4,3-b]pyridazinones 42 by the reaction 
of pyridazin-3(2/0-one 41 with ethyl hydrozono-a-bromoglyoxalate 40. [R = 
CI, NO2, CH3, OCH3; R2 = CH3, CfiHs] 
R 
H Br R2 
N JL 7=N 
^N^^^C02C2H5 + ( NH 
O 
40 
THF 
41 
(C2H5)3N 
Ri 
.N. 
^^^N^ Y^ ^^ ^^ '^ ^ 
-N 
y 
NH 
42 
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CfiapUrl 
Gagiu et al.^^ prepared //-(l,3,4-thiadiazol-2-yl) cholesteryl urethanes 43 
[R = H, alkyl, aryl] by treating cholesteryl chloroformate with thiadiazolamine. 
N—N 
// W 
-HNO2C 
43 
Bakthavatchalan et al.^'^ reported 6,7-dimethyl-l-thia-2,3-diaza-A-nor-14-
isoestra-2,5(10), 6,8-tetraen-17-one 44 from dimedone via intramolecular 
cycondensation reaction of its monotosylhydrazone. 
Rabideau et aP' ^^ reported that in order to affect reduction, a proton 
source must be added to shift the equilibrium by protonation of the radical anion, 
which fiirther protonated to give the reduced product, ArHs. It is important that 
the proton source shall not be too strong, otherwise metal will be destroyed 
rapidly, and the equilibrium will be shifted back to the left. Alcohols are most 
commonly used for this purpose and this method represent the procedure known 
as the Birch reduction (as shown below) 
ArH + M ArH ^ ^ ^ ArH2 M ArH, ROH ArH. 
11 

CHapUrl 
The chemistry of thiosemicarbazide and their cyclised products, and their 
related compounds have been showed considerable interest due to their 
biological activities and industrial importance. A large number of 
thiosemicarbazide substituted with sulphur and nitrogen are generally more 
27 28 
versatile synthetic intermediate with respect of oxygenated ones. 
• 29 
Thiosemicarbazides have been reported to show antituberculosis activities in 
vitro and this toxicity to house fly was comparable to that of DDT. 
Thiosemicarbazides are expected to be facile intermediates in the preparation of 
individual sulphur and nitrogen derivatives of steroids as well as non steroids. In 
the literature, there have been many reports on the reaction of thiosemicarbazide 
derivatives in different reaction conditions, including acidic or basic conditions. 
Synthesis and biological activities of five membered 1,2,4-triazole, thiadiazole 
and oxidotriazole derivatives have been recently reported during last few years. 
Thiadiazole nucleus is associated with a broad spectrum of biocidal activities 
possibly by virtue of the toxophoric >N=C-S moiety. '^'^ ^ In addition, triazole 
moiety containing compounds have been well studied for a number of 
pathological conditions including inflammation, cancer, pain, tuberculosis or 
hypertension.^ ^"'*' In the present study, prompted by these observations an 
attempt has been made to synthesize steroidal triazoles, thiadiazoles and 
oxidotriazole. Here we also have a novel sequence of reactions for the 
preparation of thiosemicarbazide from cholest-5-en-3y5-ol (cholesterol) in high 
yields. Thiosemicarbazide underwent chemoselective heterocyclization 
separately in presence of cone. H2SO4, cone. NaOH and iodine/4iV NaOH to 
afford 3y9-[5'-amino-l',3',4'-thiadiazole-2'-yl]methoxycholest-5-ene 48, 3^-[5'-
mercapto-r,2',4'-triazole-3'-yl]methoxycholest-5-ene 49 and 3/?-[5'-mercapto-
3',5'-oxido-l',2',4'-triazolo-3'-yl]methoxy-5a-cholestane 50. . 
12 
CHapUrl 
Reaction of cholest'5-en-3/g-ol 45 with ethyl chloroacetate : 
Ethyl-5-cholesten-3/?-0-acetate 46 ; 
Ethyl chloroacetate O 
H5C2 •O-di-H' €-0' 
45 46 
Cholest-5-en-3yff-ol (cholesterol) 45 in 1,4-dioxane on reaction with ethyl 
chloroacetate in the presence of K2CO3 at room temperature and then after usual 
work up and chromatographic purification, provided a white powdered single 
product 46, m.p. 144 '^ C,(reported'^ ^ m.p. 145 ^C) in 65 % yield. 
Characterization of compound 46 having m.p. 144 °C as ethyI-5-
cholesten-3^-0-acetate; 
he compound 46 was correctly analysed for C31H53O3. Its IR spectrum 
exhibited characteristic absorption bands at 1735 (C=0 ester), 1615 (C=C), 
O 
1215 (C-0 of -C-O-C) and 1140 cm"* (C-0).^^ The *H-NMR spectrum of 
compound 46 displayed a double doublet for single proton at S 5.62 (J=9 Hz, 
5Hz ) (C^-H), one-proton broad multiplet centered at 4.28 (W^/i 14A Hz, axial) 
for C2a-H, another singlet for two protons at 4.8 (OCH2-CO), a quartet for two 
protons at 4.1 for (-O-CH2-CU2) and a triplet for three protons at 1.3 for (O-CH2-
CHj). Angular and side-chain methyl protons were observed at S 1.15 (C10-CH3), 
0.73 (Ci3-C/fj), 0.90 and 0.82 (other steroidal side-chain methyl protons).*"* Thus 
on the basis of above evidences, compound 46 having m.p. 144 °C has been 
characterized as ethyl-5-cholesten-3y5-0-acetate, 
Ethyl-5-cholesten-3y5-0-acetate has been already prepared from different method /^ 
13 
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Reaction of ethvl-5-cholesten-3jg-0-acetate 46 with thiosemicarbazide ; 
Cholest-5-en-3|g-gloxv acetic acid thiosemicarbazide 4 7 : 
H5C2-0-C-H2C-0" 
S H H O 
H0N-6-N-N-6-CH0-O' 
46 47 
A mixture of compound 46 in 1,4-dioxane was refluxed with 
thiosemicarbazide, after completion of reaction and usual work up and 
chromatographic purification, a single compound 47, m.p. 120 V was obtained 
in 68 % yield. 
Characterization of compound 47 m.p. 120 °C as choIest-5-en-3^-gloxy 
acetic acid thiosemicarbazide; 
The obtained compound 47 was correctly analysed for C30H51N3O2S. Us 
IR spectrum exhibited characteristic absorption bands at 3375 (NH2), 3237 
O 
(NH), 1640 (-C-NH-), 1620 (C=C), 1390 (C-N), 1195 (C=S) and 1140 cm' (C-
O). The H NMR spectrum of compound 47 displayed a broad peak for two 
protons at d 9.3 (2xN/f), a singlet for two protons (Ni/2) at 6.7 (both 
exchangeable with deuterium), a double doublet for a single proton at 5.61 
(J=8Hz, 3Hz ) (Ce-H), one proton broad multiplet centred at 4.28 (W/2 14.4 Hz, 
axial, ) for C^a-H and another singlet for two protons at 4.7 {OCH2-CO-). 
Angular and side chain methyl protons were observed at 1.18 (3H, s, C,o-C//j), 
0.71 (3H, s. Ci3-C//j), 0.92 and 0.82 (other steroidal side-chain methyl 
protons).'*'' Thus on the basis of above data, the compound 47 has been 
characterized as cholest-5-en-3/5-gloxy acetic acid thiosemicarbazide. 
14 
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Reaction of cholest-5-en-3^-gloxy acetic acid thiosemicarbazide 47 in 
cone, sulphuric acid: 
3^-r5'-Amino-l',3',4'-thiadiazol-2'-vnmethoxvcholest-5-ene 48 : 
S H H O I I J cone. ^ ,^ [f 
H2N-6-N-N-6-CH2-0 ' ' ^^ ' ^^ H2SO4 H2N-C^ /C-H2C-
47 ^ 48 
Thiosemicarbazide of ethyl-5-cholesten-3/?-0-acetate 47 was stirred in 
cold cone, sulphuric acid for 3 h at room temperature and after usual work up 
and chromatographic purification, it provided a single compound 48 as a semi-
solid in 80 % yield. 
Characterization of semi solid compound 48 as 3ig-[5'-amino-l'^3',4'-
thiadiazol-2'-vnmethoxvcholest-5-ene; 
The obtained compound 48 was correctly analysed for C30H49N3OS. Its 
IR spectrum exhibited characteristic absorption bands at 3260 (N-H), 1625 
(C=N), 1615 (C=C), 1362 (C-N), 1245 (C-S) and 1210 cm' (C-O)."^ The 'H-
NMR spectrum of compound 48 showed a two-proton singlet at J 7.19 for -N//2 
(exchangeable with deuterium), a double doublet for one proton at 5.58 {J=6 
Hz, 2Hz) (Ce-H), a one-proton broad multiplet centered at 4.31 (WA 13.9 Hz. 
axial) for C^a-H and a singlet for two protons at 3.69 for OC//2. Angular and 
side chain methyl protons were observed at ^ 1.16 (C10-C//3), 0.73 (Ci3-0/^3), 
0.91 and 0.81 (other steroidal side-chain methyl protons).'*'' Thus on the basis of 
above evidences, the semi solid compound 48 has been characterized as 3/?-[5'-
amino-1 ',3 ',4'-thiadiazole-2'-y I]-methoxycholest-5-ene. 
A mechanism (Scheme-1) has been proposed for the conversion of 
steroidal thiosemicarbazide 47 to thiadiazole 48. 
15 
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H H2 
rN" V o' 
H O 
47 
conc.H?SO^ 
(a) 
(b) 
H^  
H2N-C 
— N H2 
H2N-C® ^ C - ^ ^ ^ 
N N 
II II 
HjN-C^ /C-CH2-O 
48 
Scheme-1 
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Reaction of cholest-5-en-3/g-gloxv acetic acid thiosemicarbazide 47 with 
aq. sodium hydroxide: 
3^-r5'-Mercapto-l',2'.4'-triazole-3'-vl1methoxvcholest-5-ene 49 : 
S H HO 
H2N-C-N-N-6-CH2-O 
47 
N- -N 
II 
NaOH HS—C^ ^C-HzC-O 
N 
I 
H 49 
Cholest-5-en-3)ff-gloxy acetic acid thiosemicarbazide 47 was refluxed in 
aq. sodium hydroxide solution on water bath for 7 h. After completion of 
reaction, usual work up and chromatographic purification, a single compound 49 
was obtained as an oil in 78 % yield. 
Characterization of oily compound 49 as 3i8-f5'-mercapto-l',2',4'-
triazole-3'-yl]methoxycholest-5-ene: 
The compound 49 was correctly analysed for C30H49N3OS. Its IR 
spectrum exhibited characteristic absorption bands at 3310 (NH), 2350 (SH), 
1625 (C=N), 1611 (C=C), 1268 (C-S) and 1220 cm"' (C-O).^^ The 'H-NMR 
spectrum of compound 49 showed a singlet for one proton at S 7.26 (-N//, 
exchangeable with deuterium), a single proton double doublet at 5.61 (J=8Hz, 
3Hz) (Ce-H), a one-proton broad multiplet centered at 4.27 (tV^/i 14 Hz, axial) 
for C^a-H and another singlet for two protons at 3.76 for OCH2. Angular and 
side-chain methyl protons were observed at ^ 1.14 (C10-C//3), 0.70 (C13-C//3) 
0.90 and 0.80 (other steroidal side-chain methyl protons).'*'* Thus, on the basis of 
above discussion, compound 49 has been characterized as 3;9-[5'-mercapto-
r,2',4'-triazole-3'-yl]-methoxycholest-5-ene. 
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The following mechanism (Scheme-2) has been proposed for the 
formation of steroidal mercaptotriazole 49 from thiosemicarbazide 47. 
"^n^M'"x'"~ 
H 
47 
H 
N-
M 
- N ) H2 
N OH 
H 
(C) 
-H2O 
Proton shift 
Scheme-2 
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Reaction of cholest-5-€n-3^>£loxv acetic acid thiosemicarbazide 47 with 
cold 4JV aq. NaOH in the presence of iodine in aq. (5%) Kl solution: 
3^-r5'-MercaptO'3',5'-oxido-l',2',4'-triazolo>3'-vnmethoxv-5a>cholestane 
50: 
HN—NH 
S H H O J t2'nNaOH^ LoJ u n r^ ' 
u I I n _/k y^:^ ^ HS-kr 7—H2C-0 H2N-C-N-N-C-CH2-0 ^ ^ ^^ ^1/ 
I 
H 
47 50 
The compound 47 in ethanol was subjected to react with cold. AN aq. 
NaOH in the presence of iodine [in aq. (5%) KI solution] at room temp till the 
colour of iodine persisted. After completion of reaction it was usually worked up 
and purified by column chromatography which provided a single compound 50 
as light yellow crystals m.p. 129 *^C in 90 % yield. 
Characterization of compound 50 having m.p. 129 ^C as 3/?-f5'-
mercapto-3',5'-oxido-l',2*,4'-triazolo-3'-vl1methoxv-5a-cholestane: 
The compound 50 was analysed correctly for C30H53N3O2S. Its IR 
spectrum exhibited characteristic absorption bands at 3321 (NH), 2351 (SH) 
1410 (C-N) 1269 (C-S), 1254, 1245 cm"' (C-0).'^ 'H N M R spectrum of product 
50 displayed a broad singlet for three protons at 3 7.21-7.26 for 
3xN/f(exchangeable with deuterium), a two-proton singlet at 4.89 (0-CH:). and 
a one-proton broad multiplet centered at 4.28 (W Vi 14.6 Hz, axial. C^a-H). 
Angular and side-chain methyl protons appeared atS \.\5 (3H. s. C,o-C//?). 0.71 
(Ci3-C//j), 0.91, 0.82 (other steroidal side chain methyl protons).'*'* The mass 
spectrum of compound 50 showed molecular ion peak at m'z 519 (M"^. 
C30H53N3O2S) along with M+2. Some other characteristic fragmentation ion 
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peaks were recorded at m/z 504 (C30H52N2O2S), 489 (CsoHsiNOjS), 486 
(C30H52N3O2), 472 (C30H52N2OS), 426 (C28H50N2O), 399 (C28H44O), 385 
(C27H45O) 120 (C2H4N3OS) along with other usual fragment ion peaks. The 
fragmentation pattern of these ions is given in Scheme-3. Thus, on the basis of 
foregoing discussion compound 50 has been characterized as 3^-[5'-mercapto-
3',5'-oxido-r,2',4'-triazolo-3'-yl]methoxy-5a-cholestane. 
: m/z 504 
m/z 
472-" 
m/z 486 
m/z 120 
HN—i 
* ^ ^ 
H 
_m/z 489 r^-NA L< 
-m/z 385 
m/z 399 
-m/z 426 
Mt519 
C30H53O2N3S 
Scheme-3 
The following mechanism (Scheme-4) has been proposed for the 
synthesis of steroidal oxido triazole 50 from steroidal thiosemicarbazide 47. 
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All melting points were recorded in open capillary tube and are 
uncorrected. Infrared (IR) spectra were recorded in KBr pellets/Nujol/Neat with 
spectrolab Interspec 2020 FT-IR spectrometer and values are given in cm'. 'H 
NMR spectra were run in CDCI3 on a 300 MHz instrument using TMS as an 
internal standard (chemical shift in S ppm), Mass spectra were measured on Jeol 
Spectrometer SX-102 (FAB). The values (m/z) of fragment ion from various 
compounds are given in parentheses which are the relative abundance (%) of the 
peaks with respect to base peak as 100 %. Thin layer chromatographic (TLC) 
plates were coated with silica gel G, light petroleum ether refers to a fraction of 
b.p. 6G-80°C. Anhydrous sodium sulphate (Na2S04) was used as drying agent. 
The abbreviations "s, d, dd, m, br denote "singlet, doublet, double doublet, 
multiplet and broad respectively. 
Ethvl-5-cholesten-3^-0-acetate 4 6 : 
To the solution of cholest-5-en-3/9-oI (cholesterol) 45 (5 g, 12.9 mmol) in 
1,4-dioxane (50 ml), K2CO3 (10 g) was added followed by the addition of ethyl 
chloroacetate (11 ml) and the mixture was refluxed for 25 h: The progress of the 
reaction was monitored by TLC. After completion of the reaction, the inorganic 
solid was filtered off and solvent was distilled out under reduced pressure. The 
residue was taken in diethyl ether and washed with water. The organic layer was 
separated, dried over anhyd. sodium sulphate and crystallized from methanol to 
give compound 46 as an off white powdered compound, yield 65 % , m. p. 
144 "C (reported^V.p. 145 °C). 
Analysis found 
C31H53O3 requires 
IR(KBr) 
C, 78.59; H, 11.41. 
C, 78.65; H, 11.32%. 
Vmaxl735 (C=0 ester), 1615 (C-C), 1215 (C-0 of 
O 
II 
• 1 
-C-o-C), 1140cm-'(C-0). 
'HNMR (CDCI3) : S 5.62 (dd, IH, C,-H, J=9 Hz, 5Hz), 4.8 (s, 2H, -
OCH2-CO-), 4.28(m, IH, fPA 14.4 Hz, axial, 
C^a-H), 4.1 (q, 2H, -O-C/ZrCHs), 1.3 (t, 3H, -O-
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CH2-C//5), 1.15 (s, 3H, Cio-C//,), 0.73 (s, 3H, 
Cu-CHs), 0.90, 0.82 (other steroidal side-chain 
methyl protons). 
Cholest-5-en-3^-gloxv acetic acid thiosemicarbazide 4 7 : 
To a solution of compound 46 (3 g, 6.34 mmol) in 1,4-dioxane (21 ml), 
thiosemicarbazide (0.57 g, 6.34 mmol) was added and mixture was refluxed for 
5 h. After completion of the reaction (monitored by TLC), the inorganic solid 
was filtered off and the solvent was distilled out under reduced pressure. The 
residue was taken in diethyl ether, washed with water and dried over anhyd. 
sodium sulphate. Evaporation of the solvents afforded compound 47, 
recrystallized from methanol, yield 68 %, m.p. 120 C. 
Analysis Found : C, 69.51; H, 9.98; N, 8.17. 
CjoHsiNjOzS requires : C, 69.56; H, 9.95; N, 8.12 % . 
IR (KBr) 
'HNMR (CDCI3) 
0 
v^ ax 3375 (NH2), 3237 (NH), 1640 (-C-NH-), 
1620 (C=C), 1390 (C-N), 1195 (C=S ), 1140 cm" 
' (C-0). 
S 9.3 (br s, 2H, 2xN//, exchangeable with 
deuterium), 6.7 (s, 2H, N//^, exchangeable with 
deuterium), 5.61 (dd, IH, Ce-H, y-8Hz, 3Hz), 4.7 
(s, 2H, OCH2-CO-). 4.28 (m, IH. W/2 15 Hz. 
axial,Cja-//), 1.18 (s, 3H, C^Q-CHJ), 0.71 (s, 3H, 
Ci3-Ci/i), 0.92, 0.82 (other steroidal side-chain 
methyl protons). 
3ig-f5'-Amino-l'.3'.4'-thiadiazole-3'-vI]methoxv-cholest-5-er\e48: 
Steroidal thiosemicarbazide 47 ( 0.5 g , 0.96 mmol ) in cold cone, 
sulphuric acid (5 ml) was stirred at room temp, for 3 h. The completion of 
reaction was monitored by TLC. The reaction mixture was poured over crushed 
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ice, organic layer was taken in diethyl ether. The ethereal layer was washed 
successively with water, sodium bicarbonate solution (5%) and again with water 
and dried (anhyd. Na2S04). Removal of the solvents provided an oily residue 
which was chromatographed over a silica gel column (pet.ether-diethyl ether, 
19:1) to afford compound 48 as a semi-solid, yield 80 % . 
Analysis found : C, 72.12; H, 9.89; N, 8.45. 
C30H49 N3OS requires 5 C, 72.07; H, 9.91; N, 8.41%. 
: v„,ax 3260 (N-H), 1625 (C=N), 1615 (C<:), 1362 
(C-N), 1245 (C-S), 1210 cm"' (C-0). 
: S 7.19 (s, 2H, N//2, exchangeable with 
deuterium), 5.58 (dd, IH, C(,-H, J-6 Hz, 2Hz), 
4.31 (m, m, WV2 13.9 Hz, axial, C^a-H), 3.69 (s. 
2H, O-C//2), 1.16 (s, 3H, C,o-C//3), 0.73 (s. 3H. 
C13-C//3), 0.91, 0.81 (other steroidal side-chain 
methyl protons). 
IR (Nujol) 
'HNMR(CDCl3) 
3^-r5'-Mercapto- l'.2',4'-triazole-3'-vl1methoxv-cholest-5-ene 4 9 : 
Compound 47 (0.5 g, 0.96 mmol) was refluxed in aq. sodium hydroxide 
solution (20 ml, 8 %) on water bath for 7 h. The completion of reaction was 
monitored by TLC and after completion, the reaction mixture was cooled and 
poured into water. After acidification with acetic acid it yielded a solid which 
was taken in diethyl ether, washed with water (2-3 times) and dried over anhyd. 
sodium sulphate. The solvents were evaporated and the residue was 
chromatographed over a silica gel column using pet. ether- diethyl ether as 
eluants (10:1) to give compound 49 as an oil, in yield 78 %, 
Analysis found 
C30H49N3OS requires 
[R (Neat) 
'HNMRfCDCl,) 
C. 72.11; H, 9.12; N. 8.41. 
C. 72.07; H, 9.91; N, 8.41 %. 
Vmax 3310 (NH), 2350 (SH), 1625 (C=C). 1611 
(C=N), 1268 (C-S), 1220 cm'' (C-O). 
S 7.26 (s. IH. N//. exchangeable with deuterium). 
5.61 (dd, IH, C^-H, y=8Hz, 3Hz), 4.27 (m, IH, 
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fPA 14 Hz, axial, Csa-H), 3.76 (s, 2H. O-C//^), 
1.14 (s, 3H, C,o-C//j), 0.70 (s, 3H, C,3-C//i), 0.90, 
0.80 (other steroidal side-chain methyl protons). 
3jg-f5'-Mercapto-3',5'-oxido-l'.2*.4'-triazoIo-3vl]methoxv-5a-chotestane 
50: 
Compound 47 (0.5 g, 0.96 mmol) was dissolved in ethanol followed by 
the addition of cold solution of 4iV aq. NaOH, (8 ml) at 0 V. To this, a solution 
of iodine in aq. BCI (5 %) was added gradually with stirring at room temp, till the 
colour of iodine persisted. The reaction mixture was refluxed for 3 h. After the 
completion of reaction (monitored by TLC), reaction mixture was cooled and 
poured onto crushed ice. The precipitated solid was filtered, dried and 
recrystallized from ethanol to afford compound 50 as light yellow crystals. 
having m.p. 129 "C, yield 90 %. 
Analysis found 
C30H53O2N3S requires 
IR (KBr) 
'H N M R (CDCb) 
MS 
C, 69.25; H, 10.28; N, 8.11. 
C, 69.29; H, 10.30; N, 8.08 % . 
Vmax 3321 (NH), 2351 (SH), 1410 (C-N), 1269 (C-
S), 1254, 1245 cm-' (C-O). 
S 7.21-7.26 (br s, 3H, 3^NH, exchangeable with 
deuterium), 4.89 (s, 2H, O-C//2), 4.28 (m, IH, 
fVA 14.6 Hz, axial, C^a-H), 1.15 (s, 3H, C,o-
CHj), 0.71 (s, 3H, C,3-C//j), 0.91, 0.82 (other 
steroidal side-chain methyl protons). 
m/z 519 (Mt, +2), 504 (7), 489 (12),486 (10) 472 
(7), 426 (10), 399 (6), 385 (7), 389 (9), 369 (9), 
345 (8), 322 (14), 307 (29), 297 (11), 290 (29), 
285 (33), 279 (23). 262 (10), 255 (9). 239 (17). 
232(29). 214(11), 209(13). 201 (23). 193 (11). 
178 (10), 167 (20), 165 (17), 154 (24), 155 (27). 
154 000). 152(19). 149(641 139(14). [38(34). 
137(51), 136(61), 120(14), 107(33). 
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Syntfiesis and cfiaracterization of9{ew 
steroicfaCcompounds consisting of 1,3,4-
oo^adiazofe, pyrrole andpyrazok rings 

Hydrazides and related compounds have been described as useful 
building blocks for the assembly of various heterocyclic rings, and they are also 
found to be useful as medicine. The exploitation of simple molecules with 
different functionalities for the synthesis of heterocyclic compounds is a 
worthwhile contribution in the chemistry of heterocycles. 
In recent years 1,3,4-oxadiazoles, pyrazoles and pyrroles have captured 
the attention of synthetic organic chemists due to their unusual physiological 
activity. The structure of pyrazole, 1,3,4-oxadiazole and pyrrole ring system are-
O. =.C^^3 
N—N 
> 
NH 
CH3 
Since many of these display a remarkable biological activity, their 
synthesis have been received particular interest for a long time among synthetic 
organic chemists. 
In the theoretical part of this chapter we are mentioning some recent 
methods available in literature for the synthesis of pyrazoles, 1,3,4-oxadiazoles 
and pyrrole derivatives. 
Pyrazole: 
Nargund et aO reported the synthesis of 2-[4-(acetamido-
phenoxy)carbonyl]-3,4,5-trisubstituted pyrazoles 5 and 6 by the treatment of p-
acetamido(phenoxy)acetyl hydrazides 4 with 5-bis methylene cyanoacetamide 
and acetyl acetone. These products were also tested for anti-bacterial activity. 
CdapUrll 
NHCOCHs 
OCH2CONHNH2 ^ i 
._ H3CS, CN 
H3CS' CONH2 
ii- H3C-CO-CH2-CO-CH3 
NHCOCH3 
0-C-C-N—NH 
H2N 
CONH2 
NHCOCH3 
O 
0-C-C-N—N 
Ley et al? reported the synthesis of 4,5-dihydro-l//-pyrazoles 8 by the 
treatment of a, /?-unsarurated ketones 7 with hydrazines. 
3 R4NHNH2 M » 
Padmavati et al. reported the synthesis of 4,6-diaryl-4,5-
dihydrobenzo[3,4-d] pyrazoles 10 and 4,6-diaryl-4,5,6,7-tetrahydrobenzo[3,4-
djpyrazoles 12 [Ar = Ph, Ph-OMe, Ph-Cl] from 6-hydroxymethylene-3,5-diaryl-
2-cyclohexenones 9 and 2-hydroxymethyiene-3,5-diaryl cyclohexanones 11, 
respectively by cyclocondensation with hydrazine hydrate. 
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NH2NH2 
AcOH 
HN N 
10 
11 
NH2NH2 
AcOH 
HN N 
Aggarwal et al.^ reported a convenient one-pot procedure for the 
preparation of pyrazoles 16 by 1,3-dipoiar cycloaddition of diazocompound 
generated in situ. Diazo compounds derived from formaldehydes reacted with 
terminal alkynes to furnish regioselectively 3,5-disubstituted pyrazoles 16 [R* = 
Ph,p-CNC6H4,jt?-MeOC6H4, 3-pyridyl; R^= Ph, 3-pyridyl]. 
Na'' 
TSNHNH2 ^x^^ / N V 
RI.CHO ^ Ri ^ ^ N ^ 
13 14 
•Ts PTC R ' - ^ ^ N ^ 
N 
+ 
15 
R 2 ^ = - R 3 
16 
Katritzky et al.^ synthesized pyrazoles 18 [R* - H, OH; R^ = H, CH3; R^  = 
)4 _ H, NO2; R'* = NO2; R^  = CH3, C2H5] from hydrazones using the Vilsmeir 
cyclization method by treatment with POCI3 and DMF. They used microwaves 
for cyclization. 
32 
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POCI3 
MW, 21OW, 30-50 Sec 
DMF 
18 
Another cyclization (Paal-knorr cyclization) of 1,4-diketones 19 gave 
pyrroles 20 [R = CH2C6H5, MeOCeHs, l-ClCeHj etc.] and the reaction was 
dramatically speeded up under microwave irradiation. 
O 
o 
19 
RNH2 r\ 
MW, solvent free N 
I 
R 
20 
The dehydration of unsymmetrical diacylhydrazines 21 using Burgers 
reagent provided 1,3,4-oxadiazoles 22 rapidly under microwave irradiation, [R' 
= alkyl, aryl; R^  = CI, OMe] 
0 9 
II 
MeO N^'H'NEta 
MW 
21 22 
Ramdani et al.^ synthesized A ,^A^-bis(3,5-dimethylpyrazol-l-yl-methyl)-l-
hydroxy-2-aminoethane 25 in one step by the condensation of two equivalent of 
l-hydroxymethyl-3,5-dimethylpyrazole 23 with one equivalent of 2-amino 
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ethanol 24 under microwave irradiation. The reaction was carried out in absence 
of solvent. 
H3C. 
H3C, 
OH 
.NH, 
23 24 
f ' - N ^ C H 3 
.N-
HO 
N-
,CH-: 
N 
> 
H3C 
25 
Rashad et al. synthesized some biologically active pyrazoles 27-30 from 
hydrazine derivatives 26. 
,CN 
ArNHNHj 
26 
C2H5O. 
N:: 
< 
,CN 
N 
I 
Ar 
27 
NQ .CN 
-G 
N 
I 
Ar 
CaHsO.^  .COOC2H5 
-.0. 
•NH2 
28 
COOC2H5 
N 
I 
Ar 
NH, 
29 
O 0 Me, 
A A ) 
- a 
N 
I 
Ar 
Me 
30 
34 
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AT = 
Bouabdallah et al} synthesized some l-aryl-3,5-disubstituted pyrazoles 
33 [R' - CH3, C6H5; R" = C6H5, CO2CH3, CO2CH2CH3; Ar = /7-NO2C6H5, o-
NO2C6H4] by //-arylation of 3,5-disubstituted pyrazoles 32 with 4-fluoro and 2-
fluoronitro benzene under microwave irradiation with and without solvent. 
Compound 32 was obtained by the condensation of hydrazine with 1,3-diketones 
31. 
NH2NH2 
31 32 
ArF 
R'-
Ar—N 
\ 
N-
33 
R" 
Dumitrascu et al. synthesized pyrazoles 37 by 1,3-dipolar cycloaddition 
reaction of syndones with symmetrical and non symmetrical acetylenic esters. 3-
(2,4-Dimethyl phenyl) syndones were halogenated at 4-position giving 4-
halogenosyndones. 
RI-N-C-COOH 
I 
NO 
37 
35 
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Molteni et al}^ reported the microwave irradiation promoted conversion 
of enaminoketones formed in situ into a variety of heterocycles such as 
pyrazoles, 40 [R = 2,4-Me2C6H5, Ph, 2-pyridyl, cyciohexyl, t-Bu] by reaction 
with appropriate bidentate nucieophile. 
38 
O NH-NH-R 
39 
AcOH 
Kashef e/ a/." prepared l,3-diphenyl-l//-pyrazoIe-4-carbohydrazide 43 
from 41 using l,r-carbonyldiimidazole (GDI) in an inert solvent at room 
temperature, followed by the hydrolysis of the imidazolyl intermediate 42. The 
compound 43 was found to be a key intermediate for the synthesis of 
oxadiazolinone 44, oxadiazolinethione 45, and 1,3,4-oxadiazole 46 by its 
reaction with GDI, GS2 and triethyl orthoformate, respectively. 
36 
Cfiapterll 
45 
The reaction of hydrazide 47 with ethoxy methylenemalononitrile and / or 
ethyl[ethoxymethylene]cyanoacetate in boiling ethanol gave the corresponding 
5-amino-4-substituted pyrazole derivatives 49 (a, b). 5-Amino-3-phenyipyrazole 
derivative 48 was obtained by the reaction of 47 with benzoylacetonitrile. In 
addition, the interaction of 47 with acetyl or benzoyl acetone in absolute ethanol 
afforded the corresponding pyrazole derivatives 50 (a, b) [R = CN, COOEt; R ' = 
CH3, CeHj]. 
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O NH2 ^^ O 
^ N Ph N 
NHNH2 
EtOCH=CCN(R) 
 
1 
Ph 
48 47 
I 
Ph 
RICOCH2COCH3 
:d N 
I 
Ph 
NH2 
Ph 
49 
Steroidal pyrazoles: 
Ruzicka et al}^ synthesized first steroidal pyrazole, cholest-4-eno[3,2-
c]pyrazole-5'-carboxylic acid 51. 
CRH 
HOOC 
H-N 
8^17 
1 ^ 
Clinton et al. reported several steroidal [3,2-c]pyrazoles e.g. 17/?-
hydroxy-17a-methylandrostano[3,2-c]pyrazole 52 and • 17j5-hydroxy-17o:-
methylandrostano[4,6-c]-dieno[3,2-c]pyrazole53 
38 
H—N 
H 
52 53 
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Benn et al obtained 3y9-hydroxyandrost-5-eno[16,17-c]-5'-
methylpyrazole 55 by the hydrazine reduction of 16a,17a-epoxypregnenolone 
54. 
54 55 
Hirschmann and co-workers'^  reported several [3,2-c]-pyrazoles e.g. 59, 
60 related to corticol. For the synthesis of pyrazoles related to 16«-
methylcortisol, the cortical side chain was protected by the formation of the 
bismethylenedioxy derivative 57 which was allowed to react with ethyl formate 
in benzene in the presence of sodium hydrazide to give the 2-hydroxymethylene 
derivative 58. The compound 58 was actually subjected to condensation with 
hydrazine and phenyl hydrazine to yield the [3,2-c]-pyrazoles which is 
summarised as 
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CH2OH 
- C H , 
PhNHNHa NH2NH2 
Ph-N 
59 60 
Nambara et al}^ reported the synthesis of 17y5-(3-pyrazolyl)-3yS-acetoxy-
3a-androst-14-ene 62, its a-epoxy product 63 and 17y9-(3-pyrazolyl)-14a,15a-
epoxyandrostane 64 from 20-ethoxy-21-formyl-17y5-pregna-14,20-diene 61. 
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kdO 
CHO 
61 
AcO 
OAc 
62 
63 64 
Green et al}^ reported the synthesis of steroidal pyrazoles in the 
androstane series e.g. 3y9-acetoxyandrost-5-eno[16,17-d]-diphenylpyrazole 65 
and 3y5-acetoxyandrost-5-eno[17, 16-d]-r,3'-diphenylpyrazole 66. 
AcO AcO 
N-Ph 
65 66 
18 1 
Berbaik and his co-workers reported some androsteno-pyrazoles 67 [R 
= 0 A C , 0 H ; R 2 = H ] . 
41 
PhHzC-
67 
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Oxadiazole: 
Monge et aO^ reported the transformation of A'^ -(2-cyanoethyl)-7V-
methylindole-2-carbohydrazide 68 into oxadiazolone 70 and oxadiazolethione 
69 [R = H, CH3; R* = H, OCH3, 0CH2Ph, OH] by its reaction with triphosgene 
and thiophosgene, respectively. 
(CCl30)2CO 
69 
Heindel el al. reported the synthesis of 5-aryl-2-mercapto-1,3,4-
oxadiazoles 72 by treating potassium-3-aroyldithiocarbazates 71 [R = C6H5, p-
FC6H4, o-BrC6H4, 0-CH3OC6H4, 4-pyridyl, 2-thienyl, cyclohexyl] with KOH 
and pyridine. 
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0 S 
II II . , 
R—C—NH—NH—C—S K* 
71 
21 
KOH 
Pyridine 
N N 
O 
72 
Rahman et al synthesized 5-(benzothiazole-2-yl-thiomethyl)-2-
phenylamino-l,3,4-oxadiazole 75, 5-(benzothiazole-2-yl-thiomethyl)-2-amino-
1,3,4-oxadiazole 76 and 5-(benzothiazole-2-yl-thiomethyl)-l,3,4-oxadiazole-2-
thione 77 by the oxidative cyclization of A'^'-(benzothiazole-2-yl-thioacetyl)-A^-
phenyl-3-thiosemicarbazide 74 and (benzothiazole-2-yl-thio)acetic acid 
hydrazide 73, with following sequences of reactions. 
1 ySCHoCONHNH-C 
NHPh 
NaOH 
74 
N — N 
i Q f ySCH2JlQANHPh 
75 
PhNCS 
a I VsCHzCONHNHz 
73 
KHCO3 
N N N 
ySCHAQi -NH, 
76 
CS 0 0 2 
KOW 
a ^ N N—NH 
77 
Hirata et alT^ synthesized substituted 5-[4-(benzyloxy)phenyl]-3-(2-
cyanoethyl)-l,3,4-oxadiazol-2(3i/)-one 80 [X - H, 2-1, 3-1, 4-1; Y - H, I] from 
substituted-1 -[4-(benzyIoxy)benzoyl]-2-(2-cyanoethyl)hydrazide 79. Compound 
79 was prepared from substituted-l-[4-(benzyloxy )benzoyl]-2-(2-
cyanoethyl)hydrazine 78. 
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)-\ V-f 
X 
78 
(CCl30)2CO 
H2C=CHCN 
N—N' 
X -O 
*V.y y ^ C>o 
° \ ^CONHNH' 
^ Y 
X 
79 
.CN 
XN 
80 
Chande etal.^^ synthesized 5-arylamino-2-mercapto-l,3,4-oxadiazoles 83 
[R = C6H5, /7-CH3C6H4, JP-CIC6H4 etc.] by the reaction of sodium /3-iN-
arylthiocarbamyl)thiocarbazinates 82 with ethanoUc NaOH. 
R^NH—C-NH—NH2 
81 
COS 
NaOH 
NaOH / Ethanol 
RHN 
N N 
83 
24 
s o 
II II 
•*- R—NH—C-NH—NH—C-S- Na^ 
82 
Gadaginamath et al.^"* synthesized l-furfiiryl-3-carbethoxy-5-( 1,3,4-
oxadiazol-2-yi)methoxy-2-methylindole 85 and l-furfuryi-3-carbethoxy-5-(5-
mercapto-l,3,4-oxadiazol-2-yl)methoxy-2-methylindole 86 by treating 
separately l-furfuryl-3-carbethoxy-2-methylindol-5-yloxy acetic acid hydrazide 
84 with acetonyl acetone and ethanolic KOH / CS2 respectively. 
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H2NHN 
^ , OC2H5 
H,C 
Acetonyl 
acetone 
N N 
N 
HoC 
OC2H5 
CH, 
P 
84 
CS2/KOH 
N NH 
H2C 'O 
\ 
O 
N 
H2C 
OCzHe 
CH. 
85 86 
Mankhetkom et al?^ synthesized 5-aiyl-3-(4-hydroxyphenyI)-1,3,4-
oxadiazole-2-(3/0-thiones 90 by cyclocondensation of l-(4-hydroxyphenyl)-2-
aroylhydrazines %9 with thiophosgene. 
[X = H, OMe; Y = H, Me OMe, NO2; Z = H, OMe] 
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O 
n Ar-C0NHNH2 
" ^-^ OK >=N-NH-C-Ar 
87 
nBuOH 
H O - < V - N -NH-C-Ar ^^?!^  -PhNHNHz '^ \ / H H2O 
89 e^^O^'Ar 
N N 
90 X 
Ar-Ar-HQ^y 
Z 
Gadaginamath et al synthesized l-(5-mercapto-l,3,4-oxadiazol-2-yl)-
methyl-3-ethoxycarbonyl-5-substituted-2-methylindoles 93 and l-(2,5-
dimethy Ipyrrol-1-y l)aminocarbony Imethy 1-3-ethoxy carbony 1-5-substituted-2-
methylindoles 94 by treating separately l-hydrazinocarbonylmethyl-3-
ethoxycarbonyl-5-substituted-2-methylindoles 92 with CS2/KOH and acetonyl 
acetone. Compound 92 was subsequently prepared by the reaction of 1-
ethoxycarbonylmethyl-3-ethoxycarbonyl-5-substituted-2-methylindoles 91 with 
hydrazine hydrate. [R = OH, OCH3] 
46 
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OC2H5 
Acetonyl acetone 
OC2H5 
N' ^^^3 H3C 
\ 
CH2CO—NH-N 
93 94 
H X 
Donawade et al^'' synthesized l-ftjrfuryl-3-ethoxycarbonyl-5-(5-
inercapto-l,3,4-oxadiazol-2-yl)methoxy-2-methylbenz(g)indole 96 and 1-
furfuryl-3-ethoxycarbonyl-5-(2,5-dimethylpyrrol-l-yl)aminocarboylmethoxy-2-
methylbenz(g)indole 97 by the reaction of l-fiirftiryl-3-ethoxycarbonyl-2-
methylbenz(g)indole-5-yloxyacetic acid hydrazide 95 with CS2/KOH and 
acetonyl acetone respectively. 
47 
o 
H2NHN"^0 
U 
CS2/KOH 
H2 
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95 
OCH2CH3 
96 
CH3-CO-(CH2)2-COCH3 
H,C 
HoC 
/ HaC 
OCH2CH3 
97 
Katritzky et al?^ reported the preparation of 1,2,4-oxadiazole 100 by the 
reaction of amidoxime 98 with aryl halide 99 in the presence of palladium 
catalyst. 
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N / 
OH 
II + Ar-X 
R' NHz R' 
Ar 
98 99 
N 
100 
Demibras et al.'^^ synthesized 5-alkyl-2-[(5-{[(5-mercapto-l,3,4-
oxadiazol-2-yl)methyl]thio}-l,3,4-thiadiazol-2-yl)methyl]-2,4-dihydro-3i/-
l,2,4-triazol-3-ones 102 by treating 2-({[(3-alkyl-5-oxo-4,5-dihydro-l//-1,2,4-
triazol-l-yl)methyl]-l,3,4-thiadiazol-2-yl}thio)acetohydrazide derivatives 101 
with CS2/KOH. [R = CH3, CH2C6H5, C6H5] 
N—N o 
// W ^C-NHNH2 
N—N 
XA 101 
CS2/ KOH 
N—N 
N—N 
N—N 
S^H 
w 
102 
Demibras and cowerkers^° also synthesized (5-mercapto-l,3,4-oxadiazol-
2-yl)methyl-2,4-dihydro-3/f-l,2,4-triazol-3-one 104 by reacting acetic acid 
hydrazide containing l,2,4-triazol-3-one ring 103 with CS2/KOH. [R=CH3, 
CH2C6H5, CH2C6H4CI-/7 C6H5, C2H5, C3H7 etc.] 
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N — N ' 
/ / 
X H 2 - C - N H N H 2 
CS2 / KOH 
N 
NH2 
103 
N—N / 
CH; 
/>o 
I 
NH2 
104 
N—N 
/ / \^  
O SH 
Belkadi et al?^ reported the synthesis of racemic compound 5-(2,2-
dimethyI-[l,3]dioxolan-4-yl)-3^-[l,3,4]-oxadiazol-2-thione 107 from racemic 
2,2-dimethyl-[l,3]dioxolan-4-carboxylic acid hydrazide 106 by its treatment 
with CS2/ethanolic KOH. 
H 2 N H N . , . ^ 0 
-O 
105 
Me 
Me 
HN O 
CS2 
KOH.EtOH 
I — o Me 
106 
-^ 
N: 
•°x Me 
-O Me 
107 
Pyrrole: 
Trofimov et al?^ synthesized 5-[ 1-(1-//-pyrrol-l-yl)ethyl]-l-vinyl-1^-
pyrroles 110 by acid catalysed dimerization of substituted 1-vinyl pyrroles 108. 
[R ' = Me, Et, n-Pr, t-Bu; R^ = H, Me, Et, n-Pr] 
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^ 
108 
R2-^ R^x 
Me' 
N 
(+) 
109 
Me 
rv 
Me 
110 
Soloducho e/ a/, synthesized 9,9-didodecyl-2,7-bis(pyrrol-2-yl)fluorene 
and 2,5-bis(pyrrol-2-yl)-l,4-dioxane[2,3-c]thiophene 112 and 114 starting from 
9,9-didodecylfluorene-2,7-dicarboxyiic acid 111, 2,5-bis[3-(l,3-dioxalan-2-
yi)propanoyi]-3,4-ethylenedioxythiophene 113 respectively. 
O 
i, ii, iii, iv 
H L i 
111 112 
Ar) -
(i) SOQI2 DMF 
(ii) CH2=CH-CH2NH2 ^CgHe, EtaN 
(iii) COCI2 , DMF 
(iv) t-BuOK, THF 
12^25 
NH4OAC 
CH3COONH4 
113 114 
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Langer et al.^^ synthesized ethyl(4,5-dimethyl-pyrrol-2-yl)acetate 117 
from ethyl (4,5-dimethyl-pyrroUdine-2-ylidene)acetate 116 by treating it with 
TFA and CH2CI2. Compound 116 was prepared by the treatment of ethyl-3-oxo-
5-methyl-5-hydroxy-6-azidoheptanoate 115 with triphenylphosphine. 
^OCzHg O^OCzHg 
N3 
115 
Brown et al. synthesized l-benzyl-4-methylene-2-phenylpyrrolidine 120 
using palladium-catalysed nucleophilic cleavage of allylic linkage. Six 
pyrrolidines were synthesized from a carboxy ethyl resin where the key 
transformation included a Lewis-acid promoted imino-Sakurai type reaction and 
reductive alkylation prior to the final palladium catalysed cyclization cleavage of 
the allylic carboxylate linkage. 
Ph 
118 " 9 
i Pd(acac)2, dppe, THF. 
ii PhCHO, AcOH, Me4NB(OAc)3H, CH2CICH2CI 
Banik et al.^^ synthesized the substituted pyrroles 123, [R = Ph, PhCH2, 
NH2(CH2)2] 126 and 129 [R2 = Me, Ph; R3 = Me, Ph; R4 = H, Ph] using iodine-
catalysed and montmorillonite KSF-clay induced modified Paal-Knorr methods. 
O 
RNH2 + ^ ^ ' ^ ^ ^ ^ ^ ^ Montmorillonite 
KSF N 
O R 
121 122 123 
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.0 Q 
124 
+ PhCHsNHs Montmorillonitg 
125 
R1NH2 + R2COCHCH2—COR3 
127 128 
KSF 
I2 (cat) 
THF 
R,>. ^ N . .^2 
•R4 129 
Artico et alV synthesized 1-(phenyl methoxy carbonylamino)-!//-pyrrole 
131 by the reaction of benzoyl carbazate 130 with 2,5-dimethoxy 
tetrahydrofuran in ethanol / acetic acid. 
O^^NHNHz 
130 
a,b 
131 
(a) 2,5-dimethoxytetrahydrofuran, AcOH, EtOH. (b) AcOH. 
38 Nemes et al. synthesized pyrrole derivatives 134 by the Lewis acid-
catalysed cyclocondensation of different enamines substituted with an electron 
withdrawing group 132 with unsaturated aldehyde 133 having an alkyl group in 
a position. [ R \ R^ = H, Ph or cyclic; R \ R'' = H, alkyl, aryl or cyclic] 
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R1 NHR2 
EWG 
132 
/ 
CeCIa 
134 
Demir et al?'^ synthesized (i?)-ethyl 5-methyl-2-phenyl-l-(l-phenylethyl)-
l//-pyrrole-3-carboxylate 136 by the TFA catalysed cyclization of the reaction 
of (Z)-ethy 1-2- [((/?)-1 -phenylethylamino)(phenyl)methylene]pent-4-ynoate 135 
with phenyl amine. 
O O 
Ph 
OEt PhNH; Cat TFA 
135 
40 
OEt 
136 
Steven et al. reported a new and straight forward protocol for pyrrole 
synthesis. They synthesized corresponding pyrroles 138 [Ri = Bn, CH2C00Me, 
CH2P(0)(OEt)2, o-methoxyPh etc.; R2 = H, CH3, CH2 morpholine, CI] by the 
treatment of diallylamines 137 with Gmbb's catalyst and RUCI3. XH2O. 
tf N' 
137 
Ru=CHPh 
PCY3 
RUCI3 
CICH2CH2CI 
60 °C, Ultra sound 
138 
54 
Cdapterll 
Nunes et al!^^ synthesized dichloro-1-phenyl-l^-pyrTole-2,5-dione 141 
by the reaction of aniUne 140 and dichloromaleic anhydride 139 in acetic acid. 
CI 
CI 
139 
fi^^S^ NH, 
:° ^ U AcOH 
CI 
CI 
N-A / 
140 141 
42 Vegh et al. synthesized six monosubstituted hexapyrrolyl benzene 
derivatives 143 by the reaction of appropriate 1-pentafluorophenyl-l//-pyrrol 
derivatives 142 with a sodium salt of pyrrol in dry DMF. [R' = HCHO, MeCO, 
EtCO; R^  = H; Py = IH Pyrrol-1-yl] 
o N-
DMF, rt 
>^i\cc. No ) . 
5? A J i 
. ^ r -
*''^ ''«» U^vct^^^''' 
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The growing need for the compound libraries especially for biological 
evaluation, there is an increasing demand for clean and efficient synthesis of 
organic molecules. Recently, synthesis of steroidal pyrazoles, oxadiazoles and 
pyrroles have attracted the attention of organic chemists because they display 
remarkable and unusual physiological activity. Pyrazoles have been found in 
diverse application in pharmaceutical and agrochemical industries. ' In 
particular they are known as potential antibiotic and antioxidant agents. Many 
dyes also contain pyrazole nucleus. The fusion of pyrazole ring to steroidal 
nucleus can act as potential drugs. The unusual anabolic activity observed in 
humans'*^ attached vital significance with such compounds in steroids. In 
addition, 1,3,4-oxadiazoIe constitute an important family of heterocyclic 
compounds.''^ Since many of them display a remarkable biological activity, and 
are often used in drug discovery as potential agonists for cortical muscarinic, 
benzodiazepine^*^ histamine H3 receptors^', antirhinoviral,^^ growth hormone 
secretagogues,^^ anti-inflammatory '^* and anti-tumor agents.^^ They also inhibit 
the SH2 domain of tyrosine kinase and monoamine oxidase,^^ human neutrophil 
en ea 
elastase and human DNA topoisomerases. Pyrroles are also an important 
class of heterocyclic compounds having different biological activities.^^ The 
occurrence of pyrrole nucleus in many natural and synthetic biologically active 
compounds continue to contribute to the development of some new 
heterocycles.^^ Fuctionalized pyrroles are present in a number of 
pharmacological relevant natural and unnatural products and represent useful 
synthetic intermediates. Fuctionalized pyrroles are also the building block of 
natural tetrapyrrole pigments, such as porphobilinogen or bilirubin, and various 
other natural products (e.g.-haemoglobin, chlorophyll) and also valuable 
intermediates in pyrrole chemistry.^'' ^^  
Thus, inspired by these results obtained by earlier workers, we have made an 
attempt to synthesize steroidal pyrazoles, oxadiazoles and pyrroles from 
steroidal hydrazide belonging to cholestane series. Here, we have synthesized 
3^-[3',5'-dimethyl pyrazole-l-yl]carbonylmethoxycholest-5-ene 147, 3/?-[5'-
mercapto-r,3',4'-oxadiazoIe-2-yl]methoxycholest-5-ene 148 and 3/?-[2',5'-
56 
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dimethylpyrrole-l-yl]aminocarbonylmethoxycholest-5-ene 149 from cholest-5-
en-3^-0-acetyl hydrazide 146, using acetyl acetone, CS2/KOH and acetonyl 
acetone as reagents, respectively. The compound 146 was obtained from easily 
asseccible ethyl-5-cholesten-3y5-0-acetate 145. Compound 145 was obtained by 
treating cholest-5-en-3y8-ol (cholestrol) 144 with ethyl chloroacetate. The 
structures of new compounds were established on the basis of analytical and 
spectral studies. 
Reaction of cholest-5-en-3^-ol 144 with ethyl chloroacetate in the 
presence of K2CO3; Ethyl-5-cholesten-3jg-0-acetate 145 ; 
Ethyl chloroacetate^ 
- ? 
H5C2-O-C-H2C-O 
144 145 
Cholest-5-en-3;S-ol (cholesterol) 144 in 1,4-dioxane on reaction with 
ethyl chloroacetate in the presence of K2CO3 at room temperature, after usual 
work up and chromatographic purification, provided a white powdered single 
product 145, m.p. 144 V, (reported" m.p. 145 V) in 65 % yields. 
Characterization of compound 145 having m.p. 144 »€ as ethvl-5-
cholesten-3jg-Q-acetate : 
The compound 145, was correctly analysed for C31H52O3. Its IR spectrum 
exhibited characteristic absorption bands at 1731 (C=0 ester), 1616 (C=C), 
O 
1218 (C-0 of -C-O-C) and 1143 cm '^ (C-O).^ ^ The "H NMR spectrum of 
compound 145, displayed a double doublet for single proton at d 5.62 (J=8Hz. 
2Hz) {C(,-H), one-proton broad multiplet centred at 4.26 {WA 14.4 Hz, axial) for 
C^a-H, another singlet for two protons at 4.81 (-OC//2-CO), a quartet for two 
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protons at 4.1 for (-O-C/frCHs) and a triplet for three protons at 1.41 (O-CH2-
CH}). Angular and side-chain methyl protons were observed at (51.14 {C10-CH3), 
0.73 (Ci3-C/fj), 0.93 and 0.80 (other steroidal side-chain methyl protons).^ ^ 
Thus, on the basis of above evidences, compound 145 having m.p. 144 '^ C has 
been characterized as ethyl-5-cholesten-3y9-0-acetate. 
Ethyl-5-cholesten-3y5-0-acetate 145 has also been reported in the literature by 
other method'^ .'^ ^ 
Reaction of ethyl-5-cholesten-3)g-0-acetate 145 with hydrazine hydrate: 
Cholest-5-en-3^-0-acetvl hvdrazide 146: 
I I NH2NH2.H2O O 
H2 
145 146 
To a suspension of 145 in ethanol was added 99 % of hydrazine hydrate 
and the reaction mixture was refluxed for 10-12 h. After usual work-iip and 
chromatographic purification, a single compound 146, m.p. 153 °C (reported^^ 
m.p. 152 °C) was obtained in 69 % yield. 
Characterization of compound 146 having m.p. 153 "C as cholest-5-en-
3^-O-acetvl hvdrazide : 
The obtained compound 146, was correctly analysed for C29H50N2O2. Its 
IR spectrum exhibited characteristic absorption bands at 3370 (NH2), 3232 
(NH), 1642 (-CO-NH-), 1612 (C=C), 1385 (C-N) and 1120 cm-'(C-O).^ ^ The 'H 
NMR spectrum of compound 146, displayed a broad peak for one proton at <5 9.1 
(NH), a singlet for two protons of NH2 at 6.5(both exchangeable with 
deuterium), a double doublet for a single proton at 5.63 (y=9Hz, 5Hz) (Ce-H), a 
one-proton broad muhiplet centred at 4.30 {WA 14.6 Hz. axial) for C^a-H and 
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another singlet for two protons at 4.9 {-OCH2-CO). Angular and side-chain 
methyl protons were observed at d 1.19 (3H, s, C10-CH3), 0.72 (3H, s, Cn-C/Zj), 
0.92 and 0.83 (other steroidal side-chain methyl protons).^ ^ Thus, on the basis of 
above data, compound 146 having m.p. 153 ''C has been characterized as 
cholest-5-en-3y5-0-acetylhydrazide. 
Reaction of cholest-5-en-3^-0-acetvl hvdrazide 146 with acetyl acetone: 
3jg-f3',5'-Dimethylpyrazole-l-yl]carbonylmethoxycholest-5-ene 147 : 
II ^^ 2 
H2N-NH-C-C-O' 
146 
o 
11 
H3C-C-CH,-C-CH3 , ^ _ ^ . ^cH2 /^v ,0 
H3C 
H 
147 
The compound 146 was refluxed with acetyl acetone in ethanol 
containing glacial acetic acid. After usual work up and recrystallization from 
ethanol it provided a single compound 147 as a solid, m.p. 138-141 ''C in 71 % 
yield. 
Characterization of compound 147 having m.p. 138-141 °C as 3^-f3',5'-
dimethylpyrazole-l-yl1carbonylmethoxycholest-5-ene : 
The compound 147, was correctly analyzed for C34H54N2O2. Its IR 
spectrum exhibited characteristic absorption bands at 1716 (C=0), 1624 (C=N), 
1620 (C=C), 1397 (C-N), 1215, 1089 cm"' (C-0).^'' In the ' H N M R spectrum of 
compound 147, two olefmic protons appeared separately at <5 5.6 (y=7Hz, 3Hz) 
(C6-H) and 5.49 (pyrrole ring) as a double-doublet and a singlet, respectively. It 
also showed a two-proton singlet at S 4.27 for 0-Ciy2-CO, another singlet for six 
protons (2XC//3) at 1.56 and a broad multiplet integrating for one proton at S 
4.82 (W^/2 14 Hz, axial) for Cja-H. Angular and side-chain methyl protons were 
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observed at S 1.17 (s, 3H, C10-CH3), 0.72 (s, 3H, Cn-CHj), 0.91 and 0.83 (other 
steroidal side-chain methyl protons).^^ Thus, on the basis of above discussion, 
compound 147 having m.p. 138-141 ^C has been characterized as 3/?-[3',5'-
dimethyl pyrazole-1 -yl]carbonylmethoxycholest-5-ene. 
The following mechanism is proposed for the conversion of steroidal 
acetyl hydrazide 146 into steroidal dimethyl pyrazole 147. 
9 H2 , 
H2NNH-C-C-0 
- H ^ . H * 
O 
N-NH-C~(^.0' 
(b) 
N—N CH2 
II 
H 
147 
Scheme-1 
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Reaction of cholest-5-en-3/g-0-acetvl hvdrazide 146 with CS2 in the 
presence of KOH: 
3^-f5'-Mercapto-l'^',4'-oxadiazol-2-vl]methoxYcholest-5-ene 148 ; 
O 
H2N-NH-C-C-O' 
Ho 
CS2 / KOH 
H' 
,N—N 
146 148 
The compound 146 in ethanol containing KOH was refluxed with CS2 for 
21 h. After usual work up and recrystallization from ethanol, it afforded a single 
compound 148 as a solid, m.p. 125-126 V in 67.5 % yield. 
Characterization of compound 148 having m.p. 125-126 °C as 3/3-[5'-
mercapto-l',3',4'-oxadiazoI-2-yl]methoxycholest-5-ene : 
The compound 148 was correctly analyzed for C30H48N2O2S. Its IR 
spectrum exhibited characteristic absorption bands at 1625 (C=N), 1385 (C-N), 
1220 (C-0), and 1195 cm-' (C=S).^^ The ' H N M R spectrum of compound 148 
displayed a single proton singlet at 6 9.06 (exchangeable with deuterium) for 
N// of oxadiazole ring, a two-proton singlet at 3.54 for (O-C//2-), a double 
doublet for a single proton at 5.38 (J=8Hz, 4Hz) (Ce-H), and a one-proton broad 
multiplet centered at 4.6 (W^/2 15 Hz. axial) for Csa-//. Angular and side-chain 
methyl protons were observed at 1.15 (s, 3H, C^Q-CHil 0 J4 (s, 3H, CM-CHJ), 
0.90 and 0.85 (other steroidal side-chain methyl protons).^^ Thus, on the basis of 
above data, compound 148 having m.p. 125-126 *^C has been characterized as 
3/5-[5'-mercapto-1 ',3',4'-oxadiazol-2-yl]methoxycholest-5-ene. 
The possible mechanism for the conversion of steroidal thiosemicarbazide 146 
into steroidal oxadiazole 148 is outlined in Scheme-2. 
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II 
a^S 
IMH2 
HoN-N-r-C-C-O 
B: 146 
-H,S 
/ \ 
HN ^C-CH2-0 ' 
N 
148 
// 
CS2 / KOH ©S-'^X^ 
I -B:Fr 
H (c) 
H2N^j^^C-CH2-'0 ,€6" 
H,N 
(b) 
Scheme-2 
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Reaction of cholest-5-en-3^-Q-acetvl hvdrazide 146 with acetonyl 
acetone; 
3^-f2'.5'-PimethvlpviToI-l-vIlaminocarbonvlmethoxvcholest-5-ene 149: 
0 
H2N-NH-C-C-O' 
H2 
Acetonyl acetone 
N-N -^o 
CH, 
146 149 
To a solution of compound 146 in absolute alcohol were added acetonyl 
acetone and glacial acetic acid. The reaction mixture was refluxed on water bath. 
for 7 h. After usual work up and recrystallization from ethanol, it provided a 
single compound 149 as a solid, m.p. 131-133 °C in 69 % yield. 
Characterization of compound 149 having m.p» 131-133 "C as 3^-f2',5'-
dimethyl pyrrol-l-yllaminocarbonylmethoxycholest-S-ene: 
The compound 149, was correctly analyzed for C35H56N2O2. Its IR 
spectrum exhibited characteristic absorption bands at 1753 (C=0), 1615 (C=C), 
1340 (C-N) and 1196 cm"' (C-0).^'* The ' H N M R spectrum of compound 149. 
showed a singlet for one proton at S 8.3 (-N//) (exchangeable with deuterium) 
and two olefinic protons of pyrrole ring at 5.71 (2 x C-H). A double doublet for 
a single proton at 5.28 (J=9Hz, 5Hz) iC(,-H). Six methyl protons of pyrrole ring 
appeared as singlet at S 2.34. It also showed a one-proton broad multiplet centred 
at 4.58 (W^/2 16 Hz, axial) for C^a-H and another singlet for two protons at 4.86 
(O-C//2). Angular and side-chain methyl protons were observed at 1.17 (3H. s. 
Cio-C/Zj). 0.74 (3H, s, C,3-C//j), 0.93 and 0.84 (other steroidal side-chain 
methyl protons). Thus, on the basis of foregoing discussion and spectral values, 
compound 149 having m.p. 131-133 ''C has been characterized as 3/?-[2'.5'-
dimethylpyrrol-1 -ylJaminocarbonylmethoxy-cholest-5-ene. 
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The following mechanism is proposed for the conversion of steroidal 
acetyl hydrazide 146 into steroidal dimethyl pyrrole 149 outlined in Scheme-3. 
H2N"NH"C - C - 0 
146 
O 
N-NH-C-0 
(c) 
-H2O 
O 
Acetonyl acetone 
H* 
-H* 
:N-NH-C-O 
149 
-H*/ +H* 
N-NH-C-0' 
OH 
(b) 
Scheme-3 
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All melting points were recorded in open capillary tube and are 
uncorrected. Infrared (IR) spectra were recorded in KBr pellets with spectrolab 
interspec 2020 FT-IR spectrometer and values are given in cm"*. ' H N M R spectra 
were run in CDCI3 on a 300 MHz instrument using TMS as an internal standard 
(chemical shift in 5 ppm), Thin layer chromatographic (TLC) plates were coated 
with silica gel G, light petroleum ether refers to a fraction of b.p. 60-80 C. 
Anhydrous sod. sulphate (Na2S04) was used as drying agent. The abbreviation s, 
d, dd, m, br denote "singlet, doublet, double doublet, multiplet, broad" 
respectively. 
Ethvl-5-cholesten-3^-0-acetate 145 ; 
To the solution of cholest-5-en-3)8-ol (cholesterol) 144 (5g, 12.9 mmol) in 
1,4-dioxane (50 ml), K2CO3 (10 g) was added followed by the addition of ethyl 
chloroacetate (11 ml) and the mixture was refluxed for 25 h. The progress of the 
reaction was monitored by TLC. After completion of the reaction, the inorganic 
solid was filtered off and solvent was distilled out under reduced pressure. The 
residue was taken in diethyl ether and washed with water. The organic layer was 
separated, dried over anhyd. sodium sulphate and crystallized from methanol to 
give compound 145 as an off white powdered compound, m.p. 144 °C 
(reported'^ ^ m.p. 145 "C) yield 65 %. 
Analysis found 
C31H52O3 requires 
IR(KBr) 
*HNMR (CDCI3) 
C, 78.72; H, 11.11. 
C, 78.76; H, 11.09%. 
Vmax 1731 (C=0 ester), 1616 (C=C), 1218 (C-0 of 
o 
-c-o-c), ii43cm-*(C.O-C). 
S 5.62 (dd, IH, Ce-H, J=8Hz, 2Hz), 4.81 (s, 2H, -
OCH2-CO-), 4.26 (m, IH, WA 14.4 Hz, axial, C^a-H), 
4.1 (q, 2H, -O-CH2-CU2), 1.41 (t, 3H, -O-CUj-CHs), 
1.14 (s, 3H, C^o-CHj), 0.73 (s, 3H, C13 -CH3), 0.93. 
0.80 (other steroidal side-chain methyl protons). 
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Cholesten-5-en-3^-Q-acetvlhvdrazidel46 : 
A mixture of compound 145 (2 g, 4.23 mmol), hydrazine hydrate (0.21 
ml, 4.23 mmol), pyridine 3-5 drops in absolute ethanol (40 ml), was heated at 
reflux on a boiling water bath for 11 h. The completion of reaction was 
monitored by TLC. The reaction mixture was concentrated to half its original 
volume under reduced pressure. The separated solid was filtered and taken in 
diethyl ether and dried over anhydrous sod. sulphate. The obtained compound 
was chromatographed over silica gel column (Pet. ether - diethyl ether, 20:2) to 
afford compound 146 which was recrystallized from ethanol, m.p. 153 C, 
(reported^^m.p. 152 °C), yield 69%. 
Analysis found 
C29H50N2O2 requires 
IR (KBr) 
C, 75.94; H, 11.05; N, 6.06. 
C, 75.93; H, 10.99; N, 6.11%. 
v„,a, 3370 (NH2), 3232 (NH), 1642 (-CO-NH-), 
1612 (C=C), 1385 (C-N), 1120 cm' (C-0). 
NMR(CDCl3) : (5 9.1 (br s, IH, N//, exchangeable with 
deuterium), 6.5 (s, 2H, N//2, exchangeable 
with deuterium), 5.63 (dd, IH, €5-//, y=9Hz. 
5Hz), 4.9 (s, 2H, O-C//2-CO-), 4.30 (m, IH, W 
V2 14.6 Hz, axial, C^a-H), 1.19 (s, 3H, C,o-
C//5), 0.72 (s, 3H, C,3- C//3), 0.92, 0.83 (other 
steroidal side-chain methyl protons). 
3^-[3',5*-Pimethvl pvrazole-l-vl1carbonvlmethoxvcholest-5-ene 147 : 
To a solution of compound 146 (0.5 g, 1.08 mmol), in glacial acetic acid 
(50 ml), a solution of acetyl acetone (0.11 ml, 1.08 mmol) glacial acetic acid (25 
ml), in ethanol was slowly added. The mixture was refluxed at 100-125 V in an 
oil bath 8 h. The reaction mixture was poured into ice cold water (80-100 ml), 
and allowed to stand over night. The precipitated solid was fihered. taken in 
diethyl ether, washed with water, dried over anhyd. sod. sulphate (Na2S04) and 
recrv'stallized from ethanol. to afford compound 147 m.p. 138-141 V . vield 7] 
%. 
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Analysis found 
C34H54N2O2 requires 
IR(KBr) 
^HNMR (CDCI3) 
C, 78.09; H, 10.33; N, 5.35. 
C, 78.11; H, 10.41; N, 5.36%. 
Vmaxl716 (C=0), 1624 (C=N), 1620 (C=C), 1397 
(C-N), 1215, 1089 cm'' (C-0). 
d 5.6 (dd, IH, Q^-H, J=7Hz, 3Hz), 5.49 (s, IH, 
pyrrole ring), 4.82 (m, IH, WV2 14 Hz, axial, C^a-
H), 4.27 (s, 2H, O-CH2-CO-), 1.56 (s, 6H, 
l^CH^X 1.17 (s, 3H, C10-C//3), 0.72 (s, 3H, Cn-
CH3), 0.91, 0.83 (other steroidal side-chain methyl 
protons). 
3^-r3',5'-Mercapto-l'.3',4'-oxadiazol-2-vl1methoxvcholest-5-enel48 : 
To a solution of compound 146 (0.5 g, 1.08 mmoi) in absolute alcohol (40 
ml), KOH and CS2 dissolved in alcohol (10 ml) in equimolar amount was 
added and reaction mixture was heated under reflux till the evolution of H2S 
ceased (21 h.). The reaction mixture was cooled to room temperature, poured in 
ice cooled water and neutralized with dil. HCI. The precipitated solid was 
filtered, dissolved in diethyl ether, washed with water and dried over anhyd. 
Na2S04. Evaporation of solvent and recrystallization from ethanol provided 
compound 148 having m.p. 125-126 "C, yield 67.5 %. 
Analysis found 
C30H48N2O2S requires 
IR(KBr) 
^HNMR (CDCIj) 
C, 71.92; H, 9.68; N, 5.55. 
C, 71.95; H, 9.66; N, 5.59%. 
v^ ax 1625 (C=N), 1385 (C-N), 1220 (C-0), 1195 
cm"' (C=S). 
6 9.06 (br s, IH, Ni/, exchangeable with 
deutrium), 5.38 (dd, IH, Ce-//, J=8Hz, 4Hz), 4.6 
(m, IH, WV2 15 Hz, axial, C^a-H), 3.54 (s, 2H, 
O-C//2), 1.15 (s, 3H, C10-CH3), 0.74 (s, 3H, C,3-
CH3), 0.90, 0.85 (other steroidal side-chain 
methyl protons). 
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30-f2'^'-Dimethvlpvrrol-l-vl1aminocarbonvlmethoxvcholest-5-enel49; 
A solution of compound 146 (0.5 g, 1.08 mmol) in absolute alcohol (25 
ml) was added to a solution of acetonyl acetone (0.12 ml, 1.08 mmol) and 
glacial acetic acid (5 ml). The mixture was heated on a boiling water bath for 7 
h. The completion of reaction was monitored by TLC. The reaction mixture was 
concentrated to half of its original volume and poured in ice cold water (100-150 
ml). The separated solid was collected by filtration, dissolved in diethyl ether 
washed with water, air dried and then recrystallized fi-om ethanol to get 
compound 149, m.p. 131-133 °C, yield 69 %. 
Analysis found 
C3SH56N2O2 requires 
IR(KBr) 
'HNMRCCDCla) 
C, 78.29; H, 10.55; N, 5.20. 
C, 78.31; H, 10.51; N, 5.22 %. 
v„,ax 1753 (C=0), 1615 (C=C), 1340 (C-N), 1196 
cm'' (C-0). 
d 8.3(s, IH, N/f, exchangeable with deuterium), 
5.71 (s, 2H, 2 X C// of pyrrol), 5.28 (dd IH, Cg-
H, J=9Hz, 5Hz), 2.34 (s, 6H, 2XC//3), 4.58 (m, 
m,WV2\6 Hz, axial, C^a-H), 4.86 (s, 2H, O-
CH2), 1.17 (s, 3H, C,o-C//3), 0.74 (s, 3H, C,3-
CH3), 0.93, 0.84 (other steroidal side-chain 
methyl protons). 
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Syntfiesis of(pfieny[su6stitutecf 
tfiiazoCone-l 6-tfiiacfiazolb-
(3\4'c)tfiiazo[ine of3fi - suBtitutetf 
cAolestane tfirougfi conventionaC and 
non conventionaC metfiod 

Thiadiazoles are classified as doubly unsaturated five membered 
heterocyclic compounds consisting of two nitrogen, one sulphur and two carbon 
atoms, thiazolidinones contain one nitrogen, one sulphur and three carbon atoms 
including a carbonyl group, while thiazolines consist of doubly unsaturated five 
membered ring with one nitrogen and one sulphur. 
HN 1 "J N II 
,CH S N 
Thiazolidinones play a vital role in pharmaceutical science owing to their 
wide biological activities and industrial application. Thiadiazole and thiazoline 
derivatives are also well known potent pharmaceutically active compounds. 
There have been many reports regarding the preparation methods for the 
title compounds under different reaction conditions. In the theoretical part of this 
chapter we have included some recently reported compounds by different 
workers having thiadiazole, thiazolidinone and thiazoline moieties. 
Giri et al} synthesized a number of 3-[5'-aryl-3'-mercapto-r,2',4'-triazol-
4'-yl]-2-aryl-4-thiazolidinones 2 [R = 4-Cl, 2-Cl, 2-Cl, etc.; R' = 4-Cl, 4-Cl, 
3,4(OCH3)2 etc.] by the cyclocondensation of thioglycolic acid and 
phenylsubstituted-3-mercapto-1,2,4-triazole 1. 
N—N 
Dioxane 
SHCH2COOH 
N—N 
Trivedi et al. reported the synthesis and antimicrobial activity of 
substituted 4-oxo-thiazolidines. Cycloaddition of Schiffs base 3 with 
thioglycolic acid furnished 2-substituted aryl / alkyl / heterocyclyl-3-[4-(4-
chlorophenyl)thiazol-2-yI]-4-oxo-thiazolidine 4. They also reported that 2-
Cfiapurlll 
aniino-4-(4-chlorophenyl)thiazole on treatment with chloroacetylchloride 
afforded 2-chloroacetamido-(4-chlorophenyl)thiazole 5, which on further 
reaction with substituted amines in ethanol yielded 2-substituted amino-
acetamido-4-(4-chlorophenyl)thiazoie 6, Where R = different aryl / alkyl / 
heterocychc moieties. 
'^^XX. HS-CH2COOH. '<} —N A S N = C - R H N C—R 
a , < * ^ S 
OTJ. RNH, S NHCOCH2CI NH-CO 
CH2_NHR 
Parekh et al.^^ synthesized 4-thiazolidinones 8 fi-om Schiff bases 7 by the 
treatment of thioglycolic and thiolactic acids [R = Ar; R' = H, OH] and the 
products were screened for their antimicrobial activity. 
R-HC=N-HN-0-H2C-C—<\ y—SO2—^ JKO—CH2-C0-NH-N=CH-R 
HS-CH-COOH 
1 
R' 
R-HC 
S 
N-HN-O-H2C-C 
O 
SO. \/-*"^A / O—CH2-CO-NH-N 
O 
R' 
r 
R' 
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Parekh and co-workers '^' synthesized 2-(4'-methoxyphenyI)-3-p-
acetamidophenoxyacetamido-5-///methyl-4-thiazolidinone 10 by the 
cyclocondensation of iV-4-methoxy benzal, 7V -^p-acetamidophenoxy-acyl 
hydrazine (Schiff s bases) 9 with thiogycolic and thioiactic acids respectively. 
All the compounds were screened for their antitubercular activity against 
Mycobacterium tuberculosis. (X= H, CH3; R = aryl) 
0 / = v 0 
HgC-C-HN-^^ )>-0CH2-C-NH-N=CH-R 
SH-CH-COOH 
r X 
O ==. O 
HgC-C-HN-^ y—OCHzC-NH-N—CHR 
10 O'' 
X 
Parekh and his co-workers '^' also synthesized 2-aryl-3-A -^(6'-
phenylthieno[3,2-cr| pyramid-4-yl-amino)-5-///methyl-4-thiazolidinone 12 by the 
cyclization of 4-substituted benzalhydrazino-6-phenylthieno[3,2-firipyrimidine 
11 [X = H, CH3; R = aryl] with thioglycolic and thioiactic acids. The products 
were also evaluated as potential antimicrobial agents. 
11 I J HS-CH-COOH ^ I [I 1 
HN-N=CH-R HN-N CH-R 
11 12 a ^ s 
X 
Nizamuddin et al.*^ synthesized spiro heterocyclic compounds e.g. 3'-(5-
substituted-3-mercapto-l,2,4-triazol-4-yl)5/7/ro[indol-3,2'-thiazolidine]-2,4'-
dione 15 by the heterocyclization of 5-(substituted)-3-mercapto-4-[l'//-2'-(3'//)-
oxoindol-3'-ylimino]-l,2,4-triazole 13 with thioglycolic acid in dioxane [R = H, 
2-Cl, 2-Me, 2-OMe etc.]. 
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fX^k 
15 
R 
V. 
'•cc. N o 
Ar= - ^ ,"2C0-
Nizamuddin et al^^ later reported the synthesis of (2-substituted)-
5p/ro(cyclohexane)-l',5-[l,3,4]-thiadiazolo[3,2-c]thiazoUne 19 [R = H, 2-CH3, 
3-CH3, 2-Cl, 2,4-Cl2 etc.] by the cyclocondensation of Schiff bases 3-(A -^phenyl 
thiocarbanilido)-5/7/ro(cyclohexane)-r,2-(4-thiazolidinone) 18 and thioglycolic 
acid with ice cold H2SO4. Compound 18 was prepared by the reaction of 4-
cyclohexane-thiosemicarbazones 16 with thioglycolic acid. 
NNHCSNH—\.jr^R 
16 
HSCH2C00H 
Dioxane 
S' 'N NH / ^ > ^ ^ 
17 
N N 
OH HS ^ N H ^ 
cold, cone. H2SO4 Y 
R } = 
H 
19 
18 
-N 
-NH O" 
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Kidwai et al.^ reported the synthesis of 3-(4'-methyl-2'-
quinolinyl)oxyacetamido-2-(substituted phenyl)-4-thiazolidinone 21 [R = H, CI, 
NO2, CH3, OH, OCH3], by the reaction of substituted-2-(4-methyl-2-
quinolinyi)oxyacetylhydrazone 20 with thioglycolic acid in dioxane through 
classical as well as microwave methods. 
CH3 
N=CH- / \ -F 
20 
Microwave 
8-10 min. 
HSCH2COOH 
Dioxane 
21 
^ ^ ' 
Parikh et al.^ reported the synthesis of 3-aryl-2-(2-chloro-7-methoxy 
quinolin-3-yl)-4-thiazolidinone 23 [R = H, CH3; Ar = 4-antipyrine, 4-COO-
C2H5-C6H4, 3-CI-C6H4, 3-Cl, 4-F-C6H5 etc.] by the condensation of thioglycolic 
acid/thiolactic acid with A^-aryl-(2-chloro-7-methoxyquinolin-3-yl)azomethine 
22. The products were also evaluated for antibacterial and antifungal activities. 
O 
MeO 
CH=Y R 
HS-CH-COOH 
MeO 
22 
Y = 0'^ArNH2 
Y = N-Ai/ 
23 
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Gaby et al synthesized thiazoIo-[3,2-a]-pyridine 25 by the condensation 
of thiazoHdinone derivative 24 with malononitrile and aromatic aldehydes [1:1:1 
molar ratio] in absolute ethanol containing a catalytic amount of piperidine. 
Products also showed antimicrobial activity. [Ari = CeliiBr-p, C6H4F-/?, C6H4CI-
p etc.; A12 = C6H4F-P, C6H4Br-p, C6H4CI-P etc.] 
CHAr 
24 
Ar2CH0 
CH2(CN)2 
A r 2 , / H 
^ 
Ari / 
HC 
N 
O 
25 
NH: 
g 
Russowsky et al. reported that the coupling reaction between piperidine-
2-thione 26 and 2-bromo-2-phenylmethylacetate 27 afforded the /?-
enaminocarbonyl compound 28 and in most of the cases bicyclic thiazolidinone 
29 were produced. 
26 27 
i . CH2CI2, 24 h 
ii. EtgN 
OMe iii. PhgP, rt, 18h 
' C02Me hi 
28 29 
Birader et al.^ synthesized the 4-(5'-substituted-2'-phenylindole-3'-yl)-l-
(coumarin-3"-amido)azetidin-2-ones 31, [R = CH3, OCH3, Br, CI] from 
coumarin-(5 '-substituted-2'-phenylindole-3 '-carboxyaldehy de)-3 -
carbonylhydrazone 30 by its treatment with thioglycolic acid. 
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oX 
30 
^ 
SH.CH2COOH 
anhyd. ZnCl2 
O A 
31 
N 
H 
^ 
Monforte et al}^ synthesized the 2,3-diaryl-l,3-thiazolidin-4-ones [ X = 
CH, N, etc.; Y = CH, N, etc.; R' = Me, OMe etc.; R^  = H; R^  = CI, F etc.; R^  = 
H; R^  = CI, F] 34 by reacting an aromatic aldehyde 33 with an equimoiar amount 
of (hetero) aromatic amine 32 in the presence of an excess of thiogiycolic acid. 
The microwave irradiation dramatically shortened the reaction time and afforded 
the desired products in high yields. 
Ri 
SHCH 
R2 Y NH2 
l2C00h^ 2 ^ ^ Y 
Katti et aO^ reported the one-pot procedure for the synthesis of l-thia-4-
aza 5'/7/ro[4,5]-decan-3-one 36, by the reaction of cyclohexanone 35 with 
substituted amine, substituted thiogiycolic acid and dicyclohexylcarbodiimide 
(DCC) in dry THF at r.t. These products were also evaluated as potential 
antimycobacterial agents.[R' = PhCH2, n-CgHiy; R^  = H, Me] 
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35 
RI-NH2 
HS-< CO2H 
R2 
R^-N 
36 
Sattigeri et al.^^ synthesized the acetamido methyl derivative of 
thiazolidine-2-one 42 from iV-allyl derivative 37 with the help of key reaction 
iodo-cyclothiocarbamation. 
Ar 
s 
37 
s 
N S 
38 39 
7 
N3 
O 
N "5 
42 
/ 
N H - C - C H 3 
II "^  O 
S 
Ar \ 
IV N 
41 
N H - C - C H 3 
II ^ 
O 
S 
I 
H2N 
40 
Ar=Ph,d \\T-
i = I2, CH3CN i = HS(CH2)3SH, EtsN iii = AC2O, EtsN iv = propylene oxide, TFA 
I 
F 
Mulwad et al. reported the synthesis of A'-[coumarin-6-ylamino]-2-
arylthiazololidin-4(^-one 44 and A^-[coumarin-6-ylamino]5p/>o-[3//-indole-
(l/f,2//)-3,2-(4//)-thiazolidine]-2,4-dione 46 [R, = H, CH3 etc.; R2 = H, CH3, 
OCH3 etc.; R3 = H, OCH3 etc.] by the treatment of iV-[coumarin-6-
yljhydrazonoarylmethane 43 and l,2-dihydro-3-[coumarin-6-yihydrazono]indol-
2-one 45 with thioglycolic acid, respectively. 
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0, V'^V%''^2 
V ^ N H - N = C H / > 
HSCH2COOH 
43 
R.I 
44 O 
HSCH2COOH 
0 . ^ 0 2 O 
N H - N 
46 
Talesara et al.^'^^ reported the simple method for the synthesis of 3-[(4-
oxo-l,3-thiazoIidin-2-yiiden)amino]-2-phenylquinozolin-4(3/r)-one 48 by the 
cyclization of A^-[2-phenyl-4(3//)-oxo-quinazolin-3-yl]thiourea 47 with 
chloroacetic acid and anhyd. sodium acetate. 
H N — ( 
O 
abs. alcohol 
-* LI 
N 
S 
II 
N 
47 
N-NH-C-NH2 A 
CeHs CICH2COOH, CHaCOONa 
48 
14b Talesara et al. also synthesized 2-amino-5-(4'-pyridyl)-1,3,4-
thiadiazole 50 by cyclization of isonicotinoylthiosemicarbazide 49 with cone, 
sulphuric acid. When 50 was refluxed with various aldehydes, it gave the 
corresponding arylidene derivatives 51 which on further treatment with 
mercaptosuccinic acid furnished thiazolidinone derivative 52. Another 
thiazolidinone derivative 2-isonicotinoylhydrazido-1,3-thiazolidinone 53 was 
obtained by the successive treatment of isonicotinoylthiosemicarbazide 49 with 
chloroacetic acid in the presence of sodium acetate. [Ar = 4-OCH3C6H4, 4-
CIC6H4, 3,4,5-OCH3C6H2, 3-NO2C6H4, 4-NO2C6H4, 4-(CH3)2NHC6H4, C^H,, 
C4H30(2-furyl)]. 
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O H 
H NH2 
49 
N N N—N 
c»nc. H2SO4 
—»- N. 
CICH2COOH 
Kl H 
53 
// 
II 
50 
ArCHO N. 
=\y/ 
/ 
NH, 
51 
Mercaptosuccinic acid 
52 
N I 
Ar 
-Ar 
OH 
O 
Talesara et al}'^ also synthesized thiazolidinone derivative named (2-
aryl-4-pxo-3-{[(quinolin-8-yloxy)acetyl]amino}-l,3-tliiazolidin-5-yl)acetic acid 
55 by the cyclization of A^-{[(lZ)-arylmethylene]-2-(quinolin-8-
yloxy)}acetohydrazides 54 with mercaptosuccinic acid. 
HOOC T 
COOH 
^ 
ZnCl2/THF 
Bhusare et al}^ refluxed benzylidene aniline derivative 56 in dioxane 
with thioglycolic acid which gave the corresponding 2,3-diaryl-13-thiazolidin-
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4-one 57. Some of the products showed effective antibacterial activity.[R = H; 
Ri = OCH3; R2 = OH; Ar = Antipyrine, 2,6-Dichlorophenyl, 1,2,4-triazole] 
R 
HSCH2COOH ^"^"^N \ 
Dioxane / \ 
57 
16 Kim et al. reported the synthetic route to 2-methylaminothiazolines 60 
by selective cyclization of A'-(2-hydroxyethyl)-A''-methyl-thioureas 58. 
V A 
58 
Me-N=C=S 
1 
THF 
S 
IT 
59 
TSCl 
NaOH 
\ 
NH 
60 
17 
Gamack and Behera synthesized 2-(arylimino)-4-tetra-0-acetyl-yS-D-
glucopyranosyl-4-thiazolidinone 61 [ R=(un) substituted Ph, phenyl-thiazolyl, 
pyridyl etc.] by condensation of thiourea derivatives R 'NHC(S)NHR (R' = tetra 
acetylglucopyranosyl) with CICH2COOH in presence of anhydrous NaOAc, the 
synthesized compounds exhibited fungicidal and bactericidal activity. 
61 
.18 Zimenkovsky^* prepared 2-hydrazono-3-a-naphthyl-4-thiazolidinone 62 
[X = aiylidines, CMe2, CMeEt, H2 etc.] by cyclocondensation of chloroacetic 
acid with thiosemicarbazides. 
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N-N=X 
62 
Upadhyay et al}^ prepared 1,4-bis (2'-aryl-2'-methyl-5'-carboxy-methyl-4' 
thiazolidmones-3'-yl-amino)phthalazine 63 [ R= C6H4NH2-n,n=2 -4, C6H4 R -4; 
R'=Br, CI, OH, OEt, NO2] and tested for antibiotic activity. 
Me 
R-^—N - N H 
O 
CH2COOH CH2COOH 
63 
Literature has revealed that very few steroidal thiazolidinones have been 
prepared and studied so far. 
ShafluUah and Ali reported the synthesis and mass spectral studies of 
the spiro (cyclocholestane) thiazolidinones 64 and 65. Steroidal extranucleo 
thiazolidinones of cholestane series 66 and 67 were also prepared by cyclising 
the respective thiosemicarbazones with CICH2COOH. 
p8Hl7 
64 65 
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AcO 
C«H 8^17 
66 
HN r = N - N 
I 
0 ^ ^ ' 
67 
Siddiqui et alP' prepared C-24 thiazolidinone derivatives 69 [R = H, OH, 
R ' = H; X = S] of bile acids from esters 68 [R^ = OMe] in three steps involving 
hydrazinolysis with NH2NH2 to give 68 [R^ = NHNH2], reaction with potassium 
or ammonium thiocynate to give 68 [R^ = NHNHC(S)NH2] and 
cyclocondensation with chloroacetic acid in presence of anhydrous sodium 
acetate and AcOH. 
C 0 R 2 
68 
CHONH=T 
O 
69 
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Chemistry is critical to drug discovery especially at the lead optimization 
phase, but method for the synthesis of organic compounds have remained 
essentially unchanged for the decades, since lead optimization time is usually 
very long with a very high manpower requirement, new ways to improve the 
efficiency, output and quality in this phase are always needed.One feasible 
reaction is microwave assisted synthesis which is in many ways superior to 
traditional heating: reactions are completed in minutes, yields are generally 
higher than those achievable by traditional means, and chemistry unfeasible by 
conventional procedures might be performed. Microwave energy has been 
previously used in chemical application such as digestion and extraction 
processes, now with the introduction of single mode microwave reactors for 
organic synthesis; this technology is widely applied to drug discovery. Further 
more thanks to this method, heating is immediate and volumetric, the 
temperature is accurately controlled, so that reactions can be more easily 
repeated.^ '^^ "* The manifold biological and physiological activities associated 
with thiadiazoles, thiazolidinones and thiazolines have drawn the attention of 
chemists towards their synthesis.Thiadiazoles are associated with wide variety of 
physiological activities such as antiaflatoxigenic,^^ antibacterial,^ ^"^^ anti-
mflanmiatory, tuberculostatic, and anticonvulsant activity, as well as 
fungicidal and amoebicidal properties. They are also utilized as plant growth 
regulator,^^ chemotherapeutic agent^ '* and as a drug intermediate.^^ Instead of 
thiadiazoles various thiazolidinones are endowed with a wide range of 
pharmaceutical activities including CNS-depressant,^^ anaesthetic,^^ 
anticonvulsant,^* antibacterial,-'^ antiviral,'*" antitumor,"*' hypnotic,"*^ and 
anticancer,'*^ oxytocic, catatonic,'*'* hypocholesteremics.'*^ They are also utilized and 
proved as calcium antagonists with both calcium overload inhibition and 
antioxidant'*^ activity. Apart from this thiazolidinones have also been reported as 
novel inhibitors of the bacterial enzyme Mur-B which is precursor during the 
biosynthesis of peptidoglycan."*' In addition to thiadiazoles and thiazolidinones 
research interest in thiazoline derivatives has also been increased during recent 
years due to their biological and pharmaceutical activity e.g. anti-HIV,'** 
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antidiabetic'*^ and anti-inflammatory.^ ° Thiazolines are especially interesting 
because this heterocycle can be easily converted into thiazole or penicilline 
derivatives.^ * Further more the presence of two or more different heterocyclic 
moieties in a single molecule enhances the biocidal profile remarkably in 
comparison to individual moieties. 
Thus in the contmuation of our work on fused and spiro heterocycles of 
biocidal interest and guided by the observation that application of microwave 
irradiation for rapid organic synthesis has found wide spread use due to 
substantial reduction in time, we undertook the synthesis of spiro derivatives of 
steroids containing three fused different heterocyclic moieties i.e. 6-5p/>o-[3"'-
(2'"-phenyl-4"'-oxo-l"',3'"-thiazolidin-5"-yl)-l",3",4"-thiadiazolo-(3',4'-b)-
thiazolin]-5a-cholestanes 74, 3fi-Chlow-6-spiw-[r'-(2'"-pheny\-r'-1 "•,3"'-oxo-
thiazolidin-5"-yl)-l",3",4"-thiadiazolo-(3',4'-b)-thiazolin]-5a-cholestane 79, and 
3y9-acetoxy-6-j:;7/ro-[3'"-(2"'-phenyl-4"'-oxo-r",3"'-thiazolidin-5"-yI)-l",3",4"-
thiadiazolo-(3',4'-b)-thiazoIin]-5a-cholestane 84. The condensation of 5a-
cholestan-6-one 70, 3y5-chloro-5a-cholestan-6-one 75 and 3y5-acetoxy-5a-
cholestan-6-one 80 with thiosemicarbazide in presence of cone. HCl, gave 5a-
cholestan-6-one-thiosemicarbazones 71, 3;ff-chloro-5a-cholestan-6-one-
thiosemicarbazone 76 and 3y9racetoxy-5a-cholestan-6-one-thiosemicarbazone 81 
which on treatment with benzaldehyde gave r-benzylidine-4'-(5a-cholestan-6-
yl)thiosemicarbazone 72, 1 '-benzy lidin6-4'-(3/?-chloro-5a-cholestan-6-
yl)thiosemicarbazone 77 and r-benzylidine-4'-(3/?-acetoxy-5a-cholestan-6-
yl)thiosemicarbazone 82. Compounds (72, 77, 82) on refluxing with thioglycolic 
acid in methanol furnished 5a-cholestane-6-5p/>'o{[4'-oxo-r,3'-thiazoIidin-3"-
yl)thioureido]-l"-phenylmethylsulfanyl}acetic acid 73, 3y5-chloro-5a-cholestane-
6-spiro{[4'-oxo-1 •,3'-thiazolidin-3 "-yl)thioureido]-1 "-
phenylmethylsulfanyl}acetjc acid 78, 3y9-acetoxy-5a-cholestane-6-j'/?/>o{[4'-oxo-
r,3'-thiazolidin-3"-yl)thioureido]-l"-phenylmethylsulfanyl}acetic acid 83 which 
on further cyclodehydration with cone. H2SO4 furnished the title compounds (74. 
79, 84). 
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Reaction of 5a-cholestaii-6-one 70 with thiosemicarbazide: 
5a-cholestan-6-one-thiosemicarbazone 71 : 
NH2-C-NH-NH2 
70 
The mixture of 5a-cholestan-6-one 70, thiosemicarbazide, few drops of 
cone. HCl, in methanol was refluxed for an hour. After completion of reaction 
and usual work up, the solution was concentrated under reduced pressure. The 
residue on crystallization, provided shining needles of compound 71, m.p. 112-
114"C (reported^^ m.p. 112-114 "C), yield 88 % (also compared with authentic 
sample). 
This reaction was also performed by M.W. irradiation, yield 45 %. 
Characterization of compound 71 as 5a-cholestaii-6-one-thiosemicarbazone 
The obtained compound 71 was correctly analysed for C28H49N3S. Its IR 
spectrum exhibited characteristic absorption bands at 3510 (NH2), 3370 (NH), 
1590 (C=N) and 1180 cm"^  (C=S)." The 'H N M R spectrum of compound 71 
displayed a two-proton singlet at d 6.38 for N^2, another singlet for one (HH) 
proton at 6 8.8 (both exchangeable with deuterium) and a two-proton multiplet at 
1.76 (Cv-Zf?)- Angular and side-chain methyl protons were observed at ^ 1.12 
(Cio-Ci/j), 0.93 (Cn-C/fj), 0.83 and 0.69 (other side-chain methyl protons). '^' 
Thus, on the basis of above evidences the solid compound 71 has been 
characterized as 5a-cholestan-6-one-thiosemicarbazone. 
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Reaction of l'-benzylidine-4'-(5a-cholestan-6-ylUhiosemicarbazone 72 
with thioglvcolic acid in dioxane; 
5a-cholestane-6-spf>o(r4'-oxo-l',3'-thiaz6lidin-3"-vl)thioureido1-l"-
phenvlmethvlsulfanvUacetic acid 73 : 
The compound 72 was refluxed with thioglycolic acid in dioxane for 10 
h. After completion of reaction, the reaction mixture was concentrated under 
reduced pressure and residue was poured in ice cooled water. Organic layer was 
taken in diethyl ether and worked up usually. The solvents were evaporated and 
crude product on subsequent chromatographic purification afforded a solid 
compound 73 m.p. 109-111 "C, in 70 % yield. 
HSCHjCOOH 
H 
H N-N-C-N=C-C6H5 
H 
72 
H 
O S HO S 
n— 
73 O 
CRH 6^5 
The solid product 73 was also obtained with the help of microwave 
process, yield 40 %. 
Characterization of compound 73 as 5a-cholestane-6-spt>oir4'-oxo-l'.3'-
thiazolidin-3"-vI)thioureido1-l"-phenvlmethvlsulfanvUacetic acid : 
The compound 73 was correctly analyzed for C39H59N3O3S3, its IR spectrum 
exhibited characteristic absorption bands at3410(NH), 3240-2930 (OH of COOH), 
1694 (COOH), 1649 (C=0 of thiazolidinone rings), 1585, 1542, 1485, (aromatic 
ring), 1337 (C=S), 1370 (C-N), 1157 (N-N), and 712 cm"' (C-S-C)." Its 'H N M R 
spectrum displayed two singlets integrating for two protons at S 8.01 (2xN//. 
exchangeable with deuterium) and for one proton at 4.89(Cif-Ar), two other 
singlets, one for two protons at 3.30 (SC//2) and second for one-proton at 10.45 
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Reaction of 5a-cholestan-6-one-thiosemicarba2one 71 with 
benzaldehyde; 
l'-Benzvlidine-4'-f5fl-cholestan-6-vl)thiosemicarbazone72 ; 
A mixture of thiosemicarbazone 71 and benzaldehyde in methanol was 
refluxed for 2-3 h., after completion of reaction the reaction mixture was 
concentrated under reduced pressure then it was worked up and the product was 
purified by column chromatography to afford a solid compound 72, m.p. 115 C, 
yield 62 %. 
CeHsCHO 
H N-N-C-NH2 
H 
71 
H N-N-C-N=C-C6H5 
H 
72 
The compound 72 was also prepared with the help of microwave 
irradiation, yield 49 %. 
Characterization of compound 72 as l'-benzylidine-4'-(5A-cholestan-6-
vDthiosemicarbazone; 
The obtained solid product 72 was correctly analysed for C35H53N3S. Its 
IR spectrum showed important absorption bands at 3425 (NH), 1612 (C=N), 
1580, 1530, 1495 (aromatic ring) and 1275 cm '^ (C=S)/^ The 'H N M R spectrum 
of compound 72 displayed two singlets integrating for one proton each at ^ 9.4 
(exchangeable with deuterium) which was assigned to ISIH and at S 8.4 (CH=N) 
and a multiplet at 3 1.70 (CTHI) Five aromatic protons were observed at 6 13-
12. Angular and side-chain methyl protons appeared at ^ 1.15 (C10-C//3), 0.70 
(C13-C//3), 0.93, 0.81 (other steroidal side-chain methyl protons).^ '* Thus, on the 
basis of above discussion compound 72 has been characterized as I'-benzylidine-
4'-(5a-eholestan-6-yl)thiosemicarbazone. 
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was assigned to (COO//) and a two protons multiplet at 1.70 for Cv-//^ - Five 
aromatic protons appeared at d 6.90-7.26. Angular and side-chain methyl protons 
were observed at 1.16 (C10-C//3), 0.71 (C13-C//3), 0.94, 0.79 (other steroidal 
side-chain methyl protons).^ '* Thus, on the basis of foregoing discussion 
compound 73 has been characterized as 5a-cholestane-6-5p/ro{[4'-oxo-r,3'-
thiazoUdin-3"-yl)thioureido]-1 "-phenylmethylsulfanyl}acetic acid. 
Reactionof 5a-cholestane-6-spfrolf4'-oxo-l*,3'-thiazolidin-3"-
yl)thioureido1'l"-phenvlmethylsulfanyUacetic acid 73 with cone. H2SO4: 
6-spfro-r3"'-f2'"-phenvl-4"'-oxo-l"',3'"-thiazolidin-5"-vl)-l",3",4"-
thiadiazolo-(3'.4'-b)-thiazolinl-5a-cholestane 74 : 
The compound 73 was taken in ice cooled cone. H2SO4 and kept in ice 
bath for 2 h. with constant stirring. After completion of reaction, the reaction 
mixture was poured into ice cooled water and basified with liq. NH3. The 
precipitated product was dissolved in diethyl ether, usually worked up and 
purified by column chromatography which provided a semi-solid product 74, 
yield 60 %. 
H / N ' 
"S N N 
' L ,C-N < .CRH 6^5 
73 
cold cone. H2SO4 
^ S N—N 
74 o 
Compound 74 was also prepared with the help of microwave irradiation 
process, yield 33 %. 
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Characterization of compound 74 as 6-spf>o-f3"'-(2"'-phenvl-4"'-oxo-
l'".3'"-thiazolidin-5"-vl)-l",3".4"-thiadiazolo-f3',4'-b)-thiazolin1-5a-
cholestane: 
The product 74 was correctly analysed for C39H55N3OS3. Its IR spectrum 
exhibited characteristic absorption bands at 1695 (C=0 of thiazolidinone ring), 
1625 (C=C of thiazoline moiety), 1615 (C=N), 1570, 1543, 1478 (aromatic ring), 
1210 (C-N) and 680 cm"' (C-S-C)." In the 'H N M R spectrum of compound 74, 
two singlets at d 4.71 and 5.1 integrating for one proton each were assigned to -
CH=C of thiazoline moiety and to CH-Ai, respectively. Another singlet for two 
protons at (5 3.33 was assigned to CH2S of thiazolidinone moiety. Five aromatic 
protons appeared at S 6.90-7.12 and a multiplet was observed at S 1.73 for C7-
H2. Angular and side-chain methyl protons were observed at <5 1.16 (C10-C//3), 
0.70 (C13-C//3), 0,90, 0.81 (other steroidal side-chain methyl protons).^ '^  
In its C NMR spectrum characteristic signals were observed at S 172.69, 
46.80 and 36.14 for the carbonyl, methine and methylene carbon atoms of 
thiazolidinone ring, respectively. Other important signals were observed at S 
152.09 for C=N of thiadiazole ring, S 128.58 for >C= and S 117.69 for HC= of 
thiazoline ring. Carbon atoms of phenyl ring were appeared at S 129.39-137.93. 
Signals at S 70.73, 56.82, 41.03, 18.70 were attributed to Cg, C5, C7, C3 of 
steroidal skeleton, respectively. Thus, on the basis of above evidence the semi-
solid product 74 has been characterized as 6-j/7/ro-[3"'-(2'"-phenyI-4"'-oxo-
l"',3'"-thiazolidin-5"-yl)-l",3",4"-thiadiazolo-(3',4'-b)-thiazolin]-5a-cholestane. 
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Reaction of 3g-chIoro-5a-cholestan-6-one 75 with thiosemicarbazide: 
3^-chloro-5a-cholestan-6-one-thiosemicarbazone 76 : 
NH2-C-NH-NH2 
^~ 
H O H N-N-C-NH, 
H 
75 76 
Steroidal ketone 75 was allowed to reflux with thiosemicarbazide in 
methanol in presence of few drops of cone. HCl for an hour, after completion of 
reaction, usual work up of reaction mixture and further crystallization of the 
product afforded thiosemicarbazone 76 as a solid, m.p. 135-136 '^ C, (reported" 
m.p. 136 "C), yield 92 %. 
This reaction was also done by microwave irradiation with yield 40 %. 
Characterization of the compound 76 as 3^-chloro-5a-cholestan-6-one-
thiosemicaibazone : 
The obtained product 76 was analysed for C28H4gClN3S (Beilstein 
Positive). IR spectrum of the compound showed characterstic absorption bands 
at 3515 (NH2), 3350 (hfH), 1580 (C=N), 1170 (C=S) and 710 cm"' (C-Cl).^ ^ The 
'H N M R spectrum of the compound displayed a one proton singlet at ^ 9.4 for 
N/f, and another singlet at 6.52 for N^2 (both of these signals were 
exchangeable with deuterium). A single proton multiplet appeared at ^ 3.9 {W^/2 
17.5 Hz) for Csa-H another multiplet was observed at 5 1.71 for Cq-Hi- Angular 
and side-chain methyl protons were observed at J 1.12 (Cio-C/Zj), 0.93 (C13-
CH3), 0.82 and 0.68 (other side-chain methyl protons).^ "* Thus, on the basis of 
above data compound 76 has been characterized as 3;S-chloro-5«-cholestan-6-
one-thiosemicarbazone (also compared with authentic sample). 
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Reaction of 3)g-chloro-5«-cholestan-6-one-thiosemicarbazone 76 with 
benzaldehvde : 
l'-Benzylidine-4'-(3j8-chloro-5a-choIestan-6-vUthiosemicarbazone 77: 
H N-N-C-NHo 
H 
S H 
^ N-N-C-N^C-CgHs 
H 
76 •• 77 
Thiosemicarbazone 76 was refluxed with benzaldehvde in methanol for 3 
h. After completion of reaction, the reaction mixture was concentrated, worked 
up and purified as before to provide a solid compound 77. m.p. 140 "C, \ield 
69 %. 
The compound 77 was also obtained with the help of microwave 
irradiation, yield 43 %. 
Characterization of compound 77 as l'-benzvIidine-4'-(3/g-chloro-5fl-
choIestan-6-yl)thiosemicarbazone: 
The compound 77 was analysed correctly for C35H52CIN3S (positive 
Beilstein test). IR spectrum showed bands at 3433 (NH). 1599 (C=N). 1570. 
1550. 1505 (aromatic ring), 1280 (C=S), 1155 (N-N) and 738 cm"' (C-Cl)."The 
strong bands at 1570-1505 cm"' indicated the presence of phenyl group. The 'H 
NMR spectrum of compound 77 displayed two singlets integrating for one 
proton each at S 8.9 (N//, exchangeable with deuterium), and at 8.1 (C//=N). A 
muhiplet integrating for one proton appeared at d 4.12 {Ci,a-H W Vi 17 Hz. 
axial), and another multiplet for two protons at 1.76 for C7-//2. Five aromatic 
protons were observed at S 7.0-6.9. Angular and side-chain meth\l protons 
appeared at S 1.14 (Cio-CZ/j). 0.71 (Cu-CFh). 0.92. 0.82 (other steroidal side-
chain methyl protons).^ "* Thus, on the basis of above discussion, the product 77 
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has been characterized as r-benzylidine-4'-(3yS-chloro-5a-cholestan-6-
yl)thiosemicarbazone. 
Reaction of l'-benzvlidine-4'-(3^-chloro-5a-cholestan-6-
ylUhiosemicarbazone 77 with thioglvcolic acid in dioxane : 
3^-chloro-5a-cholestane-6-sp/roU4'-oxo-l',3'-thiazolidin-3"-yl) 
thioureidol-l"-phenylmethylsulfanvl)acetic acid 78: 
A mixture of compound 77 and thioglycolic acid in dioxane was refluxed 
for 10 h. After completion of reaction, the reaction mixture was concentrated and 
poured into ice cooled water, and organic layer was taken in diethyl ether. After 
work up and purification by column chromatography a solid compound 78 
having m.p. 142 '^C was obtained in 65 % yield. 
Thioglycolic acid CI 
= I' ^ H ^ 
H N-N-C-N=C-CfiH 
H 
H 
H s N—N H 
'ens L4 ,c-N , 
O S HO s 
CRH 61^5 
77 78 
The solid compound 78 was also obtained via microwave process, yield 
52 %. 
Characterization of compound 78 as 3^-chloro-5fl-cholestane-6-spfro{[4'-
oxo-l';3'-thiazolidin-3"-vI)thioureidol-l"-phenvlmethvlsulfanvl}acetic 
acid; 
The solid product 78 was correctly analysed for C39H58CIN3O3S3 
(Positive Beilstein test), its IR spectrum showed strong bands at 3395 (N-H). 
3242-2950 (OH of COOH), 1708 (COOH), 1648 (C=0 of thiazoHdinone rings). 
1576, 1556, I486 (aromatic ring), 1390 (C-N) 1332 (C=S), 1160 (N-N) and 732 
cm' (C-Cl). The 'H NMR spectrum showed five aromatic protons at S 7.26-
6.82, a singlet for two protons at 8.6 (2xN//, exchangeable with deuterium), two 
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other singlets each for one proton at 4.81 (C//-Ar), 10.68 (COOH) and a one-
proton multiplet at 4.14 (Csa-H, W 'A 17.5 Hz , axial). A multiplet at d 1.54 (Cy-
Hi) and a singlet for two protons at 3.21 (SC//2) were also appeared. Angular 
and side-chain methyl protons were observed at (5 1.16 (Cio-C^s), 0-70 (C13-
Cifs), 0.93, 0.80 (other steroidal side-chain methyl protons).^ "^  Thus, on the basis 
of above spectral data the compound 78 has been characterized as 3;S-chloro-5a-
cholestane-6-spiro {[4'-oxo- r,3'-thiazolidin-3"-yl)thioureido]-1 "-
phenylmethylsulfanyl} acetic acid. 
Reaction of 3^-chloro-5A-cholestane-6-5pf'ro{f4'-oxo-l ',3*-thiazolidin-3"-
vl)thioureido1-l"-phenvlmethvlsulfanvllacetic acid 78 with cone. 
H2SO4: 
3^-Chloro-6-spf>o-r3"'-(2"'-phenvl-4'"-l"',3"'-oxo-thiazolid!n-5"-vl)-
l",3",4"-thiadiazolo-f3',4'-b)-thiazolin1-5a-cholestane 79 : 
A mixture of compound 78 and ice cooled cone. H2SO4 was stirred over 
an ice bath for 3 h. After completion of reaction the reaction mixture was poured 
into ice cooled water and basified with liq. NH3. Usual work up and purification 
of precipitated organic solid provided a semi-solid product 79, yield 61 %. 
^ ^ ^ ^ \ ^ H cold cone. H2SO4 I I J 
O S HO S S 1 1 
CI 
78 ° 79 
The compound 79 was also prepared with the help of microwave 
irradiation method, yield 31.9 %. 
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Characterization of compound 79 as 3^-chloro-6-spiro-f3"'-(2"'-phenvl-
4'"-oxo-l'",3'"-thiazolidin-5"-vl)-l",3",4"-thiadia2olo-(3',4'-b)-thiazolinl-
5A-cholestane; 
The semi-solid product 79 was correctly analysed for C39H54CIN3OS3 
(Beilstein Positive). Its IR spectrum exhibited bands at 1680 (CK) 
thiazolidinone moiety), 1612 (C=N), 1622 (C=C of thiazoline moiety), 1584, 
1550, 1489 (aromatic), 1225 (C-N), 665 (C-S-C) and 735 cm"' (C-Cl).^^ The ' H 
hJMR spectrum of compound 79 showed five aromatic protons at 6 6.82-7.16. 
Two singlets integrating for one and two protons were observed at 6 4.70 and 
3.30 which were assigned to C^=C of thiazoline moiety and C//2S of 
thiazolidinone ring, respectively. Another one proton singlet appeared at S 5.03 
for C//-Ar, a multiplet at 4.16 for one proton (C^a-H) and another multiplet at 
1.74 for two protons of C-J-H2. Angular and side-chain methyl protons were 
observed at 1.18 (Cjo-Ci/j), 0.75 (Cu-CHj), 0.97, 0.80 (other steroidal side-
chain methyl protons). '^* 
In its '^ C NMR spectrum characteristic signals were observed at S 172.51, 
46.07 and 36.32 for the carbonyl, methine and methylene carbon atoms of 
thiazolidinone ring, respectively. Other important signals were observed at 3 
151.19 for C=N of thiadiazole ring, S 127.89 for >C= and 6 116.78 for HC= of 
thiazoline ring. Carbon atoms of phenyl ring were appeared at S 129.08-138.68. 
Signals at S 69.59, 55.85, 51.62, 42.12 were attributed to Cg, C5, C7 , C3 of 
steroidal skeleton, respectively. 
Thus, on the basis of above evidence the semi-solid product 79 has been 
characterized as 3/ff-chloro-6-^/7j>o-[3'"-(2"'-phenyl-4"'-oxo-1 •",3'"-thiazolidin-5"-
y 1)-1 ",3",4"-thiadiazolo-(3',4'-b>thiazolin]-5a-cholestane. 
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Reaction of 3^-acetoxv-5a-cholestan-6-one 80 with thiosemicarbazide : 
3jg-Acetoxy-5a-cholestan-6-one-thiosemicarbazone 8 1 ; 
AcO 
s 
NH2C-NH-NH2 
*-
AcO S 
H N-N-C-NH2 
81 ^ 
A mixture of ketone 80, thiosemicarbazide and few drops of cone. HCl in 
methanol was refluxed for an hour. After completion of reaction and usual work 
up, the solution was concentrated under reduced pressure and the residue was 
crystallized which provided a solid compound 81, m.p. 128-129 "C, (reported^^ 
m.p. 128 ^C) yield 94 %. 
This reaction was also done by microwave irradiation process with yield 
41 %. 
Characterization of the compound 81 as 3^-acetoxv-5fi>cholestan-6-one-
thiosemicarbazone : 
The obtained crystallized product 81 was correctly analysed for 
C30H51N3O2S. The IR spectrum exhibited characterstic absorbtion bands at 3500 
(NH2), 3355 (NH), 1735 (OCOCH3), 1498 (C=N), 1175 (C=S) and 1040 cm"' 
(C-0)/"' The ' H N M R spectrum of compound 80 displayed a singlet at S 9.3 
integrating for one proton which was assigned to NH (exchangeable with D2O), 
a broadened singlet appeared at 6.39 (disappeared on addition of D2O) 
integrating for two protons was ascribed to N//2. A single proton multiplet 
appeared at d 4.69 {W^/218 Hz) for C^a-H, and a multiplet for two protons (C7-
H2) at S 1.72. Methyl protons of acetate appeared as a sharp singlet of three 
protons at S 2.01. Angular and side-chain methyl protons were observed at S 
1.15, 0.69, 0.93 and 0.81.^* Thus, on the basis of above analytical and spectral 
data, compound 81 has been characterized as 3y8-acetoxy-5a-cholestan-6-one-
thiosemicarbazone. 
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Reaction of 3/3-acetoxv-5A-cholestan-6-one-thiosemicarbazone 81 with 
benzaldehvde in methanol; 
l'-Benzyiidine-4'-(3jg-acetoxv-5a-cholestan-6-vlUhiosemicarbazone 82: 
CeHsCHO 
H N-N-C-N=C-C6H5 
81 " 82 
A mixture of thiosemicarbazone 81 and benzaldehyde in methanol was 
refluxed for 2.5 h. The reaction mixture was concentrated under reduced 
pressure, worked up and the product was purified by column chromatography, 
which afforded compound 82, m.p. 133-135 ^ C, yield 67 %. 
The compound 82 was also prepared with the help of microwave 
irradiation, yield 41 %. 
Characterization of compound 82 as l'-benzvlidine-4'-(3/g-acetoxv-5a-
cholestan-6-vl)thiosemicarbazone : 
Compound 82 was correctly analysed for C37H55N3O2S. The IR spectrum 
showed important absorption bands at 3440 (NH), 1737 (OCOCH3), 1610 
(C=N), 1595, 1545, 1500 (aromatic ring) and 1315 cm"' (C=S)" The 
appearance of a singlet in 'H NMR spectrum of compound 82 at S 9.1 
integrating for one proton was assigned to 'NH (exchangeable with deuterium). 
Five aromatic protons appeared at S 7.3-7.0. Another singlet integrating for one 
proton at S 8.5 was attributed to olefmic proton {CH=N). A broad multiplet for 
one proton (C^a-H) appeared at S 4.79 and another multiplet for two protons at S 
1.79 (C-r-Hi). A singlet was observed at S 2.01 for three methyl protons of 
acetoxy group. Angular and side-chain methyl protons were observed at 1.16 
(Cio-Ci/3), 0.73 (Cis-C/fs), 0.94, 0.83 (other steroidal side-chain methyl 
protons).^  Thus, on the basis of above characteristic evidences, the solid product 
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82 has been characterized as r-benzylidine-4'-(3yff-acetoxy-5a-cholestan-6-
yl)thiosemicarbazone. 
Reaction of l'-Beiizvlidine-4'-(3^-acetoxv-5fl-chole8tan-6-
vnthiosemicarbazone 82 with thioglvcolic acid in dioxane; 
3^-acetoxv-5a-cholestane-6-spfro(f4'-oxo-l'^'-thiazolidin-3"-
vlUhioureido1-l"-phenvlmethvlsulfanvHacetic acid 83 : 
Compound 82 was refluxed with thioglycolic acid in dioxane for 10 h., 
after completion of reaction, reaction mixture was concenterated under reduced 
pressure. The residue was poured in ice cooled water, organic layer was taken in 
diethyl ether and worked up in usual manner. The crude product was further 
purified by recrystallization from methanol to afford compound 83, m.p. 130-
131 T , yield 62%. 
AcO 
HSCH2COOH 
u II II I 
" N-N-C-N=C-C6H5 
2- Acd^f>C. / 
H 
82 
0 S HO S 
Compound 83 was also prepared with the help of microwave irradiation 
process, yield 46 %. 
Characterization of compound 83 as 3jg-acetoxy'-5<t-cholestane-6-
st?fro{r4'-oxo-l'^'-thiazolidin-3"-viUhioureidol-l"-
phenvlmethvlsulfanvllacetic acid; 
The product 83 was correctly analysed for C41H61N3O5S3. Its IR spectrum 
exhibited important absorption bands at 3405 (NH), 3235-2940 (OH of COOH) 
1738 (OCOCH3), 1702 (COOH), 1645 (C=0 of thiazolidinone ring), 1583. 
1535. 1480 (aromatic ring). 1378 (C-N), 1335 (C=S). 1238 (C-O) and 1170 cm'' 
(N-N). ^ The 'H N M R spectrum of the compound displayed a singlet for two 
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protons at S 8.31 2xNi / (exchangeable with deuterium). Five aromatic protons 
appeared at S 6.87-7.05. Two singlets were seen at d 3.34 and 2.04 for two 
protons (CH2S) of thiazolidinone rings and three methyl protons of acetate 
group, respectively. Two singlets for one proton each at S 4.95 and 10.78 were 
ascribed to CH-Ai and (COOH), respectively. A multiplet appeared at S 4.72 
(W^/215.9 Hz, axial) for C^a-Hand another muhiplet for two protons at 1.57 (C7-
H2). Angular and side-chain methyl protons were observed at (5 1.15 (C10-C//3), 
0.74 (Ci3-C^3), 0.93, 0.82 (other steroidal side-chain methyl protons).^'* Thus, on 
the basis of above evidences the compound 83 has been characterized as 3/^-
acetoxy-5«-cholestane-6-j/7/A-o{[4'-oxo-1 ',3'-thiazolidin-3 "-yl)thioureido]-1 "-
phenylmethylsulfanyl}acetic acid. 
Reaction of 3^-acetoxv-5a-cholestane-6-s;?f>o(f4'-oxo-l',3'-thiazolidin-
3"-yl)thioureido1-l"-phenvlmethvlsulfanvllacetic acid 83 with cone. 
H2SO4: 
3^-acetoxv-6-spfro-r3"'-r2"'-phenvl-4'"-oxo-l'",3'"-thiazolidin-5"-vl)-
l".3",4"-thiadiazolo-(3',4'-b)-thiazolin1-5fl-cholestane 84 ; 
ONJ' H r^tV 
ACO ^ ^ ^ _ ^ co.dconcH.SO. i ^ ^ 
O S H O S ^ S ' 1 ^ 
83 ^— cr^^ 
o:> O 84 ^ 
The compound 83 was stirred in ice cooled cone. H2SO4 over an ice bath 
for 2 h. 45 min. The reaction mixture was poured into ice cooled water and 
basified with liq. NH3. Crude precipitated product was taken in diethyl ether and 
worked up as before. Further purification provided a semi-solid product 84, yield 
40.7 %. 
The compound 84 was also prepared with the help of microwave 
irradiation method, yield 34 %. 
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Characterization of compound 84 as 3^-acetoxy-6-s;?f>o-f3"'-(2"'-phenyl-
4"'-oxo-l'".3"'-thiazolidin-5"-vn-l".3".4"-thiadiazolo-(3'.4'-b)-thiazolin1-
5fl-cholestane; 
The compound 84 was correctly analysed for C41H57N3O3S3. Its IR 
spectrum exhibited characteristic absorption bands at 1735 (OCOCH3), 1690 
(C=0 of thiazolidinone ring), 1620 (C=C), 1608 (C=N), 1579, 1548, 1497 
(aromatic), 1230 (C-N) and 675 cm"^  (C-S-C)." The 'H N M R spectrum of 
compoimd 84 displayed two singlets integrating for one proton each at 6 4.73 
and 5.05 for -CH=C of thiazoline and -CH-Ar of thiazolidinone moieties, 
respectively. Two other singlets for two and three protons appeared at <5 3.31 (S-
CH2- of thiazolidinone ring) and 2.01 (OCOCH3), respectively. Five aromatic 
protons were observed at d 6.94-7.21 and C^a proton as a multiplet centered at S 
4.83 (WY2 18 Hz, axial). A multiplet at <5 1.71 for two protons of C7-//2 was also 
seen. Angular and side-chain methyl protons were observed at ^ 1.14 (C10-C//3), 
0.70 (C13-C7/3), 0.91, 0.81 (other steroidal side-chain methyl protons).^ "* 
In its '^ C NMR spectrum, characteristic signals were observed at S 
173.40, 46.56 and 36.58 for the carbonyl, methine and methylene carbon atoms 
of thiazolidinone ring, respectively. Other important signals were observed at S 
151.87 for C=N of thiadiazole ring, d 127.98 for >C= and S 117.42 for HC= of 
thiazoline ring. Carbon atoms of phenyl ring were appeared at ^ 128-138.40. 
Signals at S 72.62, 69.98, 52.90, 43.18 were ascribed to Cg, C5, C7, C3 of 
steroidal skeleton, respectively.Thus, on the basis of above evidence the semi-
solid product 84 was characterized as 3y9-acetoxy-6-5/7/ro-[3"'-(2"'-phenyl-4"'-
oxo-l"',3"'-thiazolidin-5"-yl)-r',3",4"-thiadiazolo-(3',4'-b)-thiazolin]-5a-
cholestane. 
A mechanism has been proposed for the formation of compounds 74, 79, 84 
(Scheme 1) as follows : 
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CeHsCHO 
S 
H !• >> 
N-N-C-NH2 
H 
(70,75,80) 
N-NC-N=C-C6H5 
H 
(a) 
HSCH2COOH 
H -2H2O 
r^V 
"Mil .CRH 6^5 
H / \ ^^ S u H 
d ^ * 
HoC 
\ 
HO-C 
(b) 
N—N 
HO HS l ^ S 
CeHs 
S N—N 
(d) 
H2OJ) HS ^ ^ S 
(e) 
-H2O 
-H^ H S N—N 
75,79,84 d ^ ^ 
PeHs 
R = H, CI, OAc 
Scheme-l 
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All melting points were observed in the capillary tube and are 
uncorrected, infrared (IR) spectra were recorded in KBr pellets/ Nujol with 
spectrolab interspec 2020 FT-IR spectrometer and values are given in cm" . H 
NMR spectra were measured on a 300 MHz instrument and '^ C NMR spectra on 
a Bruker Avance II 400 spectrometer at 100 MHz, using TMS as internal 
standard and CDCI3 as solvent. Chemical shift (6) were expressed in ppm 
downfield from internal standard TMS. The abbreviation s, d, dd, m, br denote 
"singlet, doublet, double doublet, multiplet, broad respectively. Thin layer 
chromatography (TLC) plates were coated with silica gel G and exposed to 
iodine vapours, 20% perchloric acid. Pet-ether refers to a fraction of b.p. 60 - 80 
°C. Anhydrous sod. sulphate (Na2S04) was used as drying agent. 
Cholest-5-ene : 
3y9-Chlorocholest-5-ene (10 g) was dissolved in warm amyl alcohol (230 
ml) and sodium metal (20 g) was added to the solution with continous stirring 
over a period of 8 h. The reaction mixture was warmed occasionally. When all 
the sodium was dissolved, the reaction mixture was poured into water, acidified 
with dilute hydrochloric acid and allowed to stand over night. A white 
crystalline solid thus obtained was filtered under suction and washed thoroughly 
with water and air-dried. The crude material was recrystallized from acetone to 
provide cholest-5-ene, m. p. 88-89 °C (reported" m.p. 89-91 °C), yield 83 %. 
6-Nitrocholest-5-ene : 
A suspension of finely powdered cholest-5-ene (6.0 g), in glacial acetic 
acid (50 ml) was stirred at room temperature for 5 min. Fuming nitric acid (15 
ml; d, 1.52) was rapidly added. Sodium nitrite (3 g) was added gradually over a 
period of 1 h. with stirring and stirring was continued for 2 h. The temperature of 
the reaction mixture was kept between 20-25 °C by external cooling. Cold water 
was added a yellow solid thus obtained was filtered under suction, washed 
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thoroughly with water and air dried. RecrystalHzation from methanol furnished 
6-nitrocholest-5-ene, m.p. 119-120 ^ C (reported^^ m.p. 120-121 ^C), yield 53 %. 
5a-Cholestan-6-one 70 : 
6-Nitrocholest-5-ene (6 g) was dissolved in glacial acetic acid (200 ml) by 
heating and to this solution zinc dust (12.0 g) was added in small portions. After 
the initial exothermic reaction had subsided, the suspension was heated under 
reflux for 3 h., and water (24 ml) was added now and then during the course of 
reaction. The solution was then filtered and the residue was washed with 40 ml 
warm acetic acid.To the filtrate was added a few ml of water till turbidity 
developed and it was allowed to stand over night at room temperature. The 
crystalline material thus separated was filtered under suction and washed 
thoroughly with water in order to remove zinc acetate. The organic solid was air 
dried and its recrystallization firom ethanol afforded 5a-cholestan-6-one 70, m.p. 
96-98 "€ (reported" m. p. 98-100 °C), yield 60 %. 
5a-Cholestan-6-one-thiosemicarbazone 71 : 
Method - A (Classical method) : 
To a boiling solution of ketone 70 (3.5 g, 9.06 mmol) in methanol (20 
ml), a few drops of cone. HCl were added followed by the addition of solution of 
thiosemicarbazide (0.836 g, 9.19 mmol) in methanol (15 ml) with stirring. The 
reaction mixture was refluxed for 1 h and cooled. The heavy precipitate thus 
obtained was collected by filteration and purified by recrystallization from 
methanol to give thiosemicarbazone 71 as shining needles m.p. 112-114 C^ 
(reported" m.p. 112-114 °C), yield 88 %. 
Method - B (Microwave method) : 
An equimolar mixture of ketone 70 (3.5 g, 9.06 mmol) and 
thiosemicarbazide (0.8365 g, 9.19 mmol) adsorbed on silica gel (mesh 100-200) 
was placed under microwave irradiation for 4-6 min, after completion of reaction 
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(monitored by TLC) the reaction mixture was kept at room temp, for 5 min. and 
then extracted purified and crystallized as in classical method yield 45 %. 
Analysis found 
C28H49N3S requires 
IR (KBr) 
C, 73.15; H, 10.69; N, 9.18. 
C, 73.20; H, 10.67; N, 9.15%. 
Vmax 3510 (NH2), 3370 (NH), 1590 (C=N), 1180 
cm-' (C=S). 
*H NMR (CDCI3) : d 8.8 (s, IH, N//, exchangeable with deuterium), 
6.38 (s, 2H, NH2, exchangeable with deuterium), 
1.76 (m, 2H, C7-H2), 1.12 (3H, s, C1Q-CH3), 0.93 
(3H, s, Ci3-C//j), 0.83, 0.69 (other steroidal side-
chain methyl protons). 
l*-Benzvlidine-4'-(5a-cholestane-6-ylUhiosemicarbazone72 : 
Method - A (Classical method) : 
A solution of compound 71 (2 g, 4.35 mmol), in methanol (25 ml) was 
refluxed with benzaldehyde in equimolar ratio for 2-3 h. After completion of 
reaction (monitored by TLC), solvents were removed under reduced pressure 
and the residue thus obtained was purified over silica gel column using light pet. 
ether : diethyl ether (4:1) as eluant. Recrystallization from ethanol afforded 1'-
benzylidine-4'-(5a-cholestane-6-yl)thiosemicarbazone 72, m.p. 115 V , yield 
62 %. 
Method - B (Microwave method) : 
The equimolar mixture of thiosemicarbazone 71 (2 g, 4.35 mmol) and 
benzaldehyde was placed for microwave irradiation for 5-6 min. After 
completion of reaction (monitored by TLC), the reaction mixture was taken in 
diethyl ether, filtered, purified by column chromatography and recrystallized as 
in classical method which afforded compound 72, yield 49 %. 
Analysis found : C, 76.66; H, 10.01; N, 7.64. 
C35H53N3S requires : C, 76.73; H, 9.75; N, 7.67 %. 
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IR(KBr) : v„,ax 3425 (NH), 1612 (C=N), 1580, 1530, 1495 
(aromatic), 1275 cm''(C=S). 
^H NMR (CDCI3) : 6 9.4 (s, IH, N//, exchangeable with deuterium), 8.4 
(s, IH, Cif=N), 7.3-7.2 (m, 5H, ATH), 1.70 (m, 2H, 
C7 - H2\ 1.15 (3H, s, C10-CH3), 0.70 (3H, s, C,3-
CH3), 0.93, 0.81 (other steroidal side-chain methyl 
protons). 
5«-cholestane-6-sptrQ<r4'-oxo-l'^'-thiazolidin-3"-vnthioureido1-l"-
phenylmethylsulfanyHacetic acid 73; 
Method - A (classical method) : 
To a solution of compound 72 (1.0 g, 1.82 mmol), in dioxane (20 ml), 
thioglycolic acid in equimolar amount was added and the reaction mixture was 
refluxed for 10 h. After completion of reaction (monitored by TLC), excess of 
the solvent was removed under reduced pressure and the resulting residue was 
poured in excess of ice cooled water. The organic layer was taken in diethyl 
ether, washed with NaHCOs (5%) solution and water and dried over anhyd. 
Na2S04. The crude material obtained was recrystallized from methanol to give 
compound 73 m.p. 109-111 "C, yield 70 %. 
Method - B (Microwave method): 
To a solution of compound 72 (1.0 g, 1.82 mmol) in dioxane, thioglycolic 
acid in equimolar amount was added and subjected for microwave irradiation for 
5-6 min. After completion of reaction (monitored by TLC) product 73 was 
purified and crystallized as in classical method, yield 40 %. 
Analysis found 
C39H59N3O3S3 requires 
IR (KBr) 
C, 65.57; H, 8.31; N, 5.84. 
C, 65.60; H, 8.33; N 5.89 %. 
Vmax 3410 (NH), 3240-2930 (OH of COOH), 1694 
(COOH), 1649 (CK) of thiazolidinone rings). 
1585. 1542, 1485 (aromatic). 1370 (C-N). 1337 
(C=S), 1157 (N-N), 712 cm"' (C-S-C). 
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' H N M R ( C D C I J ) : d 10.45 (s, IH, COO/f), 8.01 (br s, 2H, N// ,X2 
exchangeable with deuterium), 6.90-7.26 (m, 5H, 
AxH), 4.89 iCH-Ai), 3.30 (s, 2H, -C//2-S), 1.70 
(m, 2H, C-j-Hi), 1.16 (3H, s, C10-C//3), 0.71 (3H, 
s, C13-C//5), 0.94, 0.79 (other steroidal side-chain 
methyl protons). 
6-spt>o-r3"'-(2"'-phenvl-4"'oxo-l"',3"'-thiazolidin-5"-yl)-l",3",4"-
thiadiazolo-(3',4'-b)-thiazolin1-5a-cholestane74 ; 
Method - A (classical method); 
The compound 73 (0.5 g, 0.719 mmol) was taken in ice cooled H2SO4 (5 
ml) and kept in ice bath for 2 h with constant stirring. After completion of 
reaction monitored by TLC, the reaction mixture was poured into ice cooled 
water and basified with liq. NH3. The precipitate obtained was dissolved in 
diethyl ether, washed with water several times and dried over anhyd. sodium 
sulphate. Evaporation of solvents provided an oily residue which was purified by 
column chromatography using silica gel column and pet. ether - diethyl ether 
(2:1) as an eluant to give, 6-5/7/ro-[3"'-(2'"-phenyl-4'"-oxo-l'",3"'-thiazolidin-5"-
yl)-l",3",4"-thiadiazolo-(3',4'-b)-thiazolin]-5a-cholestane 74 as noncrystallizable 
semi-solid, yield 60 %. 
Method - B (Microwave method) ; 
Compound 73 was taken in cone. H2SO4 and subjected for microwave 
irradiation to 10 min. After completion of reaction (monitored by TLC), the 
reaction mixture was poured into ice cooled water and basified with liquid 
ammonia. The precipitated product was further purified as in classical method 
which provided compound 74 as noncrystallizable semi-solid, yield 33 %. 
Analysis found : C, 69.05; H, 8.20; N, 6.18. 
C39H55N3OS3 requires : C, 69.08; H, 8.18; N; 6.20 %. 
IR(Nujol) : v^ ax 1695 (C=0 of thiazolidinone ring), 1625 
(C-C of thiazoline ring), 1615 (C=N), 1570, 
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1543, 1478 (aromatic), 1210 (C-N), 680 cm"' 
(C-S-C). 
S 6.90-1 A2 (m, 5H, ArH), 5.1 (s, IH, CH-Ar), 
4.71 (s, IH, -CH=C), 3.33 (s, 2H, -C/fj-S), 1.73 
(m, 2H, C7-//2), 1.16 (3H, s, C,o-C//j ), 0.70 
(3H, s, C,3-C//5 ), 0.90, 0.81 (other steroidal 
side-chain methyl protons). 
S 36.70 (C,), 28.07 (C2), 18.70 (C3), 56.80 (C4), 
56.82 (C5), 70.73 (Cg), 41.03 (C7), 28.11 (Cg), 
53.95 (C9), 12.08 (do), 21.57 (C,,), 39.52 
(C,2), 43.03 (Cn), 28.11 (CH) , 53.95 (€,5), 
22.89 (C,6), 56.06 (Cn), 13.21 (Cig), 12.61 
(C,9), 30.08 (C20), 18.91 (C2,), 35.76 (C22). 
24.04 (C23), 37.98 (C24), 30.73 (C25), 22.63 
(C26), 22.58 (C27), (172.69) ( C ^ ) , (152.09) 
(C=N), (128.58) (>C=),(117.69) (HC=), 46.80 
(CH), 36.14 (CH2), 129.39-137.93 ( C-of 
phenyl). 
3^-Chloro-cholest-5-ene : 
Freshly purified thionyl chloride (75 ml) was added gradually to 
cholesterol (100 g) at room temperature. A vigorous reaction ensued with the 
evolution of gaseous products. When the reaction slackened, the reaction 
mixture was, gently heated at a temperature of 50-60 *^C on a water bath for one 
hour, and then poured into cold water with constant stirring. The yellow solid 
thus obtained was filtered under suction, washed several times with cold water 
and air-dried. Recrystallization from acetone gave 3y5-chlorocholest-5-ene, m.p. 
95 V (reported^^ m.p. 96-97 V), yield 97 %. 
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3jg-Chloro-6-nitrocholest-5-ene: 
To a well stirred mixture of 3/8-chlorocholest-5-ene (12 g), glacial acetic 
acid (100 ml) and fuming nitric acid (25 ml) at room temperature, was added 
sodium nitrite (3.6 g) gradually over a period of 1 h. After the complete addition 
of sodium nitrite, the mixture was further stirred for 1 h. The content was diluted 
by the addition of water (200 ml) and stirring was continued for 10 min. more. 
The yellowish solid thus separated was filtered, washed with cold water and air 
dried. The crude product was recrystallized from methanol to give 3/9-Chloro-6-
nitrocholest-5-ene, m.p. 150-152 "C (reported^^ m.p. 153^0), yield 60 %. 
3/3-Chloro-5a-cholestan-6-one 7 5 : 
To a solution of 3/5-chloro-6-nitrocholest-5-ene (6 g) in hot glacial acetic 
acid (140 ml), zinc dust (12 g) was added gradually in small portions with 
constant shaking. The suspension was heated under reflux for 4 h. and water (10 
ml) was added at regular intervals during the course of heating. The hot solution 
was filtered to remove unreacted zinc powder and the filtrate was cooled to room 
temperature, followed by dilution with large excess of ice-cooled water. The 
organic matter was extracted with diethyl ether and ethereal solution was washed 
with NaHCOs solution (10 %) and water, and dried (anhyd. Na2S04). 
Evaporation of the solvents gave an oil which was crystallized from methanol to 
give compound 75 m.p. 127-129 V (reported^** m.p. 127-128 V), yield 63 %. 
3jg-Chloro-5a-cholestan-6-one-thiosemicarbazone 7 6 : 
Method " A (Classical method) : 
To a solution of boiling 3y5-chloro-5a-cholestan-6-one 75 (3.5 g, 8.32 
mmol) in methanol (25 ml), few drops of cone. HCl were added followed by the 
addition of solution of thiosemicarbazide (0.766 g, 8.41 mmol) in methanol (15 
ml) with stirring. The reaction mixture was refluxed for 1 h and cooled. The 
heavy precipitate thus obtained was collected by filtration and purified by 
recrystallization from methanol to give thiosemicarbazone 76 as crystalline 
solid, m.p. 135-136 '^ C (reported^^ m.p. 136 °C), yield 92 %. 
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Method - B (Microwave method) : 
A mixture steroidal ketone 75 (3.5 g, 8.32 mmol) and thiosemicarbazide 
(0.766 g, 8.41 mmol) was similarly adsorbed on silica gel (mesh 100-200 ) and 
placed under microwave irradiation for 5-6 min., after completion of reaction 
(monitored by TLC) the reaction mixture was kept at room temp, for 5 min. and 
then extracted, purified and crystallized as in classical method to afford 
compound 76, yield 40 %. 
(Beilstein positive) 
C, 68.11;H; 9.74; N, 8.47. 
C, 68.08; H, 9.72; N, 8.51%. 
Analysis found 
CasKjgCI NjSrequires 
IR (KBr) 
'H N M R (CDCI3) 
Vmax 3515 (NH2), 3350 (NH), 1580 (C=N), 1170 
(C=S), 710 cm-' (C-Cl). 
d 9.4 (s, IH, N/f,exchangeable with deuterium), 
6.52 (s, 2H, 'NH2, exchangeable with deuterium), 
3.9 (br, m, IH, W/2 17.5 Hz, Csa-H), 1.71 (m, C7-
H2), 1.12 ( 3H, s, Cio-C/Zj), 0.93 (3H, s, Cn-CHs), 
0.82, 0.68 (other steroidal side-chain methyl 
protons). 
l'-BenzyIidine-4'-f3^-chIoro-5a-cholestane-6-vnthiosemicarba2one 77: 
Method - A (Classical method) : 
To a solution of 3y5-chloro-5a-cholestan-6-one-thiosemicarbazone 76 (2 g, 
4,05 mmol) in methanol (25 ml) benzaldehyde in equimolar amount was added. 
The reaction mixture was refluxed for 3 h. After completion of reaction 
(monitored by TLC), solvents were removed under reduced pressure. The 
residue thus obtained was chromatographed over silica gel column. Elution with 
light pet. ether-diethyl ether (4:1), afforded r-benzylidine-4'-(3y9-chloro-5a-
cholestan-6-yl)thiosemicarbazone 77, recyrstallized from ethanol, m.p. 140 °C, 
yield 69 %. 
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Method - B (Microwave method) : 
Thiosemicabazone 76 and benzaldehyde were adsorbed on silica gel (100-
200) and irradiated in a microwave oven for 6 min. Progress of reaction was 
monitored by TLC, after cooling the reaction mixture was taken in diethyl ether 
and filtered. Residue obtained after evaporation of solvent was purified by silica 
gel column chromatography by eluting with light pet. ether-diethyl ether (4:1) to 
give compound 77 which was recrystallized from ethanol, yield 43 %. 
(Beilstein Positive) 
C, 72.25; H, 8.91; N, 7.18. 
C, 72.22; H, 8.94; N, 7.22 %. 
v„ax 3433 (NH), 1599 (C=N), 1570, 1550, 1505 
(aromatic), 1280 (C=S), 1155 (N-N), 738 cm"' 
(C-Cl) 
d 8.9 (s, IH, N//; exchangeable with deuterium), 
8.1 (s, IH, C//=N), 7.0-6.9 (m, 5H, AiH), 4.12 
(m, IH, Csa-// WA 17 Hz,), 1.76 (m, 2H, Cy-
H2\ 1.14 ( 3H, s, Cio-Ci/j ), 0.71 (3H, s, C,3-
CHs), 0.92, 0.82 (other steroidal side-chain 
methyl protons). 
Analysis found 
C35H52CIN3S requires 
IR(KBr) 
H^ NMR (CDCI3) 
3^-chloro-5a-cholestane-6-s;?iro|f4'-oxo-l*,3'-thiazolidin-3"-
vl)thioureido1-l"-phenvlmethvIsulfanvUacetic acid 78 : 
Method - A (classical method) : 
A solution of compound 77 (1.0 g, 1.71 mmol) in dioxane (20 ml), was 
refluxed with equimolar amount of thioglycolic acid, for 10 h. After completion 
of reaction (monitored by TLC), excess of the solvents were removed under 
reduced pressure and the resulting residue was poured in excess of ice cooled 
water. The organic layer was taken in diethyl ether and washed with (5%) 
NaHCOs solution and water and dried over anhyd. Na2S04. Crude product 
obtained was crystallized from methanol which provided compound 78, having 
m.p. 142 °C, yield 65 %. 
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Analysis found 
C39H58CIN3O3S3 requires 
IR (KBr) 
Method ' B (Microwave method); 
The mixture of compound 77 and thioglycolic acid in dioxane was 
similarly placed for microwave irradiation for 5.5 min. After completion of 
reaction (monitored by TLC).The resulting compound 78 was purified and 
recrystallized as in classical method, m.p. 142 C, yield 52 %. 
(Beilstein Positive) 
C, 62.50; H, 7.76; N, 5.60. 
C, 62.58; H, 7.81; N, 5.62%. 
Vmax 3395 (NH), 3242-2950 (OH of COOH), 
1708 (COOH), 1648 (C=0 of thiazolidinone 
rings), 1576, 1556, 1486 (aromatic), 1390 (C-
N), 1332 (C=S), 1160 (N-N), 732 cm"' (C-Cl). 
S 10.68 (s, IH, COOH), 8.6 (br s, 2H, N//,Xl 
exchangeable with deuterium), 6.82-7.26 (m, 
5H, Ar//), 4.81 (s, IH, C//-Ar), 4.14 (m, IH, 
WA 17.5 Hz, C^a-H), 3.21 (s, 2H, -Ci/2-S), 
1.54 (m, 2H, QTH2\ 1.16 ( 3H, s, C,o-C//j ), 
0.70 (3H, s, Cn-C/Zj), 0.93, 0.80 (other 
steroidal side-chain methyl protons). 
H^ NMR (CDCI3) 
3^-ChlGro-6-spf>o-r3"'-(2"'-phenvl-4'"-oxo-l"',3"'-thiazolidin-5"-
yl)l",3".4"-thiadiazolo-(3',4'-b)-thiazolin|-5a-cholestane 79 : 
Method - A (classical method); 
The compound 78 (0.5 g, 0.68 mmol) was similarly taken in ice cooled 
H2SO4 (5 ml) and kept in ice bath for 3 h. with constant stirring. Progress of the 
reaction was monitored by TLC. After completion of reaction, the reaction 
mixture was poured into ice cooled water and basified with liq. NH3 The 
precipitate obtained was taken in diethyl ether, usually washed with water 
se\eTa\ times, and dried over anhyd. sodium sulphate. Oily residue obtained after 
evaporation of solvents was purified by column chromatography eluting with 
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pet. ether - diethyl ether (2:1) to give 3y5-chloro-6-5/?/ro-[3"'-(2"'-phenyl-4"'-oxo-
l"',3"'-thiazolidin-5"-yl)-l",3",4"-thiadiazolo-(3',4'-b)-thiazolin]-5a-cholestane 
79 as semi-solid, yield 61 %. 
Method - B (Microwave method): 
Mixture of compound 78 and cone. H2SO4 was subjected for microwave 
irradiation for 10 min. After completion of reaction (monitored by TLC), the 
reaction mixture was poured into ice cooled water and basified with liq. NH3. 
The precipitate obtained was purified as in classical method which afforded 
compound 79 in 31.9 % yield. 
Analysis found 
C39H54CIN3OS3 requires 
IR (Nujol) 
*H NMR (CDCI3) 
13 C NMR (CDCI3) 
C, 65.82; H, 7.69; N; 5.78. 
C, 65.74; H, 7.64; N, 5.90%. 
Vmax 1680 (C=0 of thiazolidinone ring), 1622 
(C=C of thiazoline moiety), 1612 (C-N), 1584, 
1550, 1489 (aromatic), 1225 (C-N), 665 cm' 
(C-S-C), 735(C-C1). 
5 6.82-7.16 (m, 5H, ArH), 5.03 (-CH-Ai), 4.70 
(s, IH, CH=C), 4.16 (m, IH, m/2 l7Hz, C^a-
H), 3.30 (s, 2H, -C//2-S), 1.74 (m, 2H, C7-//2), 
1.18 (3H, s, C10-C//3), 0.75 (3H, s, C,3-C//j), 
0.97, 0.80 (other steroidal side-chain methyl 
protons). 
6 35.64 (Ci), 30.14 (C2), (51.62) (C3), 28.42 
(C4), 55.85 (C5), 69.59 (Cg), 42.12 (C7), 28.12 
(Cg), 56.24 (C9), 27.53 (C,o), 21.47 (C,,), 
42.92 (C,2), 53.84, (€,3), 57.02 (C^), 30.08 
(C15), 24.18 (Ci6), 56.76 {Cxil 12.02 (Cig), 
13.23 (C,9), 35.72 (C20), 18.68 (C2,), 38.13 
(C22), 23.56 (C23), 39.32.(C24), 30.68 (C25), 
22.62 (C26), 22.43 (C27), 172.51 (C=0), 151.19 
(C=N), 127.89 ( >C=), 116.78 (HC=), 46.07 
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(CH ), 36.32, (CH2), 129.08-138.68 (C-of 
phenyl). 
3^-Acetoxvcholest-5-ene: 
A mixture of cholesterol (100 g), pyridine (150 ml) and acetic anhydride 
(100 ml) was heated on a water bath for 2 h. The reaction mixture was poured 
into ice-cooled water and the solid thus obtained was filtered under suction, 
washed thoroughly with water and air dried. Recrystallization of the crude 
product from acetone gave 3)ff-acetoxy-cholest-5-ene, m. p. 113-114 C 
(reported '^ m.p. 117-118 ^ C), yield 95 %. 
3^-Acetoxv-6-nitrocholest-5-ene: 
3^-Acetoxycholest-5-ene (10 g) was covered with cone. HNO3 (200 ml; 
d, 1.42), sodium nitrite (10 g) was gradually added over a period of 1 h with 
continous stirring, slightly cooling was also required during the course of 
reaction and the stirring was continued for additional 2 h. A yellow spongy mass 
separated on the surface of the mixture, it was diluted with cold water (200 ml) 
then green coloured solution was obtained. The whole mass was extracted with 
diethyl ether. The ethereal layer was washed successively with water, NaHCOs 
solution (5%) (until washing become pink), water and dried (anhyd. Na2S04). 
Removal of solvents provided the nitro compound as an oil which was 
crystallized from methanol (with traces of acetone) m. p. 104 *^C (reported^^ 
m.p. 102-104 °C), yield 70 %. 
3/?-Acetoxv-5a-cholestan-6-one 80: 
3)?-Acetoxy-6-nitrocholest-5-ene (6.0 g) was dissolved in glacial acetic 
acid (250 ml) by warming the mixture and zinc dust (12 g) was added in small 
portions with shaking. The suspension was heated under reflux for 4 h., and 
water (12 ml) was added at regular intervals during the course of reaction. The 
hot solution was filtered, cooled to room temperature and diluted with a large 
excess of ice-cooled water. The precipitate thus obtained was taken in diethyl 
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ether and the ethereal solution was washed with NaHCOs solution (10%) and 
water, and then dried (anhyd. Na2S04). Evaporation of the solvents gave the 
acetoxy ketone 80 as an oil which was crystallized from methanol, m.p. 128-129 
V (reported" m. p. 127-128 V) , yield 70 %. 
3^-Acetoxy-5a'Cholestane-6-one-thiosemicarbazone 8 1 : 
Method - A (Classical method): 
To a boiling solution of ketone 80 (3.5 g, 7.88 mmol) in methanol (20 
ml), a few drops of cone. HCl were added followed by the addition of solution 
of thiosemicarbazide (0.728 g, 8.0 mmol) in methanol (15 ml) with stirring. 
The reaction mixture was refluxed for I h and cooled. The heavy precipitate thus 
obtained was collected by filtration and purified by recrystallization from 
methanol to give thiosemicarbazone 81 as shining needles m.p 128-129 "C 
(reported" m.p. 128 °C), yield 94 %. 
Method - B (Microwave method): 
A mixture of ketone 80 (3.5 g, 7.88 mmol) and thiosemicarbazide (0.728 
g, 8.0 mmol) was adsorbed on silica gel (mesh 100-200) and then it was placed 
under microwave irradiation for 4-6 min. After completion of reaction 
(monitored by TLC), the reaction mixture was extacted, purified and product 
was crystallized as in classical method. 
Analysis found : C, 69.65; H, 9.89; N, 8.08 
CjoHjiNjOzS requires : C, 69.63: H; 9.86; N; 8.12 %. 
IR(KBr) : v^ ax 3500 (NH2), 3355 (NH), 1735 (OCOCH3), 
1498 (C=N), 1175 (C=S), 1040 cm' (C-O of 
acetate). 
' H N M R (CDCI3) : S 9.3 (s, IH, N//. exchangeable with deuterium). 
6.39 (br s, 2H. N//2, exchangeable with 
deuterium), 4.69 (m, IH, W/2 18 Hz, C^a-H), 
2.01 (s. 3H. OCOC//,). 1.72 (m. 2H. C7-H2). 
1.15 (3H, s, C,o-C//3), 0.69 (3H, s, Cn-C/Zj). 
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0.93, 0.81 (other steroidal side-chain methyl 
protons). 
l'~Benzvlidme-4*-(3/3-acetoxv-5a-cholestane-6-vlUhiosemicarbazone82: 
Method - A (Classical method): 
A mixture of thiosemicarbazone 81 (2 g, 3.86 mmol) and benzaldehyde in 
equimolar ratio in methanol (25 ml) was refluxed for 2.5 h. After completion of 
reaction (monitored by TLC), the solvents were removed under reduced pressure 
and the residue thus obtained was purified over silica gel column using light pet. 
ether-diethyl ether, (4:1) as eluant which provided compound r-benzylidine-4'-
(3yff-acetoxy-5a-cholestan-6-yl)thiosemicarbazone 82 as a solid, recrystallized 
from ethanol, m.p. 133-135 °C, yield 67 %. 
Method - B (Microwave method): 
The mixture of thiosemicabazone 81 (2 g, 3.86 mmol) and benzaldehyde 
in equimolar amount was adsorbed over silica gel (100-200 mesh) allowed for 
microwave irradiation to 5-6 min. The completion of reaction was monitored by 
TLC. The reaction mixture was taken in diethyl ether, filtered, solvents were 
evaporated, residue obtained was purified by column chromatography and 
crystallized as in classical method which afforded compound 82 in yield 41 %. 
Analysis found : C, 73.32; H; 9.03; N, 6.91 
C37H55N3O2S requires : C, 73.34; H, 9.15; N, 6.94% . 
IR (KBr) : v„ax 3440 (NH), 1737 (OCOCH3), 1610 (C=N). 
1595, 1545, 1500 (aromatic), 1315 cm"' (C=S). 
'HNMR(CDCl3) : S 9.1 (s, IH, NH, exchangeable with 
deuterium), 8.5 (s, IH, C//=N), 7.3-7.0 (m, 5H. 
AT//), 4.79 (m, IH, WA 16.5 Hz. C^a-H), 2.01 
(s, 3H, OCOC//3), 1.79 (m. 2H, C7 -H2), 1.16 
(3H, s, C,o-C//,), 0.73 (3H, s, C.^-CHs), 0.94. 
0.83 (other steroidal side-chain methyl 
protons). 
118 
CfiapUrlll 
3)^-acetoxv-5a-cholestane-6-s;?f>o|f4'-oxo-l',3''thiazolidin-3"-
yl)thioureido1-l"-phenvlmethylsulfanyljacetic acid 83 ; 
Method - A (classical method): 
Compound 82 (1.0 g, 2.42 mmol) was dissolved in dioxane (25 mi) and to 
this thioglycolic acid in equimolar amount. The reaction mixture was refluxed 
for 10 h. Progress of reaction was monitored by TLC. After completion of 
reaction the excess of the solvents were removed under reduced pressure and the 
resulting residue was poured in excess of ice cooled water. The organic layer 
was taken in diethyl ether, washed with NaHCOs (5 %) solution, and water and 
dried (anhyd. Na2S04). Evaporation of solvents and recrystallization from 
methanol furnished compound 83 m.p. 130-131 "c, yield 62 %. 
Method - B (Microwave method); 
The mixture of compound 82 and thioglycolic acid was similarly placed 
for microwave irradiation for 6-7 min. Progress of reaction was monitored by 
TLC. The same product was obtained as by classical method, yield 46 %. 
Analysis found 
C^iH^iNaOsSa requires 
IR (KBr) 
^HNMR (CDCI3) 
C, 63.76; H, 7.90; N, 5.40. 
C, 63.78; H, 7.96; N, 5.44%. 
v„ax 3405 (NH), 3235-2940 (OH of COOH), 
1738 (OCOCH3), 1702 (COOH), 1645 (C=0 
of thiazoldinone rings), 1583, 1535, 1480 
(aromatic), 1378 (C-N), 1335 (C=S), 1238 (C-
O), 1170cm"'(N-N). 
d 10.78 (s, IH, COOi^, 8.31 (br s, 2H, N// .^Z 
exchangeable with deuterium), 6.87-7.05 (m, 
5H, AxH), 4.95 (s, IH, -C//-Ar), 4.72 (m, IH, 
WA 15.9 Hz, C^a-H, axial), 3.34 (s, 2H, -CH2-
S), 2.04 (s, 3H, OCOCifs), 1-57 (m, 2H, C7-
H2), 1.15 (3H, s, C10-CH3), 0.74 (3H, s. C,3-
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CH3), 0.93, 0.82 (other steroidal side-chain 
methyl protons). 
3^-Acetoxv-6-sp<>o43"'-(2"'-phenvl-4"'-oxo-l"'^"'-thiazolidin-5"-vl)-
l",3",4"-thiadiazolo-(3',4'-b)-thiazolm1-5a-cholestane 84 : 
Method - A (classical method) : 
The compound 83 (0.5 g, 0.89 mmol) was stirred in ice cooled H2SO4 (5 
ml) over ice bath for 2 h. 45 min. After completion of reaction (monitored by 
TLC), the reaction mixture was poured into ice cooled water and basified with 
liq. NH3 The product was precipitated, which was dissolved in diethyl 
ether,washed with water and dried over anhyd. sodium sulphate. Evaporation of 
solvents provided an oily residue which was purified by column chromatography 
using silica gel column, pet. ether- diethyl ether (2:1) as an eluant to give 3/S-
acetoxy-6-5/>/ro-[3"'-(2'"-phenyl-4'"-oxo-1 "',3'"-thiazolidin-5"-yl)-1 ",3",4"-
thiadiazolo-(3',4'-b)-thiazolin]-5a-cholestane 84 as non crystallisable semi solid, 
yield 40.7 %. 
Method - B (Microwave method) ; 
Compound 83 was taken in cone. H2SO4 and subjected for microwave 
irradiation to 10 min. After completion of reaction (monitored by TLC) product 
was purified as in classical method, yield 34 %. 
Analysis found : C, 66.89; H, 7.81; N; 5.69 
C41H57N3O3S3 requires : C, 66.90; H, 7.75; N, 5.71%. 
IR(NujoI) : v„,ax 1735 (OCOCH3), 1690 (C=0 of 
thiazolidinone ring), 1620 (C=C of thiazoline 
ring), 1608 (C=N), 1579, 1548, 1497 
(aromatic), 1230 (C-N), 675 cm '^ (C-S). 
' H N M R (CDCI3) : S 6.94-7.21 (m, 5H. Ar//), 5.05 (s, IH. -CH-
Ar), 4.83 (m, IH, W/2 18Hz, Cja-H), 4.73 (s. 
IH. -C//-C), 3.31 (s. 2H. -C//2-S). 2.01 (s. 3H. 
OCOC//3), 1.71 (m, 2H, C7-//2), 1-14 (3H, s. 
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C10-CH3), 0.70 (3H, s, C13-CH3), 0.91, 0.81 
(other steroidal side-chain methyl protons). 
"C NMR (CDCI3) : S 36.53 (C,), 28.07 (C2), 72.62 (C3), 24.38 
(C4), 52.9 (C5), 69.98 (Ce), 43.18 (C7), 28.57 
(Cg), 56.84 (C9), 30.12 (C,o), 17.62 (C„), 39.45 
(C12), 56.06 (C,3), 57.12 (CH), 30.34 (C.s), 
22.46 (C16), 58.08 (Cn), 12.16 (Cig), 13.27 
(C,9), 38.24 iC2o), 30.52 (C2O, 35.87 (C22), 
23.82 (C23), 42.76 (C24), 53.72 (C25), 22.36 
(C26), 21.82 (C27), 173.4 (C=0), 151.87 
(C=N), 127.98 (>C=), 117.42 (HC=), 46.56 
(CH), 36.58 (CH2), C-of phenyl(128.0-138.4), 
CH3 of acetate (18.48). 
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Convenient synthesis of steroicfaC angular 
and Rnear pyran-4-ones 

The pyranone ring system consists of unsaturated six membered ring 
containing ethereal oxygen, ketonic group and two alkyl groups. Steroidal 
derivatives having pyranone ring fused with steroidal nucleus are termed as 
steroidal pyranones. 
0 
O 
Pyranones and corresponding derivatives have been the subject of much 
research due to their importance in the field of synthetic and medicinal chemistry 
such as antiviral,' stimulant,^  anticonvulsant,^  miticidal activities.'* Inspite of 
being building blocks in the field of synthetic and medicinal chemistry, pyranone 
rings are highly susceptible to nucleophillic attack at the electrophillic centres 
(C-2, C-4 and C-6) and a variety of synthetic approaches for the preparation of 
aerenes and heteroaerenes.^  Furthermore the development of new methods with 
great efficiency, convenient procedures and better yields is of interest. 
The theoretical part of this chapter includes the recent examples of 
synthesis of pyranones by different workers. 
Christ et al^ reported that dihydro-1, 4-pyran 1 are cyclic ethers of 
aldehydes or ketones, and these substances might be expected to behave as vinyl 
ether. 
H2 
NCC CH2 
II I 
A r - C ^ /CHCOAr 
O 
Livingstone and his coworkers^ isolated and characterized Lapachenole a 
substance present in the wood oi''Brazilian white perobd". Its structure has been 
elucidated as 4'-methoxy-6:6-dimethyhiaphtho(l':2'-2:3)pyran 2 and confirmed 
by the total synthesis of its dihydrocompound. 
chapter I^/ 
OMe 
Later they synthesized 6-methoxy-2:2-dimethyl-7:8-benzochroman-4-one 
4 from the esterification of 4-methoxy-l-naphthol with ySy^ -dimethylacryloyl 
chloride by fries rearrangement of 4-methoxy-l-naphthyl-y?y5-dimethylacrylate 3 
in absence of solvent followed by acidic isomerisation and ring closures. 
OMe OMe 
0-CO-CH2-CHMe2 
Anjaneyulu et al} reported the synthesis of 7:8-benzo 2:2-dimethyl 
chromanones 5, 6 [R = R' = CH3] and 5:6-benzo-3:4-dihydro-4-phenyl 
coumarins (7-10) [R = CeHs] by the reaction of a-naphthol and y5-naphthol with 
SbCls, polyphosphoric acid, and cone. H2SO4 and ZnCli. 
RV.R ^ . R 
•R-
10 
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Gupta et al^ reported the direct synthesis of dihydro lapachenole 12 from 
l-hydroxy-4-methoxy-2-(3-hydroxy-3-methylbutyl) naphthalene 11. 
OCH, MeO. 
H2 H2 OH 
CH3 
p-TSA 
Super dry benzene 
11 12 
Hlubucek et al. "^  reported the synthesis of evodionol methyl ether 13 and 
lapachenole 14 from 2, 6-dimethoxy-4-hydroxyacetophenone and 4-methoxy-l-
naphthol, respectively. 
MeO. 
MeO' 
Khaima and co-workers'^  synthesized 2, 2-dimethyl-naphtho[l, 2-b]pyran 
15 by the treatment of 1-naphthol with 2-chloro-2-methylbut-3-yne followed by 
the cyclization with //.//-dimethylaniline. Catalytic reduction of 2,2-
dimethylnaphtho[l, 2-b]pyran 15 gave 3,4-dihydro-2,2-dimethylnaphtho[l, 2-
b]pyran 16. Similarly the corresponding isomers 2,2-dimethylnaphtho[2,3-
bjpyrah 18 and 3,4-dihydro-2,2-dimethylnaphtho[2, 3-b]pyran 17 have been 
synthesized starting from 2-naphthol. 
15 16 17 
18 
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Georgiadis et al. synthesized 2-methyl-2-[p-benzenesulphonyl)phenyl]-
6-hydroxy-2//-pyran-3(6//)-one 22 from />-(benzene-sulp.honyl)acetophenone 
19. 
/ VI_ CH3 
19 
1) Et20 
2) H2O 
CH2CI2 
MCPBA 
CIS isomer(20%) + 
21 
H3C 
trans isomer (80%) 
22 
Ahluwalia and co-workers'^ synthesized 2,2-dimethyl-2/:^-naphtho[l,2-
b]pyran 24 by the reduction of 3,4-dihydro-2,2-dimethyl-2i/-naphtho[l,2-
bjpyran 23 with DDQ or NBS. They also reported the synthesis of 1,2-dihydro-
3,3-dimethyl-3/f-naphtho[2, l-b]pyran 26 and 3,3-dimethyl-3//-naphtho[2,l-
b]pyran 25 from 2-naphthol. 
23 24 25 26 
Kabbe and Widdig''* reported the synthesis of 4-chromanones 29 by the 
condensation of o-hydroxy acetophenones 27 with ahphatic carbonyl compounds 
28 in presence of pyrrolidine. 
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COCHg 
+ R^ -C0-R2 
OH 
QNH 
27 28 29 
Suwanborirux et al}^ isolated some new chromones 30 and 31 from 10% 
aq MeOH extract of twigs and leaves of spathelia sorbifolia. 
ORi O 
11 H 
H,C 
ORi O 
30 31 
Tanden et al}^ reported the synthesis of 2, 3-dihydro-2,2-dimethyl-4^-
naphtho[l,2-b]-pyran-4-one 33 by the one-step cyclization of a-(3-methyl-2-
butenoyloxy)-naphthalene 32 withZnCl2. 
H3C CH3 
O 
II CH, p-C-CH=C 
CH3 
ZnCl2 
32 33 
Kidwai and co-workers'^  synthesized 3-(4'-methylquinolino-2'-yloxo)-2// 
benzopyran-2-ones 36 [Ri = CH3, OCH3, H.; R2 = CH3, OCH3, H.; R3 = OCH3, 
CH3, H] by the reaction of (4'-methylquinolino-2'-yloxo) acetic acid hydrazide 
34 with 2-hydroxy-4-substituted benzaldehyde followed by cyclization in 
presence of PPA. 
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H2 0 
O C-NHNH2 
H, H OH 
34 
O - ^ - - C - N H - N = C Y ^ R I 
PPA 
Speranza et al}^ isolated furoaloesone a new 2-acetonyl-5-methyl-4//-
furo[2,3-b][l]benzopyran-4-one 37. 
CH3 
^O 
- O ' ^ ^ CH3 
37 
Nelson et alP reported that /? keto ester 38 undergoes reduction with 
(NaBH4) followed by the reaction with TsOH gave 2-pyranone unit 39. 
i) NaBH4, EtOH 
Me Me 
OBu . jj) TsOH, Toluene 
Mali et al. reported that the dihydroxy phthalide 40 was monoprop-2-
ynylated using 3-chloro-3-methylbut-l-yne in DMF solution in the presence of 
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K2CO3, KI and Cul to give the prop-2-ynyl ether 41, which on heating in N,N-
dimethylaniline solution provided salfredin Bn 42, which had pyran ring. 
40 
OMe 
42 
Reagents and conditions 
I) 3-chloro-3-methylbut-l-yne, K2CO3, KI, Cul, DMF, 60 °C, 4h. 
II) PhNMez, 210 °C, 6h or MWI, 3min. 
Paradkar et al?^ synthesized naturally occurring angular naphthopyrans 
44 starting from 2-acetyl-l-naphthol derivatives 43 [R = OMe, H] and linear 
naphthopyran 46 from 3-acetyl-2-naphthol 45. 
acetone 
pyrrolidine 
CeHe 
44 
acetone 
pyrrolidine, CeHe 
45 46 
Feng et alP reported the synthesis of chiral (/?)-2-phenyl-2,3-dihydro-
4//-pyran-4-one 49 from aldehyde 48 [R = Ph, p-MeOC6H4,/?-MeC6H4 etc.] and 
Danishefsky's diene47 using chiral Hg-BINOL-Ti. 
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OMe 
OTMS' A^ 
47 
0 
II 
RCH 
48 
20% Catalyst 
TFA 
Hepworth et al?^ synthesized 2//-l-benzopyran 51 from electro 
cyclization of aryl propagaryl ethers 50 which were readily prepared from 
phenols and alkynols. 
C02Me 
C02Me 
50 51 
Tanaka and Hua^ '* prepared 2H-pyran-one 54 by the palladium catalysed 
reaction of internal alkynes 53 with (Z)-3-chloro-2-heptenaoate 52 in presence of 
EtjN. 
'COOMe + Et,N 
CI 
52 
PdCi2(PPh3) ' a) > - ^ \ 
53 54 
Elmaati and his co-worker synthesized pyrone derivative 57 by the 
reaction of 3-dimethylamino-2-(l,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-\H-
pyrazole-4-carbonyl)-acrylonitrile 55 with ethyl cyanoacetate dimer. Compound 
56 was obtained by phenazoyl acetonitrile. 
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H3C O H3C O Et02C CN 
HX-N L ^ DMFDMA N V L , „ 
w-^'^O Xylene / ^ . , - ^ 0 NMe 
An 
-CN EtOaC-
22 
,CN 
Ph 
1 3 ^ 1 
Ph NH; 
55 56 
H3C 
57 
An = Hac-NrX 
Ph 
<26 Banciu et al. reported the preparation of 2, 3, 7-
triphenylcyclopenta[c]pyran 60 from 1,2-diphenylethanedione (benzil) 58 and 
cyclopentadiene 59. 
Ph 
0 = C - P . 
0 = C — P h 
58 
W // 
59 
NaOMe 
97 
Yadav et al. synthesized 2,4-dimethoxy-2-phenyl chromane 66 by the 
reaction of salicyldehydes 64 with acetophenone 65 and trimethylorthoformate 
in presence of 5% SC(OTF) at ambient temperature. 
OMe 
* CfiH. 6 5 CH3 
64 
R = a' CHO OH 
65 
CHO ^1 ^ XHO 
66 
OH 
OMe 
Ar = 
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Clarke and Martin^* obtained single distereomers of highly substituted 
tetrahydropyran-4-one 68 [R = hexyl, /-Pr, Ph; R' = Ph, Pr, hexyl] from p-
ketoester 67. 
O 
1 1 1 BFg.OEtz 
MeO R"CHO 
67 
R'" O R 
68 
Autino and co-workers^^ synthesized chromanones 70 by the cyclization 
of 3-aryl aminopropiononitriles 69 by using AICI3 in the molar ratio of 1:1 in 
absence of solvent. [R=H, 6-CH3, 6-OCH3] 
NC 
69 
i- anhy.AICl3 
ii- H* 
Rizzacasa et al. °^ synthesized salicylihalamide a novel metabolite 
isolated from western Australian Marine sponge a pyranone unit 72 from 
apicularen 71. 
.OP 
Pouli et al?^ prepared 3',4'-dihydro-6'-nitro5/?/ro[cycloheptane-r,2' (2'-
//)[l]benzopyran]-4'-one 75 by the nitration of 2-hydroxyacetophenone 73 and 
subsequent treatment with appropriate carbocyclic ketone in presence of 
pyrrolidine. 
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75 
a) Cone. HNO3, AcOH 
b) Carbocyclic Ketone, pyrrolidine, toluene, 
reflux 
Kang et al?^ isolated various strains from the roots of. Mimosa pudica and 
one strain identified as 2-hydroxymethyl-chroman-4-one 76. 
H, 
,0> 
Toste et al?^ reported the formation of benzopyrans 78 by the 
propargylation of phenols 77 catalyzed by a cationic ruthenium complex or 
protic acid. 
ArOH 
5%(dpptn)ReCl3 
5% KPFg 
5% MeNOj 
77 78 
ArOH = 
vAAAT 
Islam et al?^ prepared 8-hydroxy-5-phenyl-furo[2,3-h]benzo(b)pyranone-
7 80 from (£)-l-(4,6-dihydroxybenzofiiran-5-yl)-3-phenylprop-2-en-l-one 79 by 
reacting with DDQ. The products were tested for anti bacterial effects. 
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79 80 
Yachevskii et al?^ described the preparation of 2,6-bis-polyfluoroalkyl-
4i/-pyran-4-ones 82 [Ri = CHF2, CF3, C2H4H, C4H9 etc.; R2 = CHF2, CF3, C2F4H 
etc.] by dehydration of bis-polyfluoroalkyl containing 1,3,5-triketones 81. 
O 
Ro 
O 
81 82 
-R, 
X = H2SO4, PPA, HCL/MeOH, (MeSiO)3PO, (EtP02)„/CHCl3. 
Yakura and co-workers^^ reported the stereoselective synthesis of 2,3-
disubstituted-3-pyranone 84 and 85 using copper catalyzed oxonium ylide 
formation -[2,3]shift of (55,7i?)-5-allyloxy- l-diazo-8-(/7-methoxy-benzyloxy)-7-
methyl-2-octanone 83. 
OPMB 
xc: 
83 
OPMB 
84 
-37 
OPMB 
85 
Trauner and co-worker reported the synthesis of molugin a chromene 
87 from 67t - electrocyclization of vinyl orth-quinonemethide 86. 
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C02Me 
87 
Markopoulou et al^^ reported the preparation of 2-amino-4-oxo-4//-
chromene-3- caibonitrile 91 throMgh a typical leaction of functionalized acetyl 
salicylic acid 88 with A'-hydroxybenzotriazole 89 and malononitrile 90 [Ri = H, 
CI, CH3, OCH3; R2 = H, OCH3; R3 = H, OCH3]. 
R,. 
J 
, ^ ^ C O O H 
T OCOCH3 
R3 ' 
88 
N 
N 
N 
HO 
89 
.CN 
< 
CN 
90 91 
i) NaH,DCC,THF ii) 10%HCl,MeOH 
Kocevar et al?^ reported one pot synthesis of A'(5-aryl-6-methyl-2-oxo-
2//-pyran-3-yl)benzamide 94 starting from the appropriate aryl substituted 
acetone derivatives 92, DMF, DMA and hippuric acid in the presence of large 
excess of acetic anhydride. The intermediates were a-enaminoketones 93 [R= 
MeOCeH,, (MeO)2C6H3]. 
O 
Me 
92 
DMF 
DMA 
O 
Me 
NMes 
93 
M e . ^ O \ ^ 0 
A AC2O, 
R ^ ^ - ^ NHCOPh 
94 
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They also reported that cycloalkanones 96 when heated with two 
equivalents of DMF, DMA, hippuric acid, pyridine, triethylamine in acetic 
anhydride giving rise to 3-aminocycloalka[b]pyran-2-ones 98. 
O 
1) DMF, DMA 
')n 
96 ' ' " 97 
^^.Os.^0 
2) PhCONHCHsCOzH/AozO, 
3) PyH/NEta, 
y^ NHCOPh 
H2SO4 
Pal et a/.'**'reported the synthesis of 4-(3-hydroxy-3-methylbut-l-ynyl)-5-
(l-hydroxy-l-methylethyl)thieno[2,3-c]pyran-7-ones 100 [ R = -C(CH3)20H, -
(CH2)20H, -(CH2)30H, -(CH2)5CH3 etc.] as a major product and 5-
alkylthieno[2,3-c]pyran-7-ones 101 as a minor product starting from 3-
iodothiophene-2-carboxylic acid 99, terminal alkynes and in presence of 
PdCl2(PPh3)2-Et3N-CuI. 
R 
/ HC=C—R 
COOH 
Pd catalyst 
99 Minor 101 
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The importance of heterocyclic compounds has long been recognized in 
the field of synthetic organic chemistry and uses of pyranones are well 
established. Especially after the discovery that some pyranones are associated 
with variety of physiological activities, they are also used in perfumes, cosmetics 
and pharmaceutical industry.'*' They have attracted considerable interest as 
modulators of potassium channels influencing the activity of the heart and blood 
pressure.^ ^ Pyran ring system is also present in number of natural products 
including flavanoids, that interact with various enzymes and receptor system of 
pharmacological significance.''^  Chromone constitute a major classes of naturally 
occurring compounds containing pyranone nucleus. Some of the biological 
activities attributed to chromone derivatives include cytotoxic (anticancer), 
neuroprotective,'*^ HlV-inhibitory,'*^ antimicrobial,'*^ antifungal^ " and 
antioxidant. '^ Inspite of being important in medicinal chemistry reactions of 
pyranones with dienophiles, have been widely investigated and utilized for the 
preparation of multitude of heterocyclic or carbocyclic products and may also 
be used as intermediates in the manufacture of compounds such as 
pharmaceuticals, electronics, chemicals and agrochemicals. In view of much 
synthetic utility of pyranones, an attempt to synthesize new steroidal pyranones 
has been made using Paradkar's amine catalyzed reaction process^' by taking 2-
acetylcholesta-2,4-dien-3-ol 103, 6-acetyl-3yff-acetoxycholesta-4,6-dien-7-ol 106, 
6-acetyl-3y9-chlorocholesta-4,6-dien-7-ol 109 and 6-acetylcholesta-4.6-dien-7-ol 
112 as substrate. Compound 103, 106, 109 and 112 prepared by refluxing 
steroidal ketone e.g. cholest-5-en-3-one 102, 3/?-acetoxycholest-5-en-7-one 105, 
3y9-chlorocholest-5-en-7-one 108 and cholest-5-en-7-one 111 with acetyl 
chloride in benzene in presence of pyridine. In conclusion, we have developed a 
new, highly efficient method for the synthesis of substituted steroidal pyran-4-
ones 104, 107, 110 and 113 fi-om compounds 102, 106, 109, and 112 
respectively using pyrrolidine, dry benzene and dry acetone in Dean Stark 
separator. The structures of all the new products were established on the basis of 
chemical and spectral studies. 
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Reaction of cholest-5-en-3-one with acetyl chloride in benzene: 
2-Acetvlcholesta-2,4-dien-3-ol 103: 
Acetyl chloride 
Pyridine 
102 
Cholest-5-en-3-one 102 was dissolved in benzene followed by the 
addition of acetyl chloride and pyridine. The mixture was refluxed till the 
completion of the reaction. Final work up and column chromatography, followed 
by recrystallization from methanol afforded product 103, having m.p. 169 C, 
yield 67 %. 
Characterization of compound 103 having m,p. 169 °C as 2-
acetvlcholesta-2.4-dien-3-ol; 
Compound 103, m. p. 169 "C was correctly analysed for C29H46O2. Its IR 
spectrum exhibited characterstic adsorption bands at 3450 (OH), 1650 (C=0) 
and 1620 cm"^  (C=C).^ ^ The *H NMR spectrum of the compound 103 displayed 
two singlets for one-proton each at d 5.45 for C-4 olefmic proton and at (5 5.1 
(exchangeable with deuterium) for hydroxyl proton. Two other singlets appeared 
o 
at S 2.32 ( C-CH3) and 1.95 (C1-H2) integrating for three and two protons 
respectively. Appearance of olefinic proton C-4 as a clear singlet suggested that 
the C5-C6 double bond has been shifted to C4-C5 position during the course of 
reaction. Kinetically it is more favourable because the molecule will be more 
stable due to extended conjugation. Other steroidal methyl signals were observed 
at (51.14 (Cio-C/fj), 0.74 (C13-CH3), 0.93 and 0.82 (side-chain methyl protons).^' 
Thus, the above spectral data led to the structure of solid product 103 as 2-
acetylcholesta-2,4-dien-3-ol. 
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Reaction of 2-acetvlcholesta-2,4-dien-3-ol with pyrrolidine 
2',2'-Pimethvlcholesta-2,4-dien-r3,2-b1-pvran-4'-one 104; 
i^ctfr pyrrolidine 
103 104 
2-Acetylcholesta-2,4-dien-3-ol 103 was allowed to react with 
pyrrolidine, in dry benzene in presence of dry acetone as catalyst. Reaction 
mixture was heated under reflux using Dean Stark separator. Final work up in 
usual manner and column chromatography, provided compound 104, m. p. 188 
V, yield 53 %. 
Characterization of compound 104 having m.p. 188 "C as 2',2'-
dimethvlchoIesta-2,4-dien-r3,2-bl-pvran-4'-one; 
Compound 104 was correctly analysed for C32H50O2. Its IR spectrum 
o 
exhibited important absorption bands at 1665 (—c—), 1610 (C-^ C) and 1145 
cm' (C-O-C).^ ^ The 'H NMR spectrum of compound 104 displayed two singlets 
each integrating for two protons at 6 3.41 for {Cy-Hi) and 6 1.86 for (C, - H2) 
and another one proton singlet at 6 5.25 for C4 olefmic proton. Six protons of 
two methyl groups (C2-2XCH3) appeared as a broad singlet at 6 1.36. Angular 
and side chain methyl protons were observed at 1.16 (Cio-C^j), 0.75 (Co-C/^j), 
0.91 and 0.83 (side-chain methyl protons).^ '* In its '^ C NMR spectrum 
characteristic signals were observed at d 191.21, 56.81, 56.85, 27.9, and 28.03 
for the carbonyl (C4.), C2S C3. and methyl carbon atoms of pyranone ring. Signals 
at d 157.03, 149.23, 36.10, 35.78 were attributed to C3, C5, Ce, C7 of steroidal 
skeleton, respectively. Thus, on the basis of above evidences compound 104 
having m.p. 188 *^C has been characterized as 2',2'-dimethylcholesta-2,4-dien-
[3,2-b]-pyran-4'-one. The formation of compound 104 was further supported by 
the proposed mechanism, Scheme-1. 
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r> o 
103 
(a) 
/ 
,c=o 
Scheme-1 
Reaction of 3/?-acetoxycholest-5-en-7-one with acetyl chloride 
6-Acetvl-3^-acetoxvcholesta-4,6-dien-7-ol 106; 
AcO 
Acetyl chloride 
Pyridine 
105 106 0"^^CH3 
3y5-Acetoxycholest-5-en-7-one 105 was dissolved in benzene followed by 
the addition of acetyl chloride and pyridine. The mixture was refluxed for 7 h. 
143 
chapter IV 
After completion of reaction it was usually worked up and purified by column 
chromatography which provided a solid compound, 106 m. p. 201-203 C with 
63% yield. 
Characterization of compound 106 having in.p. 201-203 OC as 6-acetvl-
3^-acetoxvcholesta-4,6-dien-7-ol; 
Compound 106 was correctly analyzed for C31H48O4. Its IR spectrum 
exhibited important absorption bands at 3420 (OH), 1735 (-OAc), 1665 (C=0) 
and 1615 cm"' (C=C)." The *H NMR spectrum of compound 106 displayed two 
o 
singlets integrating for three protons each at 6 2.39 ("C-CHa)^  and 2.02 for 
acetate group. C-4 Olefmic proton appeared at 8 5.52 {J=9.5 Hz) as a one-proton 
doublet and hydroxy 1 proton at d 5.01 (exchangeable with D2O) as a broad 
singlet. A one-proton broad multiplet appeared at d 4.35 {W^A 16.5 Hz,) for C-3 
axial proton. Other methyl protons were observed at <5 1.14 (Cio - CH3), 0.71 
(Ci3 - CH3), 0.91 and 0.84 (side-chain methyl protons).^ '* Therefore, in 
accordance with the analytical and spectral values, the compound 106 having 
m.p. 201-203 "'C has been characterized as 6-acetyl-3yS-acetoxycholesta-4,6-dien-
7-0I. 
Reaction of 6-acetvl-3^-acetoxvcholesta-4,6-dien-7-ol 106 with 
pyrrolidine ;2',2'-Dimethvl-3^-acetoxvcholesta-4,6-dienr7,6-b1-pvran-4'-
one 107: 
pyrrolidine 
* -
AcO ^^^^^^^T^OH AcO 
0"^XH3 
106 
Pyrrolidine was added to the solution of compound 106 in dry acetone 
and dry benzene, the reaction mixture was stirred at room temperature and then 
refluxed using Dean Stark apparatus. After completion of reaction it was usually 
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worked up and purified which provided a solid compound 107 having m.p. 211-
213 °C, yield 56 %. 
CharacterizaHon of compound 107 having m. p. 211-213 oC as 2',2'-
dimethvl-3/g-acetoxvcholesta-4.6-dien[7,6-b1-pvran-4'-one: 
Obtained product 107 was correctly analysed for C34H52O4. Its IR 
o o 
spectrum exhibited absorption bands at 1739 (—c— of acetate), 1665 (—c—), 
1612 (C=C), and 1147 cm"' (C-0-C)/^The 'H NMR spectrum of compound 107 
displayed two singlets integrating for two and three protons respectively at S 
3.32 (C3.-.//2) and 2.01 for O-COCH3. A broad multiplet for one proton was 
observed at 6 4.32 (W^/215 Hz, axial) for C^a-H. C4 Olefmic proton was seen at S 
5.83 (^10.0 Hz) as a doublet, and a singlet for six protons was observed at 1.32 
for (C2' - IxCHs). Signals for other steroidal methyl protons were observed at S 
1.15 (Cio - CH3), 0.70 (C13-CH3), 0.91, 0.82 (side-chain methyl protons).^ "* In Us 
'^ C NMR spectrum, characteristic signals were observed at 198.2, 59.7, 56.0, 
28.5, 29.2 for the carbonyl (C4'), C2', C3', methyl carbon atoms of pyranone ring. 
Signals at d 74.9, 147.3, 106.3, 169.2 were attributed to C3, C5, Ce, C7 of steroidal 
skeleton, respectively. Signals at 8 172.1, 17.9 were assigned to the carbonyl and 
methyl carbons of acetate group, respectively. Thus, on the basis of foregoing 
discussion and spectral values, compound 107 having m.p. 211-213 °C has been 
characterized as 2',2'-dimethyl-3yff-acetoxycholesta-4,6-dien[7,6-b]-pyran-4'-one. 
Reaction of 3g-chlorochoIest-5-en-7-one 108 with acetyl chloride 
6-Acetvl-3^-chlorocho]esta-4,6-dien-7-ol 109 ; 
Acetyl chloride 
Pyridine 
O'-^^CHa 
109 
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A mixture of 3y9-chlorocholest-5-en-7-one 108, acetyl chloride, pyridine 
and benzene was refluxed for 7 h. After completion of reaction and usual work 
up the product was purified by column chromatography which provided a solid 
compound 109, m. p. 179-181 °C with 61 % yield. 
Characterization of compound 109 having m.p. 179-181 »€ as 6-acetvl-
3/g-chlorocholesta-4,6-dien-7-ol: 
The obtained product 109 was correctly analyzed for C29H45CIO2 
(Beilstein positive). Its IR spectrum exhibited absorption bands at 3400 (OH), 
o 
1642 ( -C- ) , 1620 (C=C), and 750 cm"' (C-Cl)." The *H NMR spectrum of 
o 
II 
compound 8 displayed a singlet for three protons at S 2.35 of (—C-CHJ) and 
another one-proton singlet at S 5.29 (exchangeable with D2O) (OH). A broad 
multiplet for one-proton was centered at S 3.98 (WV2 14.6 Hz, axial) for Csa-H 
and a doublet for one proton was seen at S 5.55 (J=9.55 Hz) for C4 olefmic 
proton. Angular and side-chain methyl protons were observed at S 1.16 (Cio-
CH3), 0.73 (Ci3 -CH3), 0.92, 0.85 (other steroidal side-chain methyl protons).^ " 
Thus, on the basis of above evidences compound 109 having m.p. 179-181 C^ 
has been characterized as 6-acetyl-3y9-chlorocholesta-4,6-dieh-7-ol. 
Reaction of 6-acetvI-3^-chIorocholesta-4,6-dien-7-ol 109 with 
pyrrolidine: 
2'.2'-Dimethvl-3/g-chlorochoIesta-4.6-dien-r7,6-b1-pvran-4'-one 110; 
pyrrolidine ^ / ^ \ , / ^ \ . ^ / 
Pyrrolidine was added to the solution of compound 109 in dry benzene 
and dry acetone, the reaction mixture was first stirred at r.t. and then refluxed 
using Dean Stark separator. After completion of reaction it was usually worked 
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up, and purified by column chromatography which gave compound 110 having 
m.p. 222-224 "^ C, yield 56 %. 
Characterization of compound 110 having m.p. 222-224 «€ as 2',2'-
dimethvl-3jg-chlorocholesta-4,6-dien-f7,6-bl-pvran-4'-one; 
The product 110 was correctly analysed for C32H49CIO2. (Beilstein 
Positive) Its IR spectrum exhibited characterstic absorption bands at 1652 
o 
( -C- ) , 1620 (C=C), 1141 (C-O-C) and 740 cm'' (C-Cl).^ ^ The 'H NMR 
spectrum of compound 110 displayed a one proton doublet at S 5.62 (7=9.7 Hz) 
for C4-H, a singlet for two methylene protons of pyranone ring (C3-//2) at 6 3.4, 
another singlet for six protons at 1.26 (Cx-l^CHj) and a one proton broad 
multiplet at (5 4.1 {WA 15 Hz, axial) for C^a-H. Angular and side-chain methyl 
protons were observed at d 1.16 (C10-CH3), 0.81 (C,3 - CH3), 0.93, 0.82 (other 
steroidal side chain methyl protons).^ '* In its '^ C NMR spectrum, characteristic 
signals were observed at 196.8, 58.7, 55.2, 28.6, 27.6 for the carbonyl (C4'), C2', 
C3', methyl carbon atoms of pyranone ring. Signals at S 53.7, 146.7, 106.9, 168.8 
were attributed to C3, C5, C^ , C7 of steroidal skeleton, respectively. Thus, on the 
basis of above discussion compound 110 having m.p. 222-224 *^C has been 
characterized as 2',2'-dimethyl-3yff-chlorocholesta-4,6-dien[7,6-b]-pyran-4'-one. 
Reaction of choIest-5-en-7-one 111 with acetyl chloride; 
6-Acetvlcholesta-4.6-dien-7-ol 112; 
Acetyl chloride ^ 
Pyridine 
111 112 
Cholest-5-en-7-one 111 was dissolved in benzene and to this acetyl 
chloride and pyridine were added and the mixture was heated under reflux for 5-
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7 h. After completion of reaction product 112 was obtained through usual work 
up and column chromatographic purification, m. p. 158-161 ^C, yield 66 %. 
Characterization of compound 112 having m.p. 158-161 "C as 6-
acetylcholesta-4,6-dien-7-oI; 
The compound 112 was analyzed correctly for C29H46O2. Its IR spectrum 
o 
exhibited important absorption bands at 3415 (OH), 1660 (—c—) and 1616 cm"' 
(C=C)." The ' H N M R spectrum of compound 112 displayed two singlets one at 
S 2.29 for three protons of acetyl group and another for one proton at 5.61 (OH) 
exchangeable with D2O). C4 olefmic proton appeared at S 5.59 (J^9.6, 5Hz) as a 
double doublet. Angular and side chain methyl protons were observed at S 1.18 
(C,o-C//i), 0.86 (C,3-Cifj), 0.93, 0.82 (other steroidal side-chain methyl 
protons).^ '* Thus, on the basis of these spectral values, which were compatible 
with compound 112, m.p. 158-161 "C, has been characterized as 6-
acetylcholesta-4,6-dien-7-ol. 
Reaction of 6-acetvlcholesta-4,6-dien-7-ol 112 with pyrrolidine; 
2',2'-DimethvlchoIesta-4,6-dienr7.6-b1-pyran-4'-one 113 : 
Pyrrolidine was added to the solution of compound 112 in dry benzene 
and dry acetone and the mixture was first stirred at room temperature and then 
refluxed using Dean Stark separator. After completion of reaction, usual work 
up, and purification by column chromatography, compound 113 having m.p. 
205-207 ''C was obtained in 57 % yield. 
pyrrolidine 
112 113 
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Characterization of compound 113 having m.p. 205-207 "C as 2',2'-
dimethvlcholesta-4,6-dienf7,6 -bl-pvran-4*-one: 
The product 113 was correctly analyzed for C32H50O2. Its IR spectrum 
0 
exhibited characteristic absorption bands at 1670 (—c—), 1617 (C=C) and 1260 
cm"' (C-O-C).^ ^ The 'H NMR spectrum of compound 113 displayed a one-
proton double doublet at d 5.58 (J=9.6 Hz, 4Hz) for C4-H, a two proton singlet 
for methylene protons of pyranone ring at S 2.45 and another singlet for six 
protons at 1.35 (Cx-l^CHs). Other steroidal methyl signals were observed at 3 
1.17 (C,o-Ci/j), 0.85 (Cj3-Ci/j), 0.93, 0.84 (for side-chain methyl protons).^ ^ In 
its '^ C NMR spectrum, characteristic signals were observed at S 194.5, 60.1. 
58.9, 28.8,29.1 for the carbonyl (C4'), C2', C3', methyl carbon atoms of pyranone 
ring. Signals at S 29.7, 145.9, 107.0, 169.1 were attributed to C3, C5, Cg, C7 of 
steroidal skeleton, respectively. Therefore in accordance with composition and 
spectral properties as discussed, the compound m.p. 205-207 C^ has been 
characterized as 2',2'-dimethylcholesta-4,6-dien-[7,6-b]-pyran-4'-one. 
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All melting points were observed in the capillary tube and are 
uncorrected, infrared (IR) spectra were recorded in KBr pellets with spectrolab 
interspec 2020 FT-IR spectrometer and values are given in cm'. 'H NMR 
spectra were measured on a 300 MHz instrument and '^ C NMR spectra on a 
Bruker Avance II 400 spectrometer at 100 MHz, using TMS as internal standard 
and CDCI3 as solvent. Chemical shift (J) were expressed in ppm downfield from 
internal standard TMS.The abbreviation s, d, dd, m, br denote "singlet, doublet, 
double doublet, multiplet and broad respectively.Thin layer chromatography 
(TLC) plates were coated with silica gel G and exposed to iodine vapours. Pet-
ether refers to a fraction of b. p. 60 - 80 °C. Anhyd.sodium sulphate was used as 
drying agent. 
3^-Hvdoxv-5a. 6/g-dibromocholestane : 
To a solution of cholest-5-en-3y9-ol (cholesterol) (5 g) in diehyl ether (30 ml) 
was added bromine solution (0.9 ml of bromine in 20 ml of glacial acetic acid 
containing 0.2 g of anhydrous sodium acetate) with stirring. The solution turned 
yellow and promptly set to a stiff paste of bromide. The mixture was cooled in 
an ice bath and stirred with a glass rod to ensure complete crystallization. The 
product was then collected by filteration under suction and washed with cold 
diethyl ether-acetic acid mixture (3: 7) until the filfrate was completely 
colourless (6.9 g), m. p. 112-113 °C (reported^^ m. p. 113 "C). 
5a. 6/g-Dibromocholestan-3-one : 
3/?-Hydoxy-5a, 6/?-dibromocholestane (6.9 g) was suspended in acetone 
(150 ml) in a three-necked round bottom flask fitted with a stirrer and dropping 
fiinnel. The suspension was stirred for 5 min. and Jone's reagent^ ^ (10 ml) was 
then added in drops from dropping ftinnel in 15 min. The temperature of reaction 
mixture, during oxidation was maintained between 0-5 °C by external cooling. 
After the complete addition, stirring was continued for 15 min. and cold water 
(200 ml) was added. The product was collected on a Buchner fiinnel and washed 
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thoroughly with water and methanol and air-dried (5 g), m. p. 73-75 C 
(decomposed) (reported^^ m. p. 73-75 "C). 
Cholest-5-en- 3- one 102 : 
The moist 5a, 6p-dibromocholestan-3-one (5.0 g) was dissolved in diethyl 
ether (100 ml) and glacial acetic acid (2.5 ml), zinc dust (7.5 g) was added in 
small portions during 30 min. with continous shaking. After the complete 
addition, the ethereal solution containing suspended zinc dust was filtered, 
washed with water, sodium bi carbonate solution (5%) and water and dried 
(anhydrous sodium sulphate). The oily residue thus obtained after the 
evaporation of the solvent was crystallized fi-om methanol to give the desired 
product 102 (3.3 g), m. p. 126-127 °C (reported^^ m. p. - 129 "C). 
2-Acetvlcholesta-2.5-dien-3-ol 103 : 
Cholest-5-en-3-one 102 (2 g, 5.2 mmol) was dissolved in benzene (25 ml) 
followed by the addition of acetyl chloride (0.41 ml, 5.2 mmol) and pyridine 
(0.39 ml, 5.2 mmol). The mixture was refluxed for 6 h. till the completion of 
reaction, which was monitored by TLC. After the completion of reaction the 
solvents were distilled out under reduced pressure. The residue was taken in 
diethyl ether, washed with water and organic layer was dried over anhydrous 
sodium sulphate. Solvent was evaporated under reduced pressure and the crude 
product obtained was purified by column chromatography over a silica gel 
(mesh 60-120) column, using pet.ether-diethyl ether (1:1) as an eluant. 
Recrystallization from methanol afforded the desired 2-acetylcholesta-2,4-dien-
3-ol 103 having m. p. 169 °C, yield 67 %. 
Analysis found 
C29H46O2 requires 
IR(KBr) 
^HNMR (CDCI3) 
C, 81.63; H, 10.87. 
C, 81.64; H, 10.88% 
Vmax3450 (OH), 1650 (C=0), 1620 cm-* (C=C). 
S 5.45 (s, IH, C4-H), 5.1(s, IH, OH, 
exchangeable with D2O) 2.32 (s, 3H, -CO-
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CH3), 1.95 (s, 2H, C, - / / , ) , 1.14 (s, 3H, C,o-
CH3), 0.74 (s, 3H, C13-CH3), 0.93, 0.82 (other 
steroidal side-chain methyl protons). 
2,2'-Diinethvlcholesta-2,4-dienr3.2 -b1-pvran-4'"One 104 : 
A solution of 2-acetylcholesta-2,5-dien-3y8-ol 103 (1 g, 2.3 mmol), 
pyrrolidine (0.19 ml, 2.3 mmol), and dry acetone (0.16 ml, 2.3 mmol) in dry 
benzene 25 ml was first stirred at room temperature for 15 min. and then it was 
refluxed using a Dean Stark separator for about 54 h. Progress of the reaction 
was monitored by TLC. After the completion of reaction, the reaction mixture 
was acidified with dilute HCl and organic layer was taken in diethyl ether. It was 
washed with water, NaHCOa solution (5%), and again with water. Solvents were 
removed under reduced pressure and the residue was chromatographed over 
silica gel column using hexane-diethyl ether (10:1) as eluant which afforded a 
solid compound,2',2'-dimethylcholesta-2,4-dien[3,2-b]-pyran-4'-one 104, m. 
p.l88°C, yield 53%. 
C, 82.30; H, 10.83. 
C, 82.35; H, 10.80% 
v„ax 1665 (C=0), 1610 (C=C), 1145 cm"' (C-O-C). 
S 5.25 (s, 2H, C4-H), 3.41 (s, 2H, Cy-H2), 1.86 (s, 
2H, C,-i/2), 1-36 (br s, 3H, C^ - Ci/jx2), 1.16 (s, 
3H, Cio-€//i), 0.75 (s, 3H, C,3-C//j), 0.91, 0.83 
(other steroidal side-chain methyl protons). 
S 28.10 (Ci), 106.42 (C2), 157.03 (C3), 123.04 
(C4), 149.23 (C5), 36.10 (C6), 35.78 (C7), 30.72 
(Cg), 46.80 (C9), 41.09 (C,o), 24.04 (C,,), 36.95 
(C,2), 43.05 (C13), 56.10 (C,4), 23.99 (€,5), 23.86 
(C,6), 53.98 (C,7), 13.20 (Cg), 12.07 (€,9), 21.47 
(C20), 18.73 (C21), 37.98 (C22), 28.05 (C23), 30.07 
(C24), 39.52 (C25), 22.80 (C26), 22.65 (C27), 191.21, 
Analysis found 
C32H50O2 requires 
IR(KBr) 
*HNMR(CDCl3) 
13 C NMR (CDCI3) 
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56.81, 56.85, 27.9, 28.03 ( carbonyl, Cr, Cy, 
2XCH3 carbons of pyranone ring). 
3j0-Acetoxycholest-5-ene : 
A mixture of cholesterol (100 g), pyridine (150 ml) and acetic anhydride 
(100 ml) was heated on a water bath for 2 h. The reaction mixture was poured 
into ice-cooled water and the solid thus obtained was filtered under suction, 
washed thoroughly with water and air-dried. Recrystallization of the crude 
product from acetone gave 3y5-acetoxycholest-5-ene (95 g), m. p. 113-114 C 
(reported" m. p. 115-116 °C). 
3^-Acetoxvcholest-5-en-7-one 105 : 
To a solution of 3)5-acetoxycholest-5-ene (8 g) in carbon tetrachloride 
(150 ml), acetic acid (30 ml) and acetic anhydride (10 ml) was added at 0 °C a 
solution of /er/-butyl chromate [from tert-h\xty\ alcohol (60 ml), chromium 
trioxide (20 g), acetic acid (84 ml) and acetic anhydride (10 ml)]. The reaction 
was heated under reflux for 4 h. and then it was diluted with cold water. The 
organic layer was taken in diethyl ether, washed with water, sodium bicarbonate 
solution (5 %) and again with water and dried over anhyd. sodium sulphate. 
Evaporation of the solvent under reduced pressure gave an oil which was 
crystallized from methanol to give the ketone 105 (3.5 g), m. p. 156 V 
(reported^* m. p. 156-158 °C). 
6-AcetYl-3^-acetoxvcholesta-4,6-dien-7-ol 106 : 
3y5-Acetoxycholest-5-en-7-one 105 (2 g, 4.5 mmol) was taken in benzene 
(15 ml) then acetyl chloride (0.32 ml, 4.5 mmol) and pyridine (0.34 ml, 4.5 
mmol) were added to the solution. The mixture was heated under reflux for 7 h. 
till the completion of reaction, which was monitored by TLC. After the 
completion of reaction the solvent was distilled out under reduced pressure. The 
residue was taken in diethyl ether and washed with water; organic layer was 
dried over anhydrous sodium sulphate. Solvent was evaporated and the 
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compound obtained was purified by column chromatography over a siHca gel 
(mesh 60-120) column, using pet.ether-diethyl ether (5:1) as eluants. 
Recrystallization from methanol afforded the desired 6-acetyl-3/9-
acetoxycholesta-4, 6-dien-7-ol 106, m. p. 201-203 ''C, yield 63 %. 
Analysis found 
C31H48O4 requires 
IR (KBr) 
C, 76.83; H, 9.88. 
C, 76.82; H, 9.98 % . 
Vmax 3420 (OH) 1735(-OCOCH3), 1665 (C=0), 
1615 cm-' (C=C). 
'H NMR(CDCl3) : S 5.52 (d, IH, C^-H, 7=9.5 Hz), 5.01 (br s. OH, 
exchangeable with D2O), 4.35 (br m. IH. W/_, 
16.5 Hz, axial, C^a-H), 2.39 (s, 3H. CHj of 
acetyl), 2.02 (s, 3H, CH3 of acetate). 1.14 (s. 3H. 
Cio-C/Zj), 0.71 (s. 3H, C,3-C//j). 0.91. 0.84 
(other steroidal side- chain methyl protons). 
2',2'-Dimethvl-3^-acetoxvchoIesta-4,6-dien[7,6-b1-pvran-4'-one 107: 
A solution of 6-acetyl-3yff-acetoxycholesta-4,6-dien-7-ol of 106 (1 g. 2 
mmol), pyrrolidine, (0.17 ml, 2 mmol) and dry acetone (0.14 ml, 2 mmol). in dry 
benzene (10 ml) was first stirred at room temperature, for about 15 min. and then 
it was refluxed using a Dean Stark separator for about 59 h. Completion of 
reaction was monitored by TLC. The reaction mixture was poured into ice 
cooled water, acidified with dil. HCl and extracted with ether. Organic layer was 
washed with water, sodium bicarbonate solution (5 %) and again with water. 
After the removal of solvent, the residue was chromatographed over silica gel 
column. Elution with hexane-diethyl ether (10:1) gave compound 2',2'-dimethyl-
3/5-acetoxycholesta-4.6-dien[7.6-b]-pyran-4'-one 107. m. p. 211-213 "C. yield 
56 %. 
Analysis found : C. 77.81; H, 9.96. 
C34H52O4 requires : C. 77.82; H, 9.99% 
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IR(KBr) 
'HNMRCCDCb) 
*^CNMR(CDCl3) 
: v„ax 1739( -c - of acetate), 1665 (C=0), 1612 
(C=C), ll47cm-'(C-0-C). 
: d 5.83 (d, IH, C^-H, 7=10.0 Hz), 3.32 (s, 2H, €3^ 
H2), 4.32 (m, IH, Wi/2 15 Hz, axial, Q^a-H), 2.01 
(s, 3H, OCOCH3), 1.32 (s, 6H, Cj-l^CHs), 1.15 
(s, 3H, C,o-Ci/j), 0.70 (s, 3H, C,3-C//,), 0.91,0.82 
(other steroidal side-chain methyl protons). 
: 6 32.6 (Ci), 34.9 (C2), 74.9 (C3), 126.8 (C4), 147.3 
(C5), 106.3 (Ce), 169.2 (C7), 30.4 (Cg), 36.5 (C9), 
36.8 (Co), 21.4 (C„), 33.6 (C^), 41.2 (Co), 49.1 
(C14), 21.6 (Cs), 21.8 (Cie), 40.5 (Cn), 21.5 (C.g), 
20.4 (C19), 29.5 (C20), 19.2 (C2,), 36.4 (C22), 27.4 
(C23), 40.3 (C24), 28.5 (C25), 22.6 (C26), 23.4 (C27), 
172.1, 17.9, (carbonyl and CH3 of acetate) 198.2 , 
59.7, 56.0, 28.5, 29.2 ( carbonyl, Cr, Cy, 2XCH3 
carbons of pyranone ring). 
3^-Chlorocholest-5-ene : 
Freshly purified thionyl chloride (20 ml) was added gradually to 
cholesterol (25 g) at room temperature. A vigorous reaction ensued with the 
evolution of gaseous products. When the reaction slackened, the mixture was 
gently heated at a temperature of 50-60 ^C on a water bath for 1 h., and then 
poured mto cold water with stirring. The yellow solid thus obtained was filtered 
under suction, washed thouroughly with cold water and air-dried. 
Recrystallization fi-om acetone gave Syfl^ -chlorocholest-S-ene (23.5 g), m. p. 95 ^ C 
j 5 9 (reported'^ m. p. 96-97 T ) . 
3^-Chlorocholest-5-en-7-one 108 : 
A solution of t-butyl chromate [t-butyl alcohol (60 ml), CrOs (20 g), 
acetic acid (35 ml) and acetic anhydride (10 ml)] was added at 0 °C to a solution 
of 3>S-chlorocholest-5-ene (8 g) in CCI4 (150 ml), acetic acid (30 ml) and acetic 
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anhydride (10 ml). The contents were refluxed for 3 h. and then it was washed 
with NaHCOs solution (5 %) and water and dried (Na2S04). Evaporation of the 
solvents under reduced pressure furnished the ketone as an oil which was 
crystallized from methanol to give 3/?-chlorocholest-5-en-7-one (3.3 g), m.p. 
144 "C (reported^^ m. p. 144-145 "C). 
6-Acetvl-3^-chlorocholesta-4,6-dien-7-ol 109; 
A mixture of 3yS-chlorocholest-5-en-7-one 108 (2 g, 4.8 mmol) in 
benzene (25 ml) acetyl chloride (0.31 ml, 4.8 mmol) and pyridine (0.34 mi, 4.8 
mmol), was refluxed for 7 h. till the completion of reaction, which was 
monitored by TLC. The solvents were distilled out under reduced pressure. The 
residue was taken in diethyl ether and washed thoroughly with water and 
organic layer was dried over anhydrous sodium sulphate. Removal of the solvent 
gave an oil which was chromatographed over silica gel (mesh 60-120) column 
using pet.ether-diethyle ther (1:1) as an eluant. Recrystallization from methanol 
afforded the desired product 6-acetyl-3/?-chlorocholesta-4,6-dien-7-ol 109, 
m. p. 179-181 ^ C, yield 61 %. (Beilstein Positive) 
Analysis found : C, 75.57; H, 9.86. 
C29H45CIO2 requires : C, 75.54; H, 9.84 % 
o 
m (KBr) : v^ ax 3400 (OH), 1642 ( - c - ) , 1620 (C=C), 750 
cm-' (C-CI). 
^HNMRCCDCIa) : S 5.55 (d, IH, C4-H, 7=9.55 Hz), 5.29 (s, OH, 
exchangeable with deuterium), 2.35 (s, 3H, CH3 
of acetyl), 3.98 (br m, IH, W1/2 14.6 Hz, axial, 
C^a-H), 1.16 (s, 3H, C,o-C^j), 0.73 (s, 3H, €,3-
CH3), 0.92, 0.85 (other steroidal side-chain 
methyl protons). 
2', 2'-Dimethvl-3^-chlorocholesta-4,6-dienr7.6-bl-pvran-4'-one 110: 
A solution of 6-acetyl-3^-chlorocholesta-4,6-dien-7-ol 109 (1 g, 2.1 
mmol), in dry benzene containing pyrrolidine, (0.18 ml, 2.1 mmol) and dry 
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acetone(0.15 ml, 2.1 mmol), was first stirred at room temperature, for few min. 
and then it was refluxed using a Dean Stark separator for about 50 h. The 
progress of the reaction was monitored by TLC. The reaction mixture was 
acidified with dilute HCl and extracted with diethyl ether. The ethereal solution 
was washed with water, NaHCOs solution (5 %) and finally with water and dried 
over anhyd. Na2S04. After removal of solvent the residue was purified by 
column chromatography over silica gel column using hexane: diethyl ether (5:1) 
as an eluant. Recrystallization from methanol provided 2',2'-dimethyl-3/?-
chlorocholesta-4,6-dien[7,6-b]-pyran-4'-one 110, m.p. 222-224 V , yield 56 
%.. (Beilstein positive) 
: C, 76.71; H. 9.87. 
: C. 76.69; H. 9.85 %. 
Analysis found 
C32H49O2CI requires 
IR (KBr) 
' H N M R (CDCis) 
^^ C NMR (CDCI3) 
v^a, 1652 ( - C - ) , 1620 (C=C), 1141 (C-O-C). 
740 cm"' (C- CI). 
S 5.62 (d, IH, C4-//, J=9.7 Hz), 4.1 (br m. IH, 
Wi,2 15 Hz, axial, C^a-H), 3.4 (s, 2H, C3. - / / , ) , 
1.26 (s, 6H, Cr-lxCHj), 1.16 (s, 3H. Cio-C//^), 
0.81 (s, 3H, C,3-C//3), 0.93, 0.82 (other steroidal 
side-chain methyl protons). 
S 33.5 (C). 36.2 (C2), 53.7 (C3). 125.6 (C4). 
146.7 (Cs), 106.9 (Ce), 168.8 (C7), 29.8 (Cg). 37.2 
(C9), 33.9 (Co), 21.7 ( C ) , 34.2 (C,,), 42.6 (C,3K 
48.9 (C,4), 21.3 (C,5), 21.9 (C,6). 41.8 (C,;). 
22.6 (C.g), 21.6 (C,9), 30.8 (C20), 20.9 (C2,), 37.2 
(C22). 28.9 (C23). 41.7 (C24). 30.7 (C25). 23.2 
(C26). 22.9 (C27). 196.8 . 58.7. 55.2. 28.6. 27.6 
(carbonyl. C2-. Cy. 2XCH3 carbons of pyranone 
ring). 
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Cholest-5-ene : 
3y5-Chlorocholest-5-ene (40 g) was dissolved in warm amyl alcohol (920 
ml) and sodium metal (80 g) was added to the solution with continous stirring 
over a period of 8 h. The reaction mixture was warmed occasionally. When all 
the sodium metal was dissolved, the reaction mixture was poured into water, 
acidified with hydrochloric acid and then allowed to stand overnight. A white 
crystalline solid thus obtained was filtered under suction and washed thoroughly 
with water and air-dried. The crude material was recrystallized from acetone to 
provide cubic crystals of cholest-5-ene (34 g), m. p. 94 °C (reported '^ m. p. 89-
91 V). 
Cholest-5-en-7-one 111; 
A solution of t-butyl chromate [t-butyl alcohol (60 ml), CrOs (20 g), 
acetic acid (84 ml) and acetic anhydride (10 ml)] were added at 0 '^ C to a 
solution of cholest-5-ene (8 g) in CCI4 (150 ml), glacial acetic acid (30 ml) and 
acetic anhydride (10 ml). The contents were refluxed for 3 h and then diluted 
with water. The organic layer was washed with NaHCOs solution (5 %) and 
water, and dried (Na2S04). Evaporation of the solvents under reduced pressure 
provided cholest-5-en-7-one as an oil which was crystallized from methanol to 
give cholest-5-en-7one 111 (3.1 g), m.p. 128 °C (reported '^ m. p. 125 - 129 °C). 
6-Acetvlcholesta-4,6-dien-7-ol 112 : 
To a solution of cholest-5-en-7-one 111 (2 g, 5 mmol) in benzene (10 ml), 
acetyl chloride (0.36 ml, 5 mmol) and pyridine (0.38 ml, 5 mmol) were added. 
The mixture was refluxed for 6 h. till the completion of reaction, which was 
monitored by TLC. After the completion of reaction the solvents were distilled 
out under reduced pressure. The residue was taken in diethyl ether and washed 
with water; organic layer was dried over anhyd. Na2S04. After the evaporation 
of solvents the residue was chromatographed over silica gel (mesh 60-120) 
column using pet.ether-diethyl ether(l:l) as an eluant, recrstallization from 
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methanol afforded the desired product 6-acetylcholesta-4,6-dien-7-ol 112. m.p. 
158-161 V yield 66%. 
Analysis data : C, 81.65; H, 10.88. 
C29H46O2 requires : C, 81.63; H, 10.87% 
0 
IR(KBr) : v„ax3415 (OH), 1660 ( - c - ) , 1616 cm"' (C=C). 
*H NMR (CDCI3) : 5 5.59 (dd, IH, C4-//, J=9.6 Hz, 5 Hz), 5.61 (s, 
OH, exchangeable with deuterium), 2.29 (s. 3H. 
CH3 of acetyl), 1.18 (s, 3H, Cio-C/fj). 0.86 (s, 
3H, Cn-CHj), 0.93, 0.82 (other steroidal side-
chain methyl protons). 
2',2'-Dimethvlcholesta-4,6-dienr7,6-bl-pvran-4'-one 113 : 
A mixture of 6-acetylcholesta-4,6-dien-7-ol of 112 (1 g, 2.3 mmol). 
pyrrolidine, (0.20 ml, 2.3 mmol) and dry acetone(0.16 ml, 2.3 mmol). in dr>' 
benzene (5 ml) was first stirred at room temperature, for some time and then it 
was heated under reflux using a Dean Stark separator for about 51 h., after 
completion of reaction (monitored by TLC), reaction mixture was poured into 
ice-cooled water, acidified with dil. HCl and extracted with diethyl ether. 
Organic layer was washed with water, NaHC03 solution (5 %), finally with 
water, and dried over anhyd. Na2S04. The solvents were removed under reduced 
pressure, and the residue obtained was chromatographed over silica gel column. 
The elution with hexane-diethyl ether (10:1) gave desired product. 2'.2'-
dimethylcholesta-4,6-dien[7,6-b]-pyran-4'-one 113, m. p. 205-207 °C yield 
57 %. 
Analysis found : C. 82.34; H, 10.82. 
Q1H50O2 requires : C. 82.35; H. 10.80%. 
0 
IR(KBr) : v,„,, 1670 ( - c - ) . 1617 (C=C). 1260 cm"' 
(C-O-C). 
^HNMRfCDCb) : '^ ^5^ (dd. IH. C,-H. .7=9 6 Hz. 4H/). 2.4-- (v 
2H, C3. - H2), 1.35 (s, 6H. C2- - 2xCHj), 1.17 (s. 
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3H, C,o - CH3), 0.85 (s, 3H, C,3 - C//j), 0.93, 
0.84 (other steroidal side-chain methyl protons). 
"CNMR(CDCl3) : S 35.2 (C,), 30.2 (C2), 29.7 (C3), 125.4 (C4), 
145.9 (C5), 107.0 (Cg), 169.1 (C7), 30.5 (Cg), 38.0 
(C9), 32.1 (Co), 20.3 (Cn). 35.4 (C,,), 41.6 (Cn), 
47.9 (CH), 21.8 (C,5), 21.3 (C.e)- 42.7 (Cp), 20.8 
(C,8), 20.9 (C,9). 31.5 (C20), 18.9 (C.,), 35.9 
(C22), 26.9 (C23), 42.3 (C24), 28.7 (C25), 22.8 
(C26), 23.1 (C27), 194.5 , 60.1, 58.9, 28.8, 29.1 ( 
carbonyl, C2-, €3-, 2XCH3 carbons of pyranone 
ring). 
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